Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3000067	fp-pth	ng/l (ng/l)	25111	102560	0.00%
3000067	fp-pth	— (—)	6719	13399	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Depression medications

1223

1606

3.99

323.31

3.6

2.5

77.64

65.62

ng/l

3.02

1090

1448

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

702

1519

6.04

323.01

3.4

3.6

48.23

84.48

ng/l

36.65

634

1307

Azathioprine

1111

3298

3.82

320.05

9.3

3.9

108.03

86.87

ng/l

5.07

1039

2884

Nutritional anaemias

3032

14323

2.21

318.62

4.8

3.6

111.50

89.58

ng/l

16.30

2545

12204

Cerebrovascular diseases (FINNGEN)

1685

4314

2.98

317.66

5.3

2.2

107.80

63.73

ng/l

45.49

1488

3743

Obesity and other hyperalimentation

3374

16852

2.09

315.89

4.6

3.9

104.18

85.56

ng/l

18.14

2947

14762

Ulcer of lower limb, not elsewhere classified

1140

3513

3.83

315.68

8.0

3.6

153.69

93.77

ng/l

26.70

1016

2941

Obesity

3355

16767

2.09

314.26

4.6

3.9

104.32

85.50

ng/l

18.39

2933

14691

Thyrotoxicosis, other and/or unspecified

1374

4719

3.26

310.37

3.3

3.6

66.36

89.81

ng/l

19.06

1216

4037

Hyperkalaemia

567

1053

7.04

308.58

8.8

3.3

178.88

96.76

ng/l

18.10

503

875

Benign neoplasm of colon, rectum, anus and anal canal

3224

11308

2.17

308.13

4.6

3.8

101.31

91.38

ng/l

6.26

2809

9606

Oedema, not elsewhere classified

1972

8094

2.64

307.82

5.1

3.5

110.37

88.01

ng/l

14.43

1716

6883

Chronic kidney disease

6517

6177

19.76

307.65

9.9

2.1

162.00

72.71

ng/l

307.65

5939

5047

Diabetes, insulin treatment (Kela reimbursement)

5973

19445

1.97

307.65

5.1

3.5

109.52

83.83

ng/l

47.20

5169

16818

Cardiovascular diseases

3129

6313

2.83

307.65

6.0

2.5

96.13

60.59

ng/l

52.73

2847

5616

Insulin medication

4136

14406

2.66

307.65

6.4

3.7

129.97

86.11

ng/l

72.64

3611

12403

Insulin, fast-acting

2598

9462

3.04

307.65

7.2

3.8

138.26

85.57

ng/l

58.41

2290

8175

Disorders of calcium metabolism

1332

1306

22.07

307.65

6.2

3.3

83.65

86.40

ng/l

0.28

1144

1108

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5729

17994

2.05

307.65

5.2

3.5

109.69

82.12

ng/l

51.18

4966

15567

Insulin, combination of fast acting with intermediate-acting or long-acting

4142

16545

2.50

307.65

6.4

3.7

129.91

87.73

ng/l

68.29

3614

14219

Hypertension

5478

10419

3.22

307.65

6.4

2.4

114.29

66.15

ng/l

132.36

4908

9028

Autoimmune diseases

6285

17149

1.95

307.65

5.2

3.5

101.55

85.06

ng/l

22.28

5527

14882

Viral Sepsis

1522

4644

3.77

307.65

7.6

3.2

126.23

83.10

ng/l

30.48

1353

3910

Erysipelas

3229

14118

2.22

307.65

5.4

3.3

122.14

84.70

ng/l

47.37

2804

11965

Other heart diseases, wide

5062

16469

1.99

307.65

5.1

3.7

107.10

78.72

ng/l

48.74

4453

14407

Inflammatory bowel disease treatment related agents

6774

20338

1.98

307.65

4.6

3.8

93.28

89.28

ng/l

2.08

5990

17526

Explicit Sepsis

3083

11030

2.96

307.65

7.6

3.3

142.46

83.24

ng/l

74.28

2721

9347

Pneumonias (Asthma/COPD co-morbidities)

5740

21318

1.96

307.65

5.4

3.6

110.24

82.91

ng/l

46.49

5048

18471

Other metabolic disorders

1297

2795

5.71

307.65

4.4

3.1

56.49

79.29

ng/l

19.21

1143

2402

ILD medications

7426

18377

2.35

307.65

5.9

3.1

105.33

82.46

ng/l

44.39

6647

15723

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5329

17185

2.04

307.65

5.2

3.4

109.42

82.55

ng/l

41.81

4685

14833

ILD medications: azathioprine

1111

3061

4.13

307.65

9.3

3.2

108.03

81.20

ng/l

7.79

1039

2649

Hypothyroidism (congenital or acquired)

1729

1557

6.93

307.65

4.1

2.6

74.38

65.58

ng/l

1.91

1542

1400

Renal failure

7679

9028

11.81

307.65

8.8

2.1

151.75

71.95

ng/l

307.65

6952

7412

Infections, IBD-co-morbidities

1236

1647

6.16

307.65

7.2

3.2

124.19

79.87

ng/l

23.67

1120

1434

Dental caries

2155

5794

4.23

307.65

10.2

3.4

141.73

83.46

ng/l

55.04

1990

5053

Hypertensive diseases (excluding secondary)

3851

6097

4.02

307.65

6.9

2.3

114.52

62.91

ng/l

102.40

3483

5380

ILD medications: prednisolone, methylprednisolone, prednisone

7329

18186

2.42

307.65

6.0

3.1

105.63

82.79

ng/l

44.51

6549

15545

Other bacterial diseases

6527

19435

2.50

307.65

6.2

3.3

120.97

80.72

ng/l

101.08

5763

16695

Congenital malformations of the urinary system

906

1261

11.28

307.65

12.2

4.2

148.58

79.03

ng/l

34.24

856

1124

Other heart diseases

2769

6199

3.15

307.65

6.0

2.5

113.51

62.43

ng/l

76.12

2484

5480

Codeine

5262

14982

2.01

307.65

3.9

3.7

91.34

87.84

ng/l

1.40

4609

12940

Dialysis

1186

638

88.59

307.65

16.5

2.6

212.36

62.01

ng/l

127.99

1131

576

Bacterial Sepsis

3541

10868

3.26

307.65

6.7

3.3

134.66

84.89

ng/l

71.80

3113

9170

Glomerular diseases

3307

4087

13.40

307.65

11.1

3.3

161.74

84.29

ng/l

112.72

3079

3504

Cystic kidney disease

725

693

25.31

307.65

12.9

4.0

159.13

81.53

ng/l

31.85

688

625

Hypertensive Renal Disease

678

552

22.69

307.65

10.7

2.1

174.66

68.00

ng/l

43.83

625

456

Hypothyreosis and Thyroxine purchase for inclusion criteria

5628

18856

2.08

307.65

3.7

3.8

77.04

93.11

ng/l

30.56

4837

16320

Osteopathies and chondropathies

4226

15354

2.90

307.65

4.5

3.7

93.12

88.80

ng/l

1.51

3626

13153

Any gastric operation

4704

10297

2.40

307.65

4.9

2.8

94.10

76.85

ng/l

20.70

4162

8821

Heart failure,strict

3695

9711

3.04

307.65

5.7

2.6

135.67

71.55

ng/l

162.38

3235

8103

Other septicaemia

2784

9797

3.12

307.65

7.8

3.3

146.26

85.07

ng/l

68.45

2460

8254

All-cause Heart Failure

3847

12487

2.42

307.65

5.6

3.5

135.51

85.99

ng/l

100.66

3353

10485

Other soft tissue disorders, not elsewhere classified

5311

16843

2.04

307.65

4.0

90.69

90.03

ng/l

0.17

4631

14570

Renal tubulo-interstitial diseases

9282

16542

5.07

307.65

7.3

2.3

132.52

67.44

ng/l

307.65

8299

14046

Codeine or tramadol medication

6284

20363

1.78

307.65

3.9

91.94

90.96

ng/l

0.28

5485

17579

Hyperparathyroidism

3745

4954

13.41

307.65

7.7

2.8

132.80

84.08

ng/l

67.19

3265

4094

Certain disorders involving the immune mechanism

1440

4906

3.34

307.65

7.2

3.8

111.09

87.64

ng/l

9.62

1323

4255

Hypoparathyroidism

528

827

10.17

307.65

5.0

3.0

57.17

78.76

ng/l

5.56

426

703

Other nutritional deficiencies

3658

17288

2.19

307.65

4.6

3.8

102.31

85.42

ng/l

16.68

3181

15157

Insulin, fast-acting or short human

2610

10034

2.86

307.65

7.2

3.8

138.06

87.61

ng/l

54.20

2300

8653

Continuous positive airway pressure

1297

3315

3.74

307.65

5.8

3.6

110.34

74.23

ng/l

27.20

1161

2913

Care involving use of rehabilitation procedures

3772

17262

2.20

307.65

5.3

2.8

99.58

76.01

ng/l

28.61

3384

14735

Heart failure, not strict

6760

13896

3.84

307.65

7.5

2.6

138.67

69.70

ng/l

273.05

6017

11808

Insulin, intermediate and long-acting

3827

15345

2.68

307.65

6.3

3.7

128.83

87.98

ng/l

61.72

3341

13188

ILD medications: immunosuppressive drugs

4587

15759

3.06

307.65

8.0

3.2

117.68

80.81

ng/l

59.69

4205

13532

Implicit bacterial Sepsis

3233

9720

3.47

307.65

6.7

3.2

136.66

85.76

ng/l

67.10

2844

8155

Disorders of lipoprotein metabolism and other lipidaemias

5206

14473

2.42

307.65

5.3

3.3

109.80

86.44

ng/l

38.26

4549

12375

Statin medication

3787

10310

2.16

307.65

5.7

2.8

108.34

74.05

ng/l

53.41

3377

8861

Hypothyroidism, levothyroxine purchases

1711

1550

6.90

307.65

3.9

2.6

72.37

65.67

ng/l

1.29

1527

1393

Pain in limb

4642

16411

2.16

307.65

4.1

3.9

93.43

90.38

ng/l

1.11

4050

14185

Cardiovascular diseases (excluding rheumatic etc)

3637

7356

3.02

307.65

6.2

2.5

100.44

61.05

ng/l

71.96

3307

6539

Transplanted organ and tissue status

2062

1975

21.26

307.65

14.4

3.2

179.71

77.24

ng/l

117.45

1966

1744

Certain infectious and parasitic diseases

5615

15171

1.93

307.65

5.0

3.1

100.83

78.43

ng/l

35.07

4951

13064

Other disorders of skin and subcutaneous tissue

4154

19604

2.06

307.65

5.7

3.5

115.62

87.38

ng/l

35.28

3656

16724

Disorders of thyroid, IBD co-morbidities

1477

1839

6.60

307.65

3.4

3.0

67.05

78.47

ng/l

4.75

1314

1605

Diseases of oesophagus, stomach and duodenum

6159

20240

1.94

307.65

4.3

3.8

95.80

89.08

ng/l

4.58

5303

17578

All pneumoniae

5775

21427

1.95

307.65

5.4

3.7

110.19

83.56

ng/l

44.29

5078

18581

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1244

2583

6.01

307.65

4.3

3.1

55.55

79.38

ng/l

19.89

1095

2217

Sub-endpoint used in defining T1D endpoints

1943

7576

2.74

307.65

8.1

3.9

146.21

88.03

ng/l

47.81

1735

6564

Metabolic disorders

7460

16233

3.13

307.65

5.3

3.3

100.64

84.35

ng/l

23.15

6523

13996

Dyspnoea

5147

21257

1.95

307.65

4.3

3.8

102.39

87.98

ng/l

17.07

4430

18351

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2979

9126

3.80

307.65

3.7

3.8

62.52

89.03

ng/l

48.56

2668

7839

Hypothyroidism, drug reimbursement

1449

1110

10.97

307.65

3.8

2.4

61.07

68.73

ng/l

1.31

1301

977

Hypertensive Heart Disease

1457

3813

3.44

307.65

6.2

2.2

137.87

70.81

ng/l

68.16

1259

3133

Type 1 diabetes, wide definition, subgroup 1

1497

4494

3.71

307.65

8.0

3.9

145.69

80.81

ng/l

42.95

1338

3967

Gout

2338

6058

4.08

307.65

7.4

3.7

145.04

97.93

ng/l

45.90

2066

5123

Secondary hypertension

1616

1154

24.81

307.65

12.2

2.3

171.32

62.91

ng/l

104.61

1486

1002

Polyarthropathies

4584

12608

2.60

307.65

5.7

3.8

115.55

88.70

ng/l

33.57

4032

10927

Influenza and pneumonia

6080

21225

1.97

307.65

5.3

3.6

109.40

82.66

ng/l

46.93

5358

18398

Hypothyroidism, other/unspecified

5433

17683

2.14

307.65

3.7

3.9

76.78

94.08

ng/l

34.51

4678

15319

Abnormalities of breathing

5195

15343

2.11

307.65

4.3

3.9

98.65

85.77

ng/l

12.97

4510

13360

Fever of other and unknown origin

3337

13303

2.48

307.65

6.1

3.6

110.09

86.53

ng/l

19.27

2968

11457

Malaise and fatigue

3336

11217

2.69

307.65

4.3

3.5

101.10

87.77

ng/l

7.56

2840

9559

Type 1 diabetes, wide definition

1533

4977

3.40

307.65

8.1

3.9

146.65

81.50

ng/l

44.70

1372

4379

Pain in throat and chest

4606

14854

1.98

307.65

4.0

3.8

91.80

86.92

ng/l

2.33

3987

12901

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

7300

20332

2.80

307.65

5.8

3.4

112.05

82.44

ng/l

70.20

6413

17526

Pneumonia, organism unspecified

5168

19950

1.97

307.65

5.3

3.6

111.22

83.48

ng/l

46.54

4507

17251

Hypertension, essential

5165

10127

3.14

307.65

5.6

2.3

111.62

66.60

ng/l

115.24

4583

8747

Gout, idiopatic and unspecified

1960

6130

3.73

307.65

7.3

3.8

146.44

95.91

ng/l

43.95

1723

5197

Hypothyroidism and >3 levothyroxin purchases

1711

1550

6.90

307.65

3.9

2.6

72.37

65.67

ng/l

1.29

1527

1393

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1261

3685

3.80

307.65

10.4

4.3

129.00

82.46

ng/l

28.67

1178

3260

Other disorders involving the immune mechanism, not elsewhere classified

587

601

19.12

307.65

11.4

4.8

149.68

82.50

ng/l

19.68

551

536

Type 2 diabetes

5668

17763

1.99

307.65

5.0

3.3

108.46

82.54

ng/l

47.44

4915

15331

Non-invasive ventilation

1568

3883

4.24

307.65

5.4

3.3

104.78

74.08

ng/l

15.89

1459

3401

5329

17185

2.04

307.65

5.2

3.4

109.42

82.55

ng/l

41.81

4685

14833

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

6229

19141

2.36

307.65

7.1

3.0

123.12

77.71

ng/l

120.41

5467

16647

Dentinal caries

1900

5153

4.22

307.65

10.0

3.4

146.21

83.25

ng/l

53.05

1748

4490

L04AD Calcineurin inhibitors

2015

2221

16.33

307.65

13.7

3.5

164.83

79.29

ng/l

89.78

1920

1968

Nephrotic syndrome

596

628

18.49

307.65

12.9

4.2

136.89

73.52

ng/l

21.38

570

565

Complications of surgical and medical care, not elsewhere classified

5825

21777

2.02

307.65

5.2

3.6

107.81

86.64

ng/l

27.81

5104

18740

Bacterial infection, other or unspecified

3746

13371

2.78

307.65

6.8

3.3

130.30

83.84

ng/l

73.62

3309

11312

Used for control exclusion in common control thyroid runs

6483

14633

2.37

307.65

4.8

3.6

94.45

88.85

ng/l

3.33

5732

12661

Hypertensive diseases

5478

10425

3.22

307.65

6.4

2.4

114.27

66.13

ng/l

132.33

4908

9034

Complications of procedures, not elsewhere classified

4495

21182

1.92

307.65

5.0

3.6

105.15

86.40

ng/l

17.88

3944

18204

Tramadol

5017

14265

2.40

307.65

4.6

3.7

101.07

88.95

ng/l

10.45

4369

12281

GASTRO-related operations

4704

10297

2.40

307.65

4.9

2.8

94.10

76.85

ng/l

20.70

4162

8821

Septicaemia

3026

10787

3.00

307.65

7.7

3.3

143.93

84.68

ng/l

72.07

2672

9106

Glomerulonephritis

1448

2235

9.52

307.65

10.9

3.9

149.77

87.60

ng/l

31.51

1357

1950

Acute renal failure

2440

4084

7.93

307.65

7.5

2.1

142.46

72.59

ng/l

87.88

2203

3345

Implicit viral Sepsis

1518

4640

3.77

307.65

7.6

3.2

126.29

83.14

ng/l

30.40

1350

3906

Glomerular disorders in diseases classified elsewhere

2444

2457

19.96

307.65

11.6

3.3

172.99

87.93

ng/l

91.67

2280

2123

Disorders resulting from impaired renal tubular function

948

769

48.48

307.65

15.8

4.0

213.85

85.00

ng/l

65.65

890

688

Diabetic nephropathy, excluding more controls

2058

2988

8.44

307.65

10.4

3.3

175.81

86.35

ng/l

100.00

1873

2530

Deposits [accretions] on teeth

733

1395

6.44

307.65

12.7

3.6

127.90

78.56

ng/l

15.03

693

1259

Gout, unspecified

1636

4853

3.97

307.65

7.3

3.7

147.42

95.60

ng/l

37.20

1436

4108

Disorders of other endocrine glands

5325

11211

5.83

307.65

6.7

3.3

115.95

81.96

ng/l

52.49

4628

9662

Acute tubulo-interstitial nephritis

3986

13543

2.83

307.65

5.8

2.3

115.21

68.39

ng/l

94.72

3476

11408

Other disorders of fluid, electrolyte and acid-base balance

2288

7350

3.40

307.65

5.6

3.1

120.02

86.95

ng/l

23.01

1941

6175

IgA nephropathy (IgA glomerulonephritis)

527

433

29.69

307.65

12.2

4.2

154.65

85.33

ng/l

17.42

500

388

Nephropathy related operations

2929

2652

26.37

307.65

15.5

2.9

208.58

79.88

ng/l

220.24

2777

2307

Carbimazole or st.post thyroidectomy, condition for graves disease

2061

5284

4.75

307.65

3.2

3.6

51.31

87.36

ng/l

82.42

1870

4515

Other disorders of kidney and ureter

1507

3159

6.39

307.65

12.3

3.5

180.97

89.30

ng/l

67.05

1385

2689

Persons encountering health services for specific procedures and health care

7366

19400

2.51

307.65

6.9

2.8

121.22

75.03

ng/l

145.78

6607

16658

Other and unspecified anaemias

3026

11614

2.80

307.65

5.7

3.4

122.82

90.20

ng/l

32.36

2630

9741

Diabetic nephropathy

2073

4229

7.00

307.65

10.4

3.6

175.51

93.70

ng/l

88.42

1886

3580

Anaemia in chronic diseases classified elsewhere

459

506

18.85

307.65

14.3

4.0

188.22

85.72

ng/l

33.30

437

454

Gout, FINNGEN

2338

7339

3.68

307.65

7.4

3.6

145.04

95.09

ng/l

53.12

2066

6208

Anaemias

1977

1544

9.71

307.65

7.7

2.8

120.51

64.63

ng/l

39.50

1793

1394

Chronic nephritic syndrome

695

798

15.42

307.65

11.2

3.1

172.69

78.05

ng/l

26.41

644

703

Heart failure and antihypertensive medication

1997

2755

5.48

307.65

6.6

2.2

142.00

63.36

ng/l

107.82

1773

2312

Other disorders of urethra and urinary system

4047

15860

2.01

307.65

4.5

3.6

96.98

86.33

ng/l

6.48

3499

13627

Preparatory care for dialysis

1300

880

109.01

307.65

18.4

3.4

220.97

88.34

ng/l

103.69

1286

770

Glucagon-like peptide-1 (GLP-1) analogues

3798

13777

2.48

307.65

5.1

3.6

115.16

90.22

ng/l

31.39

3255

11731

Any reimbursement code in KELA

2894

5425

2.79

307.65

4.9

2.2

88.37

63.90

ng/l

30.46

2611

4748

Other dialysis

892

609

89.33

307.65

16.8

4.1

219.20

83.25

ng/l

74.78

861

545

Genitourinary diseases

3457

5774

3.17

307.65

6.2

2.3

107.85

64.10

ng/l

77.17

3138

4994

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

816

1820

5.81

307.65

3.2

3.6

48.54

85.59

ng/l

45.90

734

1556

Type 2 diabetes, wide definition

5355

15578

2.41

307.65

5.5

3.4

117.35

84.32

ng/l

61.17

4618

13357

Medical observation and evaluation for suspected diseases and conditions

4094

8870

2.49

307.65

4.7

3.5

91.83

88.11

ng/l

1.32

3583

7610

Disorders of the thyroid gland

5825

18677

2.15

307.65

3.7

3.9

78.14

94.52

ng/l

30.30

5028

16194

Other special examinations and investigations of persons without complaint or reported diagnosis

3669

8872

2.18

307.65

4.7

3.5

96.17

88.11

ng/l

3.83

3226

7612

Opioids

5437

15161

1.96

307.65

4.3

3.7

95.11

87.55

ng/l

5.09

4766

13095

Pure hypercholesterolaemia

4518

13610

2.38

307.65

5.0

3.3

107.92

86.76

ng/l

30.06

3984

11601

Unspecified kidney failure

1490

1868

12.30

307.65

8.6

2.1

163.62

74.31

ng/l

70.27

1359

1526

Antihypertensive medication - note that there are other indications

3254

6011

3.12

307.65

5.9

2.3

94.79

59.96

ng/l

54.84

2951

5279

Oral corticosteroids

6197

19892

1.97

307.65

4.0

3.8

92.25

89.82

ng/l

0.92

5428

17107

Extracorporeal dialysis

1611

1268

45.16

307.65

17.9

3.6

244.46

85.61

ng/l

153.28

1527

1131

Gout, strict definition

1545

4215

4.43

307.65

7.6

3.8

152.26

97.46

ng/l

37.66

1363

3575

Heart failure, strict

3949

12663

2.45

307.65

5.6

3.6

135.18

86.00

ng/l

102.85

3449

10642

Examination and observation for other reasons

3653

8767

2.69

307.65

4.7

3.5

93.99

87.90

ng/l

2.60

3339

7532

Other anaemias

3045

11704

2.78

307.65

5.7

3.4

122.61

90.17

ng/l

32.29

2647

9819

Disorders of mineral metabolism

1489

1674

15.75

307.65

6.2

3.4

84.77

85.02

ng/l

0.02

1284

1424

Autoimmune diseases excluding thyroid diseases, strict definition

5718

15506

2.15

307.65

5.6

3.6

109.90

88.60

ng/l

27.25

5094

13401

Parasetamol

4221

10245

2.19

307.65

4.4

3.8

95.91

86.12

ng/l

6.07

3704

9005

Type 1 diabetes

1836

5790

3.52

307.65

8.4

3.9

148.10

81.55

ng/l

56.80

1657

5082

Care involving dialysis

2368

1600

61.62

307.65

17.0

2.9

224.35

78.26

ng/l

221.17

2263

1388

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5605

21392

1.93

307.65

5.3

3.7

110.50

83.87

ng/l

42.74

4922

18548

Osteoporosis

2517

7490

3.88

307.65

3.9

3.2

81.78

89.53

ng/l

3.94

2109

6212

Diabetes mellitus

5990

18615

2.01

307.65

5.2

3.4

108.83

81.34

ng/l

54.70

5213

16141

First line medication for Crohn's disease

6982

17918

2.24

307.65

5.7

3.2

102.27

83.47

ng/l

30.44

6235

15347

Diseases of arteries, arterioles and capillaries (FINNGEN)

1685

3076

4.26

307.65

7.3

2.2

144.10

64.67

ng/l

72.21

1510

2635

Autoimmune diseases excluding thyroid diseases

6099

16876

2.10

307.65

5.5

3.6

106.90

85.76

ng/l

29.27

5433

14634

Endocrine, nutritional and metabolic diseases

5164

7797

3.60

307.65

5.0

2.8

94.73

73.75

ng/l

30.24

4594

6833

Chronic periodontitis

1211

3431

4.13

307.65

11.7

3.5

161.82

87.78

ng/l

50.42

1129

2952

L04AA Selective immunosuppressants

2352

5372

5.48

307.65

11.3

3.3

147.13

82.73

ng/l

75.83

2205

4660

Diabetes medication

5910

19347

1.94

307.65

5.0

3.5

107.19

83.19

ng/l

42.92

5125

16775

Diabetes, varying definitions

5961

18605

2.01

307.65

5.1

3.5

108.42

81.60

ng/l

52.34

5186

16131

Aplastic and other anaemias

3459

12426

2.95

307.65

6.6

3.4

128.70

89.81

ng/l

50.26

3033

10435

Implicit Sepsis

5402

16415

2.80

307.65

5.8

3.3

118.79

81.53

ng/l

74.87

4708

14008

Disorders of parathyroid gland

4177

5646

12.86

307.65

7.3

2.8

125.20

83.45

ng/l

58.21

3614

4678

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

871

2047

5.41

307.65

3.5

3.7

52.71

85.50

ng/l

33.07

781

1753

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

573

555

21.43

307.65

11.5

5.0

150.31

82.96

ng/l

18.97

538

500

Kidney transplant status

1694

973

135.70

307.65

16.1

3.3

194.49

69.66

ng/l

132.15

1623

882

General symptoms and signs

6383

16315

2.05

307.65

4.6

3.6

96.75

85.54

ng/l

10.97

5599

14132

Dialysis, with operation codes

3069

2259

32.43

307.65

15.1

2.3

207.59

68.18

ng/l

282.10

2921

1927

Hypertensive heart and/or renal disease

2057

4056

4.51

307.65

7.4

2.3

148.04

70.77

ng/l

99.71

1812

3341

Other diseases of intestines

5838

18737

1.89

307.65

4.4

3.9

93.79

87.34

ng/l

4.09

5134

16281

Condition for Implicit Sepsis (Organ dysfunction codes)

5839

17827

2.57

307.65

5.6

3.3

113.81

80.58

ng/l

69.08

5097

15318

Finngen Rheumatological endpoints

5091

16268

1.85

306.63

4.4

3.8

94.93

88.39

ng/l

3.40

4472

14136

Symptoms and signs involving the urinary system

4396

18659

1.92

306.40

4.7

3.7

102.02

90.14

ng/l

8.77

3798

15977

Diarrhoea and gastroenteritis of presumed infectious origin

3857

18597

1.98

305.61

5.9

3.7

107.99

86.85

ng/l

19.91

3396

16070

Atrial fibrillation and flutter

1689

3983

2.95

304.70

5.1

2.2

115.62

63.78

ng/l

55.29

1484

3453

Diseases of arteries, arterioles and capillaries

3928

15552

2.00

304.56

6.1

3.5

129.40

88.66

ng/l

61.48

3442

13161

Direct fill therapy

1052

3135

3.89

304.15

12.2

4.1

145.50

84.67

ng/l

29.83

1003

2775

Diseases of pulp and periapical tissues

2065

8726

2.54

303.96

7.4

3.3

128.62

83.86

ng/l

33.57

1833

7557

Intestinal infectious diseases

5089

22734

1.81

303.45

5.6

3.6

106.18

86.38

ng/l

24.90

4492

19611

Bleeding

4686

19134

1.87

300.28

5.4

3.7

115.84

87.05

ng/l

42.78

4047

16434

Complications of medical and surgical care

4122

21446

1.92

299.70

5.3

3.6

107.39

88.04

ng/l

16.93

3625

18397

Diverticular disease of intestine

4106

14663

1.96

296.42

4.3

3.7

97.78

90.54

ng/l

3.77

3538

12518

Cardiac arrhythmias

3130

10093

2.14

293.45

4.4

3.3

98.64

73.49

ng/l

29.37

2749

8868

Iron deficiency anaemia

2580

12089

2.28

291.62

4.9

3.6

113.25

88.49

ng/l

17.00

2170

10323

Osteoporosis with pathological fracture (FG)

747

1879

5.25

286.94

3.0

3.1

72.77

86.18

ng/l

4.76

610

1527

Chronic periapical parodontitis

1358

4856

3.09

284.01

8.7

3.4

143.40

84.82

ng/l

35.25

1215

4212

Benign neoplasm: Colon

2874

10753

2.19

283.94

4.6

3.8

103.34

91.46

ng/l

7.70

2523

9115

Disorders of choroid and retina

4547

18762

1.85

282.72

5.6

3.6

118.65

88.57

ng/l

42.25

3883

16087

Isolated proteinuria

395

567

10.54

282.45

8.9

4.2

124.26

87.23

ng/l

5.87

373

506

Pain in joint

3134

10306

2.11

280.70

3.8

4.0

83.15

91.85

ng/l

5.29

2787

8940

Malignant neoplasm of endocrine gland

722

1787

5.12

279.57

3.5

3.7

53.05

83.93

ng/l

24.27

644

1535

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2142

5738

2.48

279.40

4.8

2.2

100.31

63.26

ng/l

38.87

1899

5042

Other retinal disorders

3701

16001

1.97

278.59

5.9

3.6

124.17

89.84

ng/l

40.92

3162

13648

Heart failure and bmi 25plus

2252

6894

2.46

278.12

5.6

3.7

135.97

88.14

ng/l

57.95

1951

5725

Obesity due to excess calories

2513

11981

2.23

276.02

4.7

3.9

105.20

85.96

ng/l

13.56

2173

10508

Low back pain

3881

16257

1.92

275.81

3.5

4.1

85.48

93.61

ng/l

5.20

3326

14060

Malignant neoplasm of thyroid gland

688

1672

5.25

273.27

3.2

3.5

48.95

83.15

ng/l

35.91

616

1440

Hyperlipidaemia, other/unspecified

2217

9558

2.36

272.37

5.9

3.2

120.46

89.20

ng/l

25.47

1867

8049

Other (not insulin) diabetes medications

5113

18158

1.76

264.55

4.2

3.4

99.88

84.75

ng/l

18.33

4388

15653

Thyrotoxicosis

1691

7017

2.66

263.65

3.4

3.5

68.14

86.55

ng/l

15.92

1488

5978

Insulin, fast-acting (human)

968

2966

3.63

263.40

8.7

3.6

147.71

83.42

ng/l

25.96

889

2599

Neurological diseases, wide definition

1444

2467

3.06

261.13

4.4

3.5

83.91

74.20

ng/l

2.92

1295

2190

Asthma, unspecified (mode), excluding more controls

2704

10413

2.14

260.62

3.9

3.3

93.90

79.67

ng/l

10.75

2373

8958

Other diseases of urinary system

5455

18399

1.73

260.11

4.5

3.8

97.68

87.59

ng/l

7.76

4769

15950

Disorders of lens

3802

13089

1.93

259.25

5.9

3.6

117.80

85.83

ng/l

35.26

3252

11429

Acute peritonitis

618

1439

5.40

257.84

13.3

3.9

196.66

91.60

ng/l

27.38

579

1246

Symptoms and signs involving the circulatory and respiratory systems

5215

15389

1.75

256.72

4.3

3.9

92.90

85.79

ng/l

4.71

4578

13403

Atrial fibrillation and flutter with reimbursement

1407

3238

2.98

256.31

4.1

2.2

101.97

65.04

ng/l

37.73

1215

2761

Peripheral artery disease

2680

10745

2.16

254.78

6.5

3.5

139.85

92.12

ng/l

54.03

2331

8985

Diabetic retinopathy, excluding more controls

1755

3998

2.76

253.89

7.7

3.3

143.05

83.41

ng/l

45.47

1555

3398

Calculus of kidney and ureter

1822

7932

2.50

253.27

3.9

4.1

85.00

97.67

ng/l

6.09

1629

6849

Other and unspecified iron deficiency

2010

9131

2.38

252.42

4.8

3.6

112.18

87.16

ng/l

13.99

1702

7802

Fall on same level

5965

20612

1.67

250.90

4.1

4.0

93.89

88.11

ng/l

3.27

5118

18095

Symptoms and signs involving cognition, perception, emotional state and behaviour

5090

21495

1.72

249.82

3.7

4.0

89.77

90.96

ng/l

0.37

4353

18673

Other specific joint derangements/joint disorders

3640

13287

1.91

249.81

3.8

83.52

86.53

ng/l

1.06

3232

11604

Headache

3283

14672

1.95

249.11

3.8

3.5

82.88

83.92

ng/l

0.26

2871

12706

Other CVD (FINNGEN)

730

1440

4.49

248.69

5.0

2.2

114.71

66.91

ng/l

17.46

622

1208

Nontoxic multinodular goitre

1444

5753

2.82

247.79

3.3

65.54

89.70

ng/l

21.34

1243

4845

Unspecified haematuria

2387

9921

2.20

244.89

5.3

3.9

108.89

94.59

ng/l

7.26

2072

8479

Dorsalgia

5162

16724

1.73

244.88

3.6

4.1

84.46

93.42

ng/l

8.44

4503

14466

Urolithiasis

1912

8632

2.39

243.42

4.0

4.2

85.80

98.48

ng/l

6.38

1704

7450

General examination and investigation of persons without complaint and reported diagnosis

3216

8848

2.01

242.79

4.6

3.5

96.81

88.01

ng/l

3.27

2798

7596

Nontoxic goitre/thyroid nodule

2031

9483

2.35

241.42

3.2

3.4

66.49

88.30

ng/l

28.50

1750

8007

Type 2 diabetes, definitions combined

4873

17333

1.74

240.66

4.1

3.3

97.82

82.76

ng/l

18.25

4183

14933

Type 2 diabetes, strict (exclude DM1)

4881

17433

1.73

237.82

4.1

3.3

97.73

82.99

ng/l

17.56

4191

15018

Gastro-oesophageal reflux disease

3648

18249

1.85

236.70

4.0

3.8

92.77

89.52

ng/l

1.01

3054

15779

Nausea and vomiting

1681

7136

2.50

236.55

6.4

3.7

113.25

87.32

ng/l

13.35

1474

6090

Asthma, excluding more controls

3771

11071

1.88

235.92

3.8

3.4

90.47

79.75

ng/l

8.02

3349

9559

Lower back pain or/and sciatica

5306

22736

1.68

235.48

3.6

4.0

84.23

92.38

ng/l

7.69

4597

19654

Gastrointestinal diseases

2991

7595

2.04

233.99

4.8

2.9

89.32

75.27

ng/l

10.48

2644

6600

Persons encountering health services in other circumstances, wide

6345

20952

1.62

233.93

4.8

3.7

102.46

86.62

ng/l

20.54

5494

18152

Hypothyroidism, strict autoimmune

3616

13270

1.87

233.69

3.8

3.3

89.26

88.36

ng/l

0.22

3036

11377

Persons encountering health services for examination and investigation

3349

8872

1.96

233.15

4.3

3.5

92.09

88.11

ng/l

1.34

2901

7612

Autoimmune diseases related-to ILD

4421

23254

1.74

232.22

4.4

3.9

90.95

90.19

ng/l

0.18

3885

20085

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5808

20815

1.64

230.50

5.0

3.7

103.35

86.46

ng/l

21.19

5070

18057

Renal tubulo-interstitial disorders in diseases classified elsewhere

202

160

29.52

229.95

9.7

1.8

127.46

64.54

ng/l

8.62

185

141

Abnormal findings on examination of urine, without diagnosis

466

951

6.43

229.59

8.2

3.9

121.68

89.52

ng/l

5.16

434

836

Constipation

4734

20569

1.72

228.51

3.9

4.0

92.04

90.13

ng/l

0.56

4010

17810

Type 2 diabetes, definitions combined, including avohilmo

4832

17251

1.72

227.82

4.1

3.3

97.63

82.93

ng/l

17.41

4150

14879

Vocal cord dysfunction

777

2073

3.78

226.92

4.0

3.1

76.28

71.23

ng/l

0.83

671

1838

Benign neoplasms

4858

16314

1.71

226.87

4.6

3.8

95.96

89.21

ng/l

3.99

4269

14204

Asthma, unspecified (mode)

2763

11390

2.01

226.52

3.9

3.4

94.23

83.59

ng/l

6.33

2417

9783

Non-ischemic cardiomyopathy

1856

6909

2.40

226.35

5.1

3.4

122.15

82.62

ng/l

39.15

1587

5737

Benign neoplasm of colon, rectum, anus and anal canal

3452

17632

1.87

225.67

4.6

3.7

102.44

91.69

ng/l

7.85

3014

14934

Hernia of abdominal wall, postoperative

1008

3483

3.15

222.41

6.0

2.8

116.50

81.94

ng/l

12.78

895

2953

Sleep disorders (combined)

5102

20704

1.67

222.29

4.1

3.9

94.57

89.46

ng/l

2.89

4345

18071

Valvular heart disease excluding rheumatic fever

2588

9660

2.07

222.18

5.0

3.6

114.51

80.75

ng/l

37.72

2226

8247

Diseases of the skin and subcutaneous tissue

5323

16447

1.67

221.30

4.8

3.5

100.79

84.22

ng/l

19.55

4656

14193

Non-rheumatic valve diseases

2573

9590

2.07

221.14

5.0

3.5

114.65

80.88

ng/l

37.41

2210

8177

Obesity, other/unspecified

1810

8295

2.33

220.10

4.4

3.8

101.79

85.68

ng/l

8.28

1632

7261

Benign neoplasms

3612

11411

1.85

218.83

4.8

4.0

95.80

88.92

ng/l

3.10

3213

9994

Nerve, nerve root and plexus disorders

5470

21699

1.64

217.85

4.1

3.8

93.44

91.25

ng/l

0.77

4796

18660

Follow-up examination after treatment for conditions other than malignant neoplasms

2313

7387

2.14

217.06

3.7

3.3

85.66

86.33

ng/l

0.11

2029

6323

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3302

18638

1.85

216.94

5.5

3.6

110.77

88.64

ng/l

16.19

2903

15983

Asthma (only as main-diagnosis), excluding more controls

3374

11071

1.88

216.78

3.8

3.4

90.85

79.75

ng/l

7.97

2977

9559

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1803

3836

2.44

216.10

4.4

3.3

85.97

79.28

ng/l

2.00

1609

3297

Diabetic retinopathy, strict definition

1306

4649

2.83

214.10

8.9

4.2

159.60

99.56

ng/l

30.07

1149

3972

Thyrotoxicosis with diffuse goitre

929

3155

3.29

214.04

3.1

3.5

61.70

87.27

ng/l

16.36

831

2727

Disorders of gallbladder, biliary tract and pancreas

5155

20825

1.65

213.17

4.3

3.8

98.13

89.66

ng/l

6.23

4476

17949

Gout due to impairment of renal function

214

25.29

212.90

13.4

3.9

192.46

85.67

ng/l

14.93

199

189

COPD/asthma related infections

5466

17192

1.64

210.85

4.5

3.4

98.39

82.55

ng/l

18.09

4782

14840

COPD/asthma/ILD related infections

5466

17192

1.64

210.85

4.5

3.4

98.39

82.55

ng/l

18.09

4782

14840

Asthma

3916

12121

1.79

210.58

3.8

3.5

91.46

83.51

ng/l

4.78

3467

10450

Congenital malformations, deformations and chromosomal abnormalities

2886

15114

1.91

209.72

6.8

3.7

106.09

84.81

ng/l

17.30

2613

13257

Other cataract

2468

9859

2.06

209.36

5.7

3.6

115.29

86.95

ng/l

19.81

2125

8561

Spondylopathies

4179

15114

1.74

208.39

3.6

4.0

89.26

95.46

ng/l

3.34

3605

12984

Atherosclerosis, excluding cerebral and coronary sclerosis

2433

10053

2.07

207.89

6.3

3.4

140.54

92.71

ng/l

48.01

2112

8395

Oxycodone

1958

9140

2.21

207.80

4.4

3.7

107.09

93.01

ng/l

4.48

1674

7754

Presence of cardiac and vascular implants and grafts

2510

9898

2.04

206.02

4.8

3.2

125.86

87.11

ng/l

43.43

2161

8395

Mood disorders, excluding more controls

4815

18143

1.67

205.79

3.9

89.42

90.57

ng/l

0.29

4151

15839

Papillary adenocarcinoma of thyroid gland

518

1263

5.24

205.16

3.4

3.5

49.44

82.71

ng/l

24.30

464

1098

Excluding asthma or asthma-COPD overlap

4148

12231

1.75

204.41

4.3

3.5

94.54

83.48

ng/l

8.16

3638

10546

Other pulmonary diagnosis

4147

12231

1.75

204.18

4.3

3.5

95.26

83.48

ng/l

9.10

3637

10546

Chronic periodontitis, complicated

717

2172

3.88

203.73

11.9

3.8

170.95

91.76

ng/l

30.01

668

1896

Chronic tubulo-interstitial nephritis

405

815

6.39

201.57

9.9

2.2

145.25

68.73

ng/l

19.67

372

689

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

363

659

6.87

200.24

10.9

3.7

158.29

79.40

ng/l

13.52

333

609

Other functional intestinal disorders

2451

12338

1.99

199.64

4.2

3.7

92.97

87.01

ng/l

1.93

2100

10543

Neoplasms

3525

10750

1.81

197.63

4.6

4.0

90.51

87.56

ng/l

0.78

3160

9421

Asthma (mode)

3809

12230

1.77

196.81

3.8

3.5

90.28

83.45

ng/l

3.71

3377

10551

Benign neoplasm: Colon

2920

16127

1.88

196.46

4.7

3.7

103.97

92.60

ng/l

7.26

2565

13651

Symptoms and signs involving the digestive system and abdomen

5186

16391

1.63

196.13

4.6

3.9

96.04

88.99

ng/l

4.25

4515

14210

Amputation

744

2369

3.63

194.14

9.4

3.6

169.00

96.22

ng/l

24.32

650

1991

ILD differential diagnosis

4102

12230

1.73

194.14

4.3

3.5

94.44

83.45

ng/l

7.95

3592

10551

COPD differential diagnosis

4102

12234

1.73

193.93

4.3

3.5

94.43

83.46

ng/l

7.94

3592

10555

Infections of the skin and subcutaneous tissue

2823

15701

1.87

193.03

5.8

4.0

113.18

88.35

ng/l

18.90

2511

13715

Other disorders of teeth and supporting structures

1240

5126

2.62

192.99

7.0

3.3

122.25

84.95

ng/l

18.31

1075

4406

Neurological diseases

4382

13396

1.70

192.53

4.0

4.1

88.07

88.32

ng/l

0.05

3817

11734

Other dorsopathies, not elsewhere classified

5042

16788

1.63

192.50

3.6

4.1

84.65

93.27

ng/l

7.73

4426

14527

Other and unspecified polyneuropathies, also in other diseases

1209

5000

2.68

190.88

6.1

3.9

115.94

96.05

ng/l

5.83

1078

4247

Asthma (only as main-diagnosis)

3474

12121

1.79

190.52

3.8

3.5

91.13

83.51

ng/l

4.18

3058

10450

Psychiatric diseases

5608

18206

1.59

189.07

3.9

4.0

89.38

90.52

ng/l

0.32

4816

15921

Abdominal and pelvic pain

5132

16379

1.62

189.03

4.3

3.9

93.92

89.02

ng/l

2.43

4471

14198

Diseases of peritoneum

775

2575

3.47

188.53

11.4

3.7

176.02

89.55

ng/l

27.05

711

2187

Senile cataract

3347

11996

1.81

188.36

5.5

3.6

115.63

86.76

ng/l

26.26

2821

10441

Other arrhythmias

3150

13833

1.81

187.90

3.7

3.5

93.10

79.72

ng/l

10.98

2721

11977

Hypokalaemia

776

2578

3.40

186.87

4.7

3.1

98.80

84.99

ng/l

2.52

653

2162

Failure and rejection of transplanted organs and tissues

203

218

15.80

185.05

15.9

4.0

204.20

68.16

ng/l

17.34

194

197

Postmenopausal osteoporosis with pathological fracture

614

1843

4.32

184.16

3.0

71.89

87.83

ng/l

5.65

497

1491

STROKE

2931

11440

1.86

184.12

4.6

3.2

102.69

76.96

ng/l

28.38

2556

9789

Diseases of oral cavity, salivary glands and jaws

4754

15350

1.64

182.95

4.9

3.3

96.02

85.22

ng/l

9.67

4118

13201

Episodal and paroxysmal disorders

5602

18770

1.57

182.49

3.9

4.0

89.62

89.00

ng/l

0.17

4851

16326

Peripheral artery operations in Hilmo

863

3094

3.12

180.93

8.6

3.6

161.52

94.82

ng/l

25.88

750

2594

Systemic connective tissue disorders

2061

10711

2.06

180.50

4.6

3.5

89.94

88.50

ng/l

0.26

1815

9087

Pain (limb, back, neck, head abdominally)

3731

11057

1.74

180.34

4.2

4.0

90.60

91.86

ng/l

0.28

3271

9559

Diseases of the digestive system

2481

13642

1.91

179.36

5.1

3.8

107.67

92.06

ng/l

8.75

2136

11638

Exposure to unspecified factor

4782

23977

1.60

178.95

4.3

3.9

96.23

88.68

ng/l

4.09

4082

20868

Diseases of the eye and adnexa

3859

11567

1.72

178.24

5.0

3.7

97.10

81.67

ng/l

13.13

3431

10275

Polyneuropathies and other disorders of the peripheral nervous system

1307

5760

2.48

178.03

5.9

3.9

114.92

95.46

ng/l

6.18

1162

4898

Any mental disorder

5705

18845

1.56

177.89

3.9

4.0

89.00

90.98

ng/l

0.69

4887

16449

Hydronephrosis

680

2146

3.54

177.24

6.9

2.3

135.78

68.90

ng/l

20.67

598

1786

Sleep apnoea

4595

19922

1.62

176.96

4.1

3.9

96.87

90.37

ng/l

3.87

3895

17393

Amputation of toe

564

1622

4.16

174.71

9.6

3.9

170.08

100.14

ng/l

16.55

500

1382

Graves disease, strict definition

701

2289

3.48

174.43

2.7

3.6

52.02

80.63

ng/l

18.65

630

1988

Factors influencing health status and contact with health services

1526

3334

2.38

173.24

4.7

2.5

95.56

75.87

ng/l

11.71

1355

2885

Soft tissue disorders

5087

17114

1.59

173.12

4.0

91.18

90.00

ng/l

0.32

4427

14807

Haemorrhage from respiratory passages

1861

8728

2.09

172.49

4.7

3.8

112.99

90.68

ng/l

12.18

1599

7402

Charcot foot

218

277

11.66

172.01

10.6

3.1

164.41

78.43

ng/l

11.80

202

244

Parodontitis or operation codes

4529

21475

1.61

171.83

5.7

3.6

108.95

88.42

ng/l

22.48

3954

18523

Mood [affective] disorders

5040

21723

1.57

171.77

3.9

88.18

89.74

ng/l

0.46

4356

18888

All influenza

1381

6281

2.35

171.75

6.2

3.7

117.26

85.78

ng/l

15.49

1230

5415

Mood disorders

5049

21755

1.57

171.17

3.9

88.15

89.73

ng/l

0.47

4362

18915

Other intervertebral disc disorders

4124

15757

1.65

171.02

3.4

4.0

84.89

94.96

ng/l

8.85

3656

13585

Biguanides

4735

18842

1.60

170.79

3.7

94.58

88.46

ng/l

3.68

4027

16278

Parodontitis

4520

21473

1.61

170.69

5.7

3.6

108.78

88.46

ng/l

22.02

3945

18521

Benzodiazepine use

4938

23037

1.57

170.56

3.3

4.0

86.18

92.03

ng/l

3.61

4143

20051

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2993

17659

1.77

170.22

5.4

3.6

110.48

89.11

ng/l

13.71

2621

15158

Sleep apnoea, including avohilmo

4805

20275

1.59

170.00

4.0

3.9

95.37

90.24

ng/l

2.76

4082

17706

Idiopathic gout

628

1961

3.71

169.44

7.6

3.8

156.44

97.13

ng/l

16.38

556

1672

Spinal stenosis

2738

12255

1.84

168.59

3.6

3.9

92.07

96.29

ng/l

1.44

2358

10397

Dizziness and giddiness

3798

19204

1.67

168.47

3.6

3.9

88.88

91.63

ng/l

1.03

3228

16570

Disorders of eyelid, lacrimal system and orbit

4299

21605

1.62

168.39

3.8

3.9

88.33

90.87

ng/l

0.90

3694

18618

Chronic periodontitis, including avohilmo

4494

21478

1.60

168.16

5.7

3.6

108.95

88.47

ng/l

22.15

3919

18528

Covid-19 confirmed case

1539

7381

2.23

167.63

6.3

3.8

120.53

90.35

ng/l

15.22

1342

6356

Other/unspecified cytomegaloviral diseases

241

358

10.12

167.27

12.8

3.9

182.77

73.11

ng/l

17.42

229

323

Cystitis

4268

16549

1.63

165.80

4.0

3.6

89.41

86.03

ng/l

1.41

3718

14265

Codes for special purposes

2193

11893

1.93

165.71

5.8

3.8

111.91

87.92

ng/l

15.40

1893

10384

Use of hypnotics and sedatives

5286

20291

1.55

165.61

4.0

94.29

91.04

ng/l

1.29

4603

17600

L04AX Other immunosuppressants

2811

16426

1.79

165.38

5.3

3.8

85.16

88.46

ng/l

0.88

2522

14246

Other antidepressants

5136

17591

1.57

165.19

3.4

4.2

86.84

94.28

ng/l

5.25

4400

15314

Provisional assignment of new diseases of uncertain etiology

2189

11881

1.93

164.98

5.8

3.8

111.56

87.96

ng/l

15.13

1889

10376

Cytomegalovirus infection, IBD co-morbidity

264

436

8.66

164.87

12.5

4.2

177.18

78.68

ng/l

16.35

251

396

Second line medication for Crohn's disease

2856

16789

1.78

164.27

5.3

3.8

84.92

88.70

ng/l

1.10

2563

14573

Other diseases of hard tissues of teeth

3099

13682

1.75

163.96

6.3

3.3

98.24

82.95

ng/l

10.82

2726

11923

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

635

2050

3.65

163.66

4.9

3.7

100.47

96.82

ng/l

0.36

555

1717

5744

20452

1.52

163.57

4.5

3.6

96.77

87.04

ng/l

8.79

4983

17600

Diabetic retinopathy

2111

7078

2.05

162.64

7.4

4.2

141.79

99.76

ng/l

29.72

1858

6043

Gingival hyperplasia

324

656

6.36

160.42

13.5

3.5

114.90

78.80

ng/l

6.16

303

586

Cytomegaloviral disease

267

458

8.18

160.18

12.4

4.3

175.72

80.18

ng/l

15.79

254

415

Diseases of the musculoskeletal system and connective tissue

2513

6859

1.89

159.79

4.3

4.0

86.91

85.54

ng/l

0.24

2245

6015

Diseases of liver

1800

9350

2.05

157.14

4.5

3.9

94.81

91.87

ng/l

0.59

1584

8078

Syncope and collapse

2204

10760

1.90

154.91

4.1

3.5

101.37

89.18

ng/l

5.08

1852

9161

Other bacterial intestinal infections

1086

4696

2.52

153.95

6.0

3.5

119.95

88.73

ng/l

11.98

963

3942

Symptoms and signs involving the skin and subcutaneous tissue

3391

21070

1.66

153.86

4.3

3.8

89.42

89.32

ng/l

0.02

3028

18187

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3284

18838

1.68

153.78

4.2

3.8

96.81

92.13

ng/l

1.54

2875

16058

Gingivitis and periodontal diseases

4525

15161

1.58

153.09

4.7

3.3

97.65

85.33

ng/l

12.11

3936

13045

Depression

4538

20611

1.56

151.17

3.9

4.0

88.12

89.08

ng/l

0.23

3939

17960

Falls/tendency to fall

5339

17993

1.52

150.97

4.1

4.0

93.36

87.50

ng/l

3.06

4624

15797

Volume depletion

595

1923

3.48

149.80

5.5

3.4

122.88

91.02

ng/l

5.93

503

1611

Pain, not elsewhere classified

1352

6424

2.23

149.54

4.1

3.5

91.66

84.40

ng/l

1.93

1172

5553

Anxiety disorders, excluding more controls

3919

16609

1.61

149.23

3.8

3.9

85.86

88.69

ng/l

0.95

3390

14538

Hypothyroidism, strict autoimmune, 3 medication purchases required

4032

17749

1.60

148.39

3.7

3.8

88.36

91.83

ng/l

1.50

3363

15339

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

536

1129

3.76

146.92

4.3

3.0

103.83

82.80

ng/l

3.28

466

957

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

4310

16630

1.58

146.76

4.0

87.14

90.32

ng/l

1.19

3809

14394

Benign neoplasm: Parathyroid gland

184

241

14.38

146.61

7.0

3.6

119.23

80.35

ng/l

2.77

168

215

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

4308

16629

1.58

146.37

4.0

87.17

90.33

ng/l

1.18

3807

14393

Malignant neoplasm, wide definition for exclusion

4308

16635

1.58

146.16

4.0

87.17

90.32

ng/l

1.18

3807

14399

Parodontitis and operation codes

4178

21355

1.57

145.54

5.7

3.6

108.24

88.71

ng/l

18.77

3645

18454

Hypo-osmolality and hyponatraemia

991

4226

2.55

143.97

4.6

3.0

103.50

87.59

ng/l

3.92

828

3505

Unspecified nephritic syndrome

251

452

7.57

142.65

10.8

3.1

160.08

76.52

ng/l

10.14

232

399

Benign neoplasm: Parathyroid gland

184

252

13.71

141.42

7.0

3.2

119.23

75.68

ng/l

3.43

168

224

Arthropathies in other diseases classified elsewhere

326

738

5.48

140.52

9.1

3.8

153.75

89.22

ng/l

9.79

297

648

Osteomyelitis

468

1368

4.00

140.37

8.3

4.3

152.65

93.68

ng/l

11.08

420

1211

Isolated proteinuria with specified morphological lesion

174

221

13.28

140.02

9.1

3.2

152.95

74.10

ng/l

7.38

162

196

Heart failure and coronary heart disease

1872

7541

1.98

139.05

5.7

3.6

149.06

94.73

ng/l

52.23

1627

6221

Other disorders of gingiva or/and edentulous alveolar ridge

399

1059

4.48

138.21

12.0

3.4

111.02

82.90

ng/l

5.07

368

931

Arthropathies

4191

13891

1.57

138.16

4.3

3.9

92.41

86.87

ng/l

2.46

3696

12113

Dorsopathies

4916

16944

1.52

137.24

3.8

4.1

86.53

92.91

ng/l

4.39

4293

14679

Enterocolitis due to Clostridium difficile

725

2756

2.95

136.91

6.5

3.5

133.65

91.77

ng/l

11.88

648

2312

Other arthrosis

2547

10737

1.76

136.82

3.9

3.6

87.96

90.46

ng/l

0.49

2226

9243

Vitreous haemorrhage

668

2445

3.09

135.97

9.2

3.9

164.59

93.89

ng/l

18.64

604

2082

Intracranial trauma

2561

11314

1.74

135.36

3.5

4.1

88.09

87.04

ng/l

0.20

2159

9948

Bacterial intestinal infections, IBD co-morbidities

1078

4925

2.37

134.31

6.1

3.6

121.19

90.96

ng/l

11.12

959

4149

Other necrotizing vasculopathies (FG)

460

1371

3.94

134.29

7.4

3.5

114.22

89.50

ng/l

3.74

434

1154

Asthma (diagnoses ohter than nonallergic)

4147

23766

1.54

133.23

3.8

4.0

91.40

88.90

ng/l

0.84

3647

20503

Cough

2030

11009

1.85

133.15

4.4

3.8

89.94

84.69

ng/l

1.44

1762

9486

Other arthritis (FG)

1513

7816

2.04

133.05

4.8

3.7

98.60

87.91

ng/l

3.25

1322

6768

Other systemic involvement of connective tissue (FG)

1382

6889

2.12

132.89

3.2

3.4

80.04

87.88

ng/l

2.52

1192

5815

Abnormal findings on examination of blood, without diagnosis

2265

12404

1.79

131.80

4.9

4.1

100.88

96.53

ng/l

1.12

2019

10635

Abnormalities of heart beat

1728

9261

1.94

131.67

3.6

91.84

86.04

ng/l

1.56

1477

7918

Depression or dysthymia

3440

12201

1.62

131.21

3.8

4.2

90.23

93.91

ng/l

1.11

2944

10719

Ischaemic heart disease, wide definition

3843

15789

1.58

130.36

5.1

3.6

115.72

85.01

ng/l

41.67

3312

13484

Other disorders of skin and subcutaneous tissue, not elsewhere classified

867

3663

2.60

130.16

6.0

3.5

124.22

88.11

ng/l

9.88

748

3104

Sciatica+with lumbago

2408

13629

1.74

129.97

3.5

4.0

81.59

92.86

ng/l

7.95

2164

11741

Bacterial pneumoniae

2062

10414

1.83

129.77

5.4

3.6

116.95

86.99

ng/l

17.72

1860

8881

Paroxysmal tachycardia

961

3497

2.44

129.61

4.5

2.3

102.02

63.11

ng/l

26.67

849

3036

Peripheral arterial reconstruction

1008

4565

2.42

129.11

6.4

3.8

149.39

99.62

ng/l

17.60

869

3819

Bipolar affective disorders

895

3810

2.49

129.03

3.2

3.9

81.23

86.24

ng/l

0.85

782

3396

Presence of other functional implants

2881

12631

1.68

128.90

4.7

3.1

112.65

83.35

ng/l

27.89

2274

10750

Other external causes of accidental injury

4098

13526

1.56

128.05

4.0

3.9

93.34

86.98

ng/l

3.12

3529

11861

Asthma, hospital admission 2, infections

2830

17406

1.66

127.33

4.2

4.0

96.35

89.38

ng/l

2.79

2493

14953

Asthma-related infections

2830

17406

1.66

127.33

4.2

4.0

96.35

89.38

ng/l

2.79

2493

14953

Other necrotizing vasculopathies

538

1830

3.43

126.81

8.1

3.7

118.92

92.43

ng/l

4.69

506

1551

Bacterial pneumonia, not elsewhere classified

1971

9897

1.85

126.49

5.4

3.6

117.97

87.17

ng/l

17.68

1792

8431

Chronic gastritis

1554

8296

1.99

125.54

4.0

3.5

98.64

91.71

ng/l

1.67

1331

7014

Symptoms and signs concerning food and fluid intake

622

2269

3.02

125.50

4.6

3.7

80.75

85.85

ng/l

0.70

545

1930

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1215

5947

2.18

125.48

4.6

4.0

101.21

87.90

ng/l

4.25

1042

5213

Conduction disorders

1480

6392

2.03

124.40

4.4

3.5

108.77

82.28

ng/l

17.59

1240

5414

Cholelithiasis, broad definition with cholecystitis

4235

19686

1.52

124.15

4.0

3.7

94.71

88.91

ng/l

3.14

3654

16899

Accidents

4073

13526

1.55

123.72

4.0

3.9

92.73

86.98

ng/l

2.66

3510

11861

Hard cardiovascular diseases

3859

16482

1.55

123.36

5.1

3.6

113.83

86.16

ng/l

36.94

3345

14098

Cutaneous abscess, furuncle and carbuncle

1233

6109

2.13

122.44

6.3

4.0

122.97

88.43

ng/l

12.31

1119

5344

Obesity related asthma

1666

9158

1.92

121.82

4.1

4.0

98.66

89.94

ng/l

2.64

1454

7935

Bronchitis

5031

23150

1.46

121.74

4.8

3.7

100.94

87.51

ng/l

13.56

4385

19997

Other specified/unspecified arthritis

1313

6672

2.07

121.23

4.8

3.7

100.66

87.39

ng/l

4.03

1150

5767

Disorder of lipoprotein metabolism, unspecified

756

3099

2.66

120.69

6.1

3.3

128.35

90.77

ng/l

11.37

652

2600

Other disorders of glucose regulation and pancreatic internal secretion

542

1896

3.20

119.20

6.7

4.3

119.24

89.59

ng/l

7.26

485

1646

Other/unspecified dorsalgia

1830

10332

1.84

119.10

3.7

3.9

86.32

92.75

ng/l

2.09

1584

8843

Diaphragmatic hernia

1920

11101

1.83

119.08

3.8

3.6

92.09

90.77

ng/l

0.27

1661

9441

Injuries to the abdomen, lower back, lumbar spine and pelvis

1934

11100

1.81

118.77

4.1

3.8

93.08

92.25

ng/l

0.12

1637

9516

Dermatitis

2903

18584

1.62

118.65

4.9

3.8

101.04

88.46

ng/l

6.63

2541

16074

Shoulder lesions

3692

14976

1.55

118.50

3.7

3.8

87.28

92.95

ng/l

2.75

3238

12869

Cholelithiasis

4084

19491

1.51

118.29

3.9

3.7

94.12

88.87

ng/l

2.60

3516

16721

Ischemic heart diseases

3832

16073

1.54

118.27

5.1

3.6

116.20

84.89

ng/l

42.91

3298

13747

Other gastritis (incl. Duodenitis)

1224

6171

2.11

116.85

4.9

3.7

103.52

91.60

ng/l

3.23

1071

5227

Coronary atherosclerosis

3367

14217

1.58

116.57

5.3

3.6

122.80

85.93

ng/l

47.36

2924

12089

Dermatitis and eczema

5080

23636

1.44

115.45

4.5

3.9

95.00

89.03

ng/l

3.31

4434

20464

Other diseases of the digestive system

1638

9126

1.89

114.84

5.4

3.8

116.10

94.60

ng/l

9.87

1405

7706

Malignant neoplasm

4251

17289

1.50

114.61

4.0

87.65

90.92

ng/l

1.19

3748

14940

Cerebrovascular diseases

3631

17468

1.54

113.74

4.7

3.7

105.82

91.32

ng/l

12.86

3100

14906

Anxiety disorders

4088

19862

1.50

113.52

3.9

4.0

84.99

88.20

ng/l

1.23

3543

17348

Neurotic, stress-related and somatoform disorders

4038

19641

1.50

113.30

3.9

4.0

85.03

88.05

ng/l

1.10

3499

17166

Concussion

2126

10934

1.73

113.25

3.3

4.1

83.91

87.56

ng/l

0.96

1792

9611

Benign neoplasm: Colon, unspecified

1262

6500

2.06

112.11

5.1

3.8

108.60

95.21

ng/l

4.26

1092

5454

Hernia

4468

21165

1.47

112.06

4.5

3.8

95.69

90.13

ng/l

2.88

3883

18227

GI-bleeding

1628

9127

1.88

111.67

5.4

3.8

116.16

94.96

ng/l

9.68

1400

7702

Viral infections characterized by skin and mucous membrane lesions

1961

11579

1.76

110.94

6.0

3.9

101.30

89.49

ng/l

4.61

1703

10059

Any event in cancer register

4285

17561

1.48

110.68

3.9

4.0

86.74

90.59

ng/l

1.61

3777

15217

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

381

1157

3.96

109.35

5.4

3.6

106.97

92.96

ng/l

1.71

331

970

Other reaction to severe stress, and adjustment disorders

1574

8747

1.87

109.32

4.8

4.0

94.56

85.40

ng/l

2.41

1377

7755

Sulfonylureas

1890

8803

1.80

108.90

5.4

3.6

126.73

94.62

ng/l

23.82

1582

7355

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

700

2920

2.64

108.51

5.9

3.9

132.62

98.52

ng/l

8.67

614

2451

Adjustment and management of implanted device

996

4799

2.23

108.15

4.5

2.7

118.27

84.68

ng/l

20.52

844

3975

Vitamin D deficiency

188

333

7.48

108.09

5.0

3.8

85.84

74.11

ng/l

1.37

159

298

Other acute lower respiratory infections

2495

15020

1.64

107.64

5.3

3.9

105.09

90.47

ng/l

7.54

2150

12921

Other joint disorders

3838

13813

1.51

107.61

3.8

3.9

85.75

87.11

ng/l

0.33

3360

12036

Retention of urine

1598

7550

1.88

107.27

4.5

3.9

115.31

98.14

ng/l

5.18

1383

6399

Cellulitis

1082

5378

2.14

107.13

6.0

4.1

119.01

89.09

ng/l

11.41

954

4676

External causes of morbidity and mortality

3230

10526

1.57

106.98

4.1

3.8

89.49

83.69

ng/l

2.45

2803

9198

Diseases of the respiratory system

3196

10398

1.58

106.94

4.0

3.4

89.56

82.84

ng/l

3.25

2770

8955

Bacterial pneumonia (organism specified)

2193

12228

1.70

106.92

5.4

3.8

116.39

91.71

ng/l

13.43

1976

10349

Dentofacial anomalies [including malocclusion]

1236

6347

2.01

106.36

6.0

3.1

77.91

76.86

ng/l

0.18

1100

5564

Autoimmune hyperthyroidism

405

1285

3.55

105.51

3.1

3.0

63.40

79.67

ng/l

2.87

375

1105

Gonarthrosis [arthrosis of knee](FG)

3481

13733

1.53

104.72

3.5

3.6

86.14

90.60

ng/l

2.21

3020

11801

Coxarthrosis [arthrosis of hip](FG)

2544

11626

1.64

104.46

3.7

3.6

90.00

92.11

ng/l

0.50

2156

9886

Pacemaker

1725

9768

1.81

104.08

4.2

3.7

118.97

96.34

ng/l

14.19

1448

8115

Arthrosis

3291

11958

1.55

103.98

3.7

87.57

90.23

ng/l

0.66

2851

10324

Asthma-related pneumonia

1808

10643

1.78

103.84

4.5

3.9

103.86

91.05

ng/l

4.87

1605

8997

Benign neoplasm of other and unspecified endocrine glands

709

3031

2.56

103.65

4.8

3.8

97.82

91.69

ng/l

0.79

630

2580

Anxiety (asthma-related co-morbidities)

2481

12323

1.63

103.48

3.6

4.1

79.10

86.53

ng/l

3.81

2152

10906

Asthma, hospital admissions 3, pneumonia

1809

10667

1.77

103.22

4.5

3.9

103.87

91.00

ng/l

4.92

1606

9018

Asthma-related pneumonia or sepsis

1809

10667

1.77

103.22

4.5

3.9

103.87

91.00

ng/l

4.92

1606

9018

Chronic lower respiratory diseases

5603

22146

1.40

103.15

3.9

4.0

93.59

88.66

ng/l

2.65

4903

19221

Other and unspecified dermatitis

2394

15156

1.64

102.94

4.9

3.7

101.33

87.75

ng/l

6.17

2103

13093

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

4495

20761

1.44

102.72

4.3

3.8

97.41

90.80

ng/l

3.84

3893

17931

Cardiomyopathy

864

4005

2.30

102.70

5.3

3.7

125.31

84.15

ng/l

18.72

782

3427

2044

12357

1.70

102.23

4.3

4.1

93.37

87.40

ng/l

1.67

1794

10704

Injuries to the head

5026

23691

1.41

101.75

3.8

4.0

93.03

89.28

ng/l

1.64

4240

20684

Visual disturbances and blindness

2415

15375

1.63

101.70

4.3

3.8

93.40

89.13

ng/l

1.13

2123

13186

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

622

2540

2.71

101.20

6.0

3.9

131.01

97.55

ng/l

7.93

550

2135

Exclusions for E4_PCOS_BROAD

886

4181

2.27

100.98

4.6

4.4

87.20

85.77

ng/l

0.13

764

3668

Other symptoms and signs involving cognitive functions and awareness

2165

12605

1.68

100.69

3.4

3.8

91.75

94.29

ng/l

0.58

1823

10735

AV-block

886

3773

2.27

100.49

4.6

3.4

117.94

84.93

ng/l

13.79

745

3142

Injuries to the hip and thigh

2274

13109

1.65

98.98

4.1

3.8

99.34

93.26

ng/l

1.38

1938

11128

Fungal Sepsis

291

787

4.45

98.87

6.8

3.4

133.50

80.72

ng/l

3.28

261

678

Dental operations

3256

11112

1.54

98.80

4.1

3.5

93.95

89.40

ng/l

1.71

2770

9511

Dysphagia

1227

6564

1.98

98.07

3.7

3.6

84.67

90.39

ng/l

1.21

1048

5633

Personality disorders, excluding more controls

1010

5045

2.08

96.73

3.5

4.1

86.86

86.42

ng/l

0.05

877

4527

Coxarthrosis

2331

9946

1.64

96.27

3.7

3.6

90.52

92.07

ng/l

0.31

1988

8492

Venous thromboembolism

2624

16723

1.58

96.07

4.6

3.7

104.19

92.17

ng/l

6.84

2287

14162

Disorders of tooth development and eruption

307

835

3.98

95.93

14.1

3.5

74.88

64.66

ng/l

1.36

300

775

Fracture of lumbar spine and pelvis

1158

6133

2.01

95.93

3.8

3.5

89.04

93.81

ng/l

0.95

962

5137

Recurrent or chronic depression

1730

7300

1.76

95.30

3.5

4.2

78.82

89.49

ng/l

4.85

1495

6481

Spondylosis

2466

13674

1.60

94.44

3.3

4.0

81.66

95.45

ng/l

12.70

2096

11706

Exclusions for E4_PCOS_CONSORTIUM

3367

14400

1.51

94.24

3.6

84.77

81.67

ng/l

0.85

2869

12571

Dental caries 1 and operation codes

4224

15321

1.45

93.71

4.2

3.7

92.27

89.40

ng/l

1.04

3614

13188

Other viral diseases

1255

6811

1.92

93.68

7.6

4.1

109.22

85.32

ng/l

9.58

1134

6053

679

2963

2.46

93.57

6.2

3.5

106.53

82.53

ng/l

6.12

604

2585

Benign neoplasm of other and ill-defined parts of digestive system

937

4667

2.16

93.43

4.4

3.5

96.70

90.94

ng/l

1.00

803

3925

Coagulation defects, purpura and other haemorrhagic conditions

972

4894

2.12

93.28

5.6

3.9

108.37

88.46

ng/l

5.31

868

4218

Myalgia

1064

5512

2.03

92.99

3.5

3.8

76.54

88.14

ng/l

5.05

918

4784

Chronic ulcer of skin, not elsewhere classified

444

1604

3.14

92.95

7.3

3.5

146.50

91.96

ng/l

8.24

397

1364

Implicit fungal Sepsis

271

730

4.49

92.82

6.8

3.3

137.94

76.75

ng/l

3.87

243

629

Fracture of femur

1414

7320

1.86

92.66

4.1

3.5

98.83

95.61

ng/l

0.52

1188

6056

Abnormal findings on diagnostic imaging of lung

2278

14249

1.62

92.34

4.2

3.8

98.23

94.82

ng/l

0.70

1983

12145

Reimbursement for rheumatic diseases

2747

18345

1.54

91.70

4.2

3.8

81.94

89.02

ng/l

3.04

2433

15745

Vitamin deficiency

338

1055

3.69

91.36

4.6

3.9

89.29

88.94

ng/l

0.02

276

922

Vitamin deficiency, wide

338

1055

3.69

91.36

4.6

3.9

89.29

88.94

ng/l

0.02

276

922

Explicit bacterial Sepsis

543

2176

2.71

90.73

7.2

3.3

132.74

83.71

ng/l

12.26

483

1847

Gastroduodenal ulcer

1302

7261

1.88

90.12

5.1

3.7

113.61

96.24

ng/l

5.09

1122

6104

Any operation in hilmo

163

8.86

89.83

4.2

1.8

76.26

62.99

ng/l

1.06

151

Missing teeth due to accident, extraction or parodontitis

629

2715

2.52

89.76

7.1

3.3

120.98

87.12

ng/l

8.50

555

2312

Disorders of phosphorus metabolism and phosphatases

22.71

89.59

8.9

4.2

96.88

71.32

ng/l

1.10

Acute nephritic syndrome

197

429

5.78

89.50

11.8

3.8

129.86

76.75

ng/l

7.42

185

379

Iron deficiency anaemia secondary to blood loss (chronic)

882

4370

2.17

89.16

5.5

3.6

123.24

88.76

ng/l

10.01

739

3693

Benign neoplasm: Colon, unspecified

1262

7043

1.90

89.06

5.1

3.7

108.60

94.54

ng/l

4.65

1092

5954

All anxiety disorders

2492

13109

1.57

88.91

3.6

4.0

79.00

87.08

ng/l

4.43

2163

11572

Asthma, including avohilmo

5354

23178

1.37

88.40

3.7

4.1

90.03

90.02

ng/l

0.00

4694

20056

Viral pneumonia

637

2781

2.46

87.92

6.6

3.8

116.03

84.01

ng/l

9.18

562

2395

Asthma/COPD (KELA code 203)

4320

22086

1.41

87.45

3.6

4.0

89.23

88.69

ng/l

0.13

3754

19163

Hypoglycaemia, other or unspecified

413

1476

3.12

87.41

6.6

4.4

121.07

90.83

ng/l

5.63

372

1296

Lumbar disc prolapse

2784

14870

1.53

87.33

3.4

4.1

83.99

94.45

ng/l

6.79

2467

12870

Dental caries 3 and operation codes

4359

16098

1.42

87.32

4.1

3.8

92.25

89.01

ng/l

1.28

3737

13890

Gonarthrosis

2937

11314

1.53

87.15

3.5

3.6

84.86

90.70

ng/l

3.14

2557

9727

Other disorders of lacrimal gland

1643

9904

1.74

87.10

3.9

3.6

87.70

88.13

ng/l

0.06

1393

8486

Other and/or unspecified nontoxic goitre

522

2119

2.74

86.44

3.0

3.4

63.37

88.33

ng/l

15.09

479

1787

Benign neoplasm of other and unspecified endocrine glands

709

3280

2.35

86.22

4.8

3.8

97.82

90.58

ng/l

1.00

630

2822

Injuries to the thorax

2018

12808

1.63

85.93

4.1

4.0

95.29

95.44

ng/l

0.02

1703

11025

All influenza (not pneumonia)

712

3284

2.30

85.41

6.4

3.9

118.76

83.96

ng/l

9.49

636

2857

Disorders of synovium and tendon

2317

13641

1.57

84.59

4.0

3.8

86.14

89.32

ng/l

0.88

2019

11806

Acute bronchitis

1920

11842

1.65

84.41

5.1

3.8

105.71

90.11

ng/l

7.03

1629

10132

Other CVD

1016

5392

2.01

84.25

4.6

3.6

112.22

96.83

ng/l

3.22

849

4489

Other systemic involvement of connective tissue

1409

8245

1.80

83.82

3.3

3.4

79.95

87.67

ng/l

2.56

1216

6955

Dental caries 1

3824

13858

1.44

83.58

4.1

3.6

92.29

89.16

ng/l

1.13

3279

11909

Myocardial infarction, without ST-elevation

1919

11176

1.65

83.53

5.3

3.7

131.78

96.31

ng/l

24.59

1646

9350

Selective serotonin reuptake inhibitors

4601

17725

1.39

83.46

3.5

4.2

85.85

93.96

ng/l

6.43

3937

15445

Diabetic neuropathy

716

3381

2.35

83.35

8.0

4.8

150.65

110.43

ng/l

8.49

634

2906

Melanocytic naevi

1249

7056

1.85

82.92

5.7

3.9

102.79

88.60

ng/l

4.33

1140

6090

Convulsions, not elsewhere classified

968

4970

2.00

82.73

4.6

3.9

89.96

86.92

ng/l

0.38

851

4344

Dental caries, including avohilmo

3815

13848

1.44

82.71

4.1

3.6

92.23

89.16

ng/l

1.10

3271

11901

Behavioural syndromes associated with physiological disturbances and physical factors

1294

7376

1.82

82.54

4.6

4.0

90.94

84.55

ng/l

1.28

1132

6526

Polycystic ovarian syndrome, consortium definition

3296

13859

1.47

82.23

3.4

3.2

80.61

78.92

ng/l

0.40

2780

11932

Visual disturbances

2155

14032

1.59

82.22

4.0

3.8

90.54

88.82

ng/l

0.31

1905

12073

Other diseases of liver

886

4519

2.09

82.17

4.4

3.9

91.99

89.87

ng/l

0.25

777

3906

Injury, poisoning and certain other consequences of external causes

2582

8499

1.56

81.97

4.2

3.7

87.73

82.66

ng/l

1.75

2245

7384

Noninfective enteritis and colitis

2069

13327

1.60

81.88

4.5

4.0

90.71

89.41

ng/l

0.22

1839

11585

Other neurological diseases

3355

19065

1.45

81.80

4.0

3.8

96.19

91.80

ng/l

1.62

2903

16254

Injuries to the elbow and forearm

3135

19821

1.47

81.78

3.9

90.86

87.58

ng/l

0.97

2644

17148

Chronic pancreatitis

622

2779

2.42

81.76

5.6

4.3

115.31

95.63

ng/l

2.98

535

2405

Other anxiety disorders

1775

9731

1.66

81.69

3.5

4.0

77.45

86.05

ng/l

3.98

1539

8639

Unspecified fall

2238

14589

1.57

81.57

4.1

4.0

93.33

91.21

ng/l

0.42

1906

12578

Fracture of rib(s), sternum and thoracic spine

1376

8053

1.79

81.36

3.9

4.0

94.48

96.07

ng/l

0.21

1141

6895

Disorders of skin appendages

2010

12887

1.61

81.24

5.1

3.9

101.55

86.52

ng/l

7.14

1782

11294

Other headache syndromes

1870

11809

1.64

80.99

3.2

3.8

78.40

86.13

ng/l

3.51

1627

10286

Amputation of foot

211

527

5.00

80.89

11.1

4.0

176.95

103.31

ng/l

7.06

189

456

Primary_lymphoid and hematopoietic malignant neoplasms

1145

6375

1.89

80.70

4.1

4.0

89.52

94.83

ng/l

1.02

991

5388

Disorders of continuity of bone

505

2071

2.65

80.68

4.2

3.7

90.26

83.37

ng/l

0.40

448

1819

Molar incisor enamel hypoplasia

229

587

4.51

80.62

15.1

5.4

67.80

54.20

ng/l

1.84

223

565

Injuries to the knee and lower leg

5351

23129

1.35

80.59

4.1

3.9

92.38

89.39

ng/l

1.11

4679

20003

Exposure to other specified factors

3128

20588

1.46

80.18

4.1

92.75

89.61

ng/l

0.72

2751

17996

Mycoses

1231

7021

1.84

79.81

5.2

3.9

108.50

90.42

ng/l

3.63

1072

6034

Irritable bowel syndrome

1237

7050

1.83

79.68

3.3

3.5

78.45

84.79

ng/l

2.19

1065

6087

Viral warts

525

2206

2.58

79.41

8.8

4.0

117.08

82.81

ng/l

6.38

473

1945

Thyrotoxicosis with toxic multinodular goitre

428

1661

2.96

79.10

3.3

3.4

67.90

87.22

ng/l

5.72

378

1376

Multiple myeloma, excluding all cancers (controls excluding all cancers)

331

1119

3.45

79.07

4.4

3.6

95.78

94.78

ng/l

0.06

297

937

Hypoplasia of dental enamel , including avohilmo

216

545

4.65

78.83

14.8

5.6

68.50

54.90

ng/l

1.69

210

526

Deforming dorsopathies

1290

7468

1.80

78.82

3.8

4.0

81.89

90.48

ng/l

2.64

1122

6454

Disorders of lacrimal system

1972

12724

1.61

78.76

3.8

3.6

88.05

87.49

ng/l

0.08

1681

10857

Dental pulpitis 2

3444

12409

1.45

78.54

4.1

3.6

93.53

88.43

ng/l

2.09

2925

10654

Other diseases of anus and rectum

1381

8156

1.76

78.36

4.2

3.6

100.38

90.51

ng/l

2.65

1171

6922

Acute upper respiratory infections of multiple and unspecified sites

3203

16893

1.45

77.98

5.0

3.8

97.43

87.86

ng/l

4.98

2813

14722

Malignant neoplasm of urinary organs

567

2503

2.49

77.73

6.0

3.9

136.13

97.50

ng/l

8.84

500

2122

Myocardial infarction

2369

11323

1.55

77.69

5.5

3.6

128.97

88.12

ng/l

42.34

2057

9563

Hypotension

877

4562

2.06

77.47

4.6

3.6

111.93

97.64

ng/l

2.54

727

3781

Drug-induced cataract

208

532

4.89

77.36

10.4

3.9

146.89

80.45

ng/l

3.20

188

477

Streptococcal septicaemia

457

1827

2.74

77.31

7.2

3.4

136.40

82.90

ng/l

11.44

405

1559

Asthma, hospital admissions , main diagnosis only

3665

23804

1.41

77.21

3.8

4.0

91.07

88.73

ng/l

0.71

3221

20567

Dental caries 3

3985

14757

1.41

76.88

4.1

3.8

92.53

88.75

ng/l

1.52

3412

12715

Multiple myeloma and malignant plasma cell neoplasms

326

1116

3.40

76.19

4.4

3.6

96.76

94.79

ng/l

0.11

292

934

Wegener granulomatosis

161

343

6.19

76.05

9.4

3.9

118.36

86.06

ng/l

3.16

153

305

Other diseases of pleura

2087

12131

1.58

75.99

5.1

3.8

115.52

95.35

ng/l

9.33

1771

10304

Substance abuse, excluding more controls

2211

12803

1.55

75.58

3.8

4.3

95.76

ng/l

0.00

1899

11287

Acute sinusitis

2165

13345

1.55

75.18

4.6

3.8

91.74

86.83

ng/l

1.24

1908

11682

Calcific aortic valvular stenosis, operated

1461

8699

1.73

75.09

5.1

3.7

125.70

97.32

ng/l

14.41

1254

7193

Calcific aortic valvular stenosis

1461

8699

1.73

75.09

5.1

3.7

125.70

97.32

ng/l

14.41

1254

7193

Carpal tunnel syndrome

2768

17373

1.48

75.05

3.9

3.7

89.24

88.81

ng/l

0.08

2440

14873

Diseases of the ear and mastoid process

5253

20155

1.34

74.88

4.1

4.0

90.03

90.19

ng/l

0.04

4540

17626

Calcific aortic valvular stenosis, diagnosis (helper)

1455

8680

1.72

74.21

5.1

3.6

126.10

97.44

ng/l

14.58

1248

7176

Operations 2 for CAVS

1455

8680

1.72

74.21

5.1

3.6

126.10

97.44

ng/l

14.58

1248

7176

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1025

5623

1.88

74.04

3.2

3.9

82.44

86.17

ng/l

0.51

876

5039

Benign neoplasm of other and ill-defined parts of digestive system

937

5060

1.98

73.95

4.4

3.6

96.70

91.62

ng/l

0.82

803

4286

Calcific aortic valvular stenosis, including rheumatic fever

1460

8719

1.72

73.90

5.1

3.6

125.89

97.45

ng/l

14.47

1253

7210

Other disorders of ear

4199

20749

1.38

73.80

3.7

4.0

91.04

91.28

ng/l

0.05

3569

17998

Rotator cuff syndrome

2738

14075

1.48

73.58

3.6

3.9

85.76

93.10

ng/l

3.92

2399

12097

Malignant neoplasm of kidney, except renal pelvis

523

2287

2.52

73.42

6.1

3.9

134.80

97.61

ng/l

8.20

465

1948

Viral and other specified intestinal infections

836

4210

2.01

72.99

7.7

3.8

102.92

80.84

ng/l

4.95

757

3700

Dental pulpitis 2, only avohilmo

3490

12769

1.43

72.87

4.0

3.7

92.73

89.20

ng/l

1.28

2968

10971

Rheumatoid arthritis

1479

8213

1.70

72.73

3.5

3.4

84.22

87.95

ng/l

0.59

1285

7000

Soft tissue disorders related to use, overuse and pressure

1217

7096

1.79

72.73

4.0

3.8

96.80

91.94

ng/l

0.57

1069

6089

Angina pectoris

2804

13190

1.48

72.42

4.6

3.5

112.91

86.36

ng/l

24.61

2387

11165

Other obstructive and reflux uropathy

242

704

3.81

71.87

8.3

2.4

140.60

64.12

ng/l

7.95

212

605

Diseases of pulp and periapical tissues, including avohilmo

4977

19620

1.34

71.10

4.0

3.8

93.88

87.78

ng/l

3.44

4281

17034

Dental pulpitis 4

4979

19647

1.34

70.61

4.0

3.8

94.01

87.78

ng/l

3.55

4286

17057

Major coronary heart disease event excluding revascularizations

3024

14819

1.45

70.59

5.1

3.7

123.00

89.89

ng/l

37.16

2604

12536

Sequelae of external causes of morbidity and mortality

1193

6997

1.79

70.39

5.5

3.7

116.88

90.79

ng/l

7.92

1074

5955

Multiple myeloma and malignant plasma cell neoplasms

326

1170

3.23

70.10

4.4

3.8

96.76

96.93

ng/l

0.01

292

1002

Hernia of abdominal wall

1984

13138

1.56

70.07

5.2

3.9

107.69

93.10

ng/l

6.07

1726

11362

Thyroiditis, ILD-related definition

596

2788

2.29

69.91

3.8

3.5

83.03

79.86

ng/l

0.41

519

2396

Dental pulpitis 1

4973

19655

1.34

69.83

4.0

3.8

93.99

87.81

ng/l

3.51

4280

17064

DVT of lower extremities and pulmonary embolism

1952

12864

1.57

69.77

4.3

3.7

102.52

92.73

ng/l

3.71

1689

10889

Persons encountering health services in other circumstances

1602

10096

1.64

69.76

4.2

3.7

96.55

86.11

ng/l

2.84

1333

8799

Temporomandibular joint disorders

690

3397

2.13

69.41

3.5

3.6

74.19

84.93

ng/l

3.05

596

2941

Tubulo-interstitial nephritis, not specified as acute or chronic

367

1386

2.88

69.32

7.3

2.2

133.22

70.15

ng/l

11.79

320

1148

Polyuria

1017

5722

1.87

69.23

4.1

3.8

92.37

93.37

ng/l

0.12

871

4867

Need for other prophylactic measures

345

1276

3.04

69.12

7.5

4.2

95.79

85.22

ng/l

1.20

330

1131

Cardiomyopathies, Primary/intrinsic

567

2606

2.32

69.04

5.7

3.8

133.53

84.03

ng/l

15.82

516

2254

Other diseases of intestine

613

2918

2.25

68.85

5.7

3.7

112.34

92.71

ng/l

1.96

542

2470

Non-selective monoamine reuptake inhibitors

1836

11641

1.58

68.61

3.3

3.8

87.14

91.17

ng/l

0.98

1546

9990

Cardiomyopathy (excluding other)

584

2724

2.28

68.54

5.7

3.8

132.47

83.71

ng/l

16.13

531

2354

Acute upper respiratory infections

4696

22377

1.34

68.43

4.4

3.7

92.07

89.09

ng/l

1.10

4093

19277

Drug-induced osteoporosis with pathological fracture

158

367

5.81

67.93

3.6

79.47

80.27

ng/l

0.04

135

318

COPD (mode)

1377

6644

1.71

67.68

4.4

3.4

110.84

89.30

ng/l

8.18

1151

5641

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

488

2150

2.51

67.56

4.9

3.5

100.17

92.26

ng/l

0.88

423

1798

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2511

11860

1.49

67.44

4.4

3.8

100.58

92.11

ng/l

3.18

2145

10044

Excessive, frequent and irregular menstruation

1824

6494

1.61

67.39

3.5

3.3

78.64

79.12

ng/l

0.09

1555

5620

Symptoms and signs involving the nervous and musculoskeletal systems

2547

17831

1.47

67.36

3.6

4.0

88.80

90.82

ng/l

0.47

2192

15399

Paralytic ileus and intestinal obstruction

1161

6840

1.77

66.77

4.8

3.6

104.71

92.11

ng/l

2.15

995

5777

Acute pancreatitis

897

4911

1.92

66.74

5.0

4.0

110.77

94.90

ng/l

3.10

774

4209

Polyarthrosis

1006

5471

1.86

66.53

3.2

3.3

78.74

88.37

ng/l

3.49

827

4582

1986

12536

1.55

66.31

4.2

3.5

104.18

94.85

ng/l

2.91

1686

10415

Primary_lymphoid and hematopoietic malignant neoplasms

1145

6761

1.78

66.08

4.1

4.0

89.52

95.00

ng/l

1.06

991

5724

Benign neoplasm: Transverse colon

531

2443

2.37

65.87

5.0

3.8

106.02

96.17

ng/l

1.34

482

2054

Viral hepatitis, IBD co-morbidity

193

504

4.05

65.72

4.5

2.9

99.73

76.01

ng/l

2.55

176

460

Other diseases of arteries and capillaries

487

2163

2.44

65.35

8.0

3.5

141.59

88.89

ng/l

11.99

431

1841

Fracture of lower leg, including ankle

2437

16956

1.47

65.24

4.2

3.8

95.00

88.94

ng/l

2.06

2118

14587

Skin changes due to chronic exposure to nonionizing radiation

1893

11948

1.56

65.19

4.2

3.5

105.06

95.60

ng/l

2.80

1607

9885

Parodontitis or/and operation codes

2902

12268

1.44

65.10

5.7

3.7

107.65

87.86

ng/l

12.64

2541

10636

In situ neoplasms

1573

9592

1.62

64.94

4.2

3.5

101.10

89.00

ng/l

4.40

1343

8045

Disorders of parathyroid gland, other and/or unspecified

100

163

9.83

64.76

5.6

2.9

114.69

73.71

ng/l

2.43

139

Stroke, including SAH

2895

15354

1.43

64.74

4.6

3.8

108.49

92.56

ng/l

11.88

2456

13049

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

2299

10813

1.50

64.69

4.3

3.7

99.19

92.51

ng/l

2.08

1958

9111

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2172

14549

1.50

64.52

4.0

4.2

84.44

94.72

ng/l

5.28

1904

12681

Actinic keratosis

1841

11621

1.57

64.52

4.3

3.5

105.60

95.82

ng/l

2.87

1566

9600

Gastric ulcer

870

4777

1.92

64.34

5.1

3.7

108.37

95.22

ng/l

2.68

751

3994

Functional dyspepsia

1193

7158

1.74

64.18

3.7

3.6

86.05

87.21

ng/l

0.17

1019

6152

Stroke, excluding SAH

2756

14593

1.44

63.80

4.5

3.8

108.71

93.25

ng/l

10.70

2336

12367

Speech therapy

1286

7906

1.70

63.49

4.5

3.8

94.19

90.80

ng/l

0.53

1111

6755

Disorders of vitreous body and globe

2319

15771

1.48

63.41

5.0

3.6

108.31

89.22

ng/l

10.76

2007

13475

Melanocytic naevi

1249

7607

1.71

63.29

5.7

3.8

102.79

87.77

ng/l

4.77

1140

6590

Dental operations, only avohilmo

3332

12417

1.40

62.93

3.8

4.0

92.09

94.06

ng/l

0.52

2839

10641

Fibrosis and cirrhosis of liver

424

1816

2.58

62.58

5.4

3.9

102.98

91.55

ng/l

1.21

384

1557

Disturbances of skin sensation

1126

6690

1.75

62.56

3.6

3.8

80.27

87.34

ng/l

1.89

1003

5805

Disorders of adult personality and behaviour

1067

6242

1.77

62.23

3.4

4.1

84.49

86.67

ng/l

0.31

929

5590

Disorders of vitreous body

2254

15376

1.48

61.91

5.0

3.6

107.99

89.06

ng/l

10.27

1955

13127

Purpura and other haemorrhagic conditions

654

3317

2.10

61.88

5.6

4.1

108.42

89.82

ng/l

3.44

587

2861

Haemolytic anaemias

240

776

3.58

61.73

8.6

4.1

125.40

85.05

ng/l

4.83

209

689

Major coronary heart disease event

3228

15803

1.40

61.49

5.2

3.7

122.10

88.98

ng/l

40.19

2794

13392

Renal agenesis and other reduction defects of kidney

13.42

61.46

10.0

4.1

132.47

65.02

ng/l

4.07

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

674

3465

2.07

61.37

5.1

4.3

102.62

98.03

ng/l

0.48

596

2993

Pain in thoracic spine

675

3458

2.05

61.30

3.2

3.9

74.58

90.60

ng/l

6.16

603

2989

Unspecified contracted kidney

107

11.76

61.28

8.8

3.1

167.64

70.23

ng/l

4.51

Disorders of sclera, cornea, iris and ciliary body

2292

16031

1.47

60.99

4.7

3.8

98.43

90.04

ng/l

3.08

2013

13874

Other blood glucose lowering drugs, excl. Insulins

834

4607

1.92

60.90

4.5

3.7

108.77

92.06

ng/l

4.06

696

3863

Other diseases of upper respiratory tract

5081

20601

1.31

60.85

3.9

4.0

87.33

92.47

ng/l

3.14

4431

17754

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1042

6026

1.77

60.72

5.8

3.9

75.75

79.61

ng/l

0.70

929

5414

Undetermined asthma, excluding more controls

570

2761

2.18

60.28

4.0

3.2

86.03

79.50

ng/l

1.05

501

2355

KRA_PSY_EATING, excluding more controls

288

1017

2.96

60.04

4.1

3.5

75.88

65.26

ng/l

0.99

256

946

Benign neoplasm: Sigmoid colon

842

4685

1.90

60.01

4.6

3.8

98.30

94.92

ng/l

0.45

745

3936

Benign neoplasm: Ascending colon

645

3302

2.10

59.95

4.8

3.7

110.69

94.01

ng/l

3.73

569

2764

Amyloidosis, other/unspecified

147

351

5.26

59.93

5.9

3.0

126.09

84.73

ng/l

1.02

129

303

Amyloidosis

164

423

4.72

59.91

5.9

3.1

126.42

88.69

ng/l

1.00

142

364

Elevated blood glucose level

433

1899

2.48

59.89

6.0

4.0

106.95

90.27

ng/l

2.58

384

1648

SLE (Finngen)

229

735

3.55

59.14

5.6

3.3

90.59

76.13

ng/l

1.91

211

647

Injuries to the ankle and foot

2720

17897

1.41

58.87

4.8

4.0

95.24

86.92

ng/l

3.57

2370

15747

Diseases of male genital organs

1945

6548

1.53

58.37

5.6

5.1

114.32

103.13

ng/l

2.86

1723

5841

Other noninfective gastroenteritis and colitis

1108

6696

1.72

57.93

5.0

3.9

93.48

86.74

ng/l

1.29

975

5762

Cholecystectomy

3159

20752

1.38

57.68

4.0

3.7

93.15

89.81

ng/l

1.09

2728

17761

Myocardial infarction, strict

2114

10677

1.49

57.36

5.4

3.6

127.70

88.58

ng/l

36.21

1832

9001

Acquired haemolytic anaemia

182

521

4.19

57.25

8.6

3.9

129.42

86.28

ng/l

3.85

160

459

Zoster [herpes zoster]

862

4900

1.86

57.25

5.0

3.5

101.80

91.25

ng/l

2.08

729

4128

Acute pancreatitis (for exclusion)

897

5149

1.83

57.11

5.0

3.9

110.77

94.17

ng/l

3.37

774

4418

Schizophrenia or delusion, excluding more controls

1148

6950

1.69

56.99

3.3

4.1

85.56

90.69

ng/l

0.91

958

6129

Fracture of forearm

2450

16420

1.43

56.98

3.8

3.7

90.26

86.00

ng/l

1.30

2055

14123

Personality disorders

1010

5969

1.75

56.86

3.5

4.0

86.86

86.10

ng/l

0.09

877

5337

Misadventures to patients during surgical and medical care

662

3472

2.02

56.73

5.6

3.6

110.99

88.32

ng/l

4.48

580

2966

Intracranial injury

2406

16592

1.43

56.66

3.5

4.1

89.69

91.74

ng/l

0.45

1984

14402

Special screening examination for other diseases and disorders

371

1543

2.54

56.63

5.8

3.4

139.00

86.62

ng/l

7.08

334

1325

Intestinal malabsorption

273

991

3.08

56.60

6.4

3.9

105.53

84.72

ng/l

2.32

240

868

Other viral diseases, not elsewhere classified

782

4299

1.90

56.59

7.2

4.2

99.99

83.69

ng/l

3.32

702

3820

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

2187

10524

1.48

56.47

4.2

3.7

100.07

92.60

ng/l

2.30

1853

8849

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

497

2366

2.27

56.34

6.4

3.8

127.22

90.82

ng/l

3.89

453

2041

Late syphilis

122

264

5.92

56.31

9.1

4.0

154.27

86.29

ng/l

5.37

110

236

Other disorders of adrenal gland

255

893

3.19

56.29

3.9

3.8

74.23

77.08

ng/l

0.22

213

785

Amputation of ankle bones

163

437

4.46

56.21

12.9

3.9

200.49

96.72

ng/l

10.48

147

376

Ischaemic Stroke, excluding all haemorrhages

2556

13914

1.43

55.95

4.5

3.7

108.73

93.81

ng/l

9.34

2165

11756

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

2212

10665

1.47

55.68

4.1

3.7

99.53

92.58

ng/l

2.08

1873

8978

Unspecified privation

524

2550

2.20

55.62

5.7

4.0

111.80

89.26

ng/l

4.24

477

2208

Other skin changes

813

4590

1.87

55.33

5.9

3.7

110.34

91.80

ng/l

4.03

727

3881

Benign neoplasm: Transverse colon

531

2622

2.20

55.04

5.0

3.9

106.02

96.49

ng/l

1.25

482

2241

Adrenocortical insufficiency

219

715

3.48

55.01

3.9

3.5

72.26

78.42

ng/l

0.57

183

627

Unspecified mental disorder

1630

10878

1.54

54.98

3.4

4.1

83.56

91.07

ng/l

2.30

1377

9513

Symptoms and signs involving speech and voice

1473

9663

1.58

54.85

3.8

3.7

83.77

89.81

ng/l

1.53

1280

8289

Other benign neoplasms of skin

1577

10279

1.55

54.81

4.5

3.7

98.74

90.61

ng/l

2.00

1349

8670

Other specified disorders of kidney and ureter

223

741

3.47

54.76

9.2

3.5

156.96

82.17

ng/l

5.71

200

645

Fibromyalgia

416

1857

2.39

54.65

2.6

3.5

70.64

81.36

ng/l

1.58

368

1624

Candidiasis

640

3364

2.02

54.57

5.0

3.7

106.37

85.77

ng/l

2.00

538

2895

Migraine

1860

10800

1.50

54.52

3.1

3.8

70.88

82.75

ng/l

9.77

1664

9541

Sequelae with surgical and medical care as external cause

940

5551

1.78

54.51

5.7

3.7

118.51

91.07

ng/l

6.54

840

4701

Ventral hernia

1095

6718

1.70

54.47

4.9

3.7

101.67

91.97

ng/l

1.95

945

5702

Undetermined asthma

570

2868

2.09

54.42

4.0

3.3

86.03

82.39

ng/l

0.46

501

2441

Fracture of foot, except ankle

975

5797

1.75

54.12

5.1

3.9

92.87

87.91

ng/l

0.72

849

5075

Disorders of magnesium metabolism

106

10.00

53.95

4.8

3.7

101.05

94.98

ng/l

0.13

Diagnoses used for exclusion with ILD

1142

7091

1.68

53.93

4.2

3.9

89.73

94.64

ng/l

0.82

988

6055

Somatoform disorder

723

3962

1.91

53.63

3.3

3.7

79.19

85.31

ng/l

1.01

622

3439

Menorrhagia

1665

6092

1.56

53.46

3.2

3.3

75.87

80.85

ng/l

1.83

1402

5253

Other renal tubulo-interstitial diseases

160

435

4.24

53.42

9.4

2.3

126.62

64.37

ng/l

6.61

143

388

Specific personality disorders

874

5056

1.79

53.25

3.4

3.9

83.34

85.39

ng/l

0.29

762

4518

Early onset COPD, excluding more controls

822

4677

1.83

53.24

4.5

3.7

103.57

89.06

ng/l

3.04

704

4032

Cardiac arrest

261

796

3.00

53.17

6.3

2.3

141.32

65.87

ng/l

14.07

226

670

Malignant neoplasm of skin

2836

15767

1.39

53.17

4.1

3.6

102.66

92.81

ng/l

4.43

2407

13284

Open wound of head

2152

15026

1.44

52.96

4.0

4.3

95.82

94.79

ng/l

0.16

1776

13064

Weight loss

502

2459

2.20

52.89

3.7

4.1

79.39

90.46

ng/l

2.00

432

2114

Type 1 diabetes, definitions combined

406

1809

2.35

52.50

7.8

4.7

112.22

69.08

ng/l

8.66

375

1672

Degeneration of macula and posterior pole

2152

12588

1.45

52.44

4.0

3.5

102.53

92.53

ng/l

3.77

1756

10543

Neuromuscular dysfunction of bladder

440

2050

2.30

52.37

4.5

3.8

99.58

90.21

ng/l

0.83

382

1757

Acidosis

135

331

4.83

52.29

6.4

3.6

120.79

87.38

ng/l

2.09

115

290

Sarcoidosis

634

3372

1.99

52.20

4.4

3.7

87.01

90.15

ng/l

0.27

569

2902

Donors of organs and tissues

106

214

6.01

52.17

2.6

2.9

61.64

69.75

ng/l

0.92

194

Artrosis, including avohilmo

3637

15169

1.34

52.10

3.5

4.2

86.71

95.93

ng/l

5.26

3138

13223

Nonorganic sleeping disorders, excluding more controls

676

3652

1.92

51.86

4.1

4.0

87.59

87.23

ng/l

0.03

585

3249

Benign neoplasm: Stomach

504

2495

2.18

51.69

4.0

3.5

95.53

91.01

ng/l

0.46

439

2100

Alcohol use disorder, Swedish definition

2129

14018

1.44

51.62

4.0

4.4

99.46

97.71

ng/l

0.27

1847

12278

Other problems related to primary support group, including family circumstances

486

2296

2.17

51.23

8.0

4.0

67.76

71.14

ng/l

0.58

447

2092

Noninfectious colitis NAS

635

3398

1.97

51.12

5.1

3.9

96.17

86.94

ng/l

1.24

565

2927

Melanocytic naevi of trunk

507

2510

2.14

51.04

6.7

3.8

106.22

88.40

ng/l

3.23

465

2175

Persons encountering health services for specific procedures, not carried out

344

1459

2.52

50.83

5.5

2.8

107.11

76.02

ng/l

4.97

308

1269

Type 1 diabetes, strict (exclude DM2)

402

1810

2.33

50.72

7.8

4.7

112.35

69.24

ng/l

8.52

371

1677

Gonarthrosis,primary

4008

19582

1.31

50.68

3.4

3.9

85.06

94.48

ng/l

9.99

3458

16760

Mental and behavioural disorders due to psychoactive substance use

2288

15557

1.42

50.63

3.9

4.3

96.41

96.26

ng/l

0.02

1960

13643

Complications of internal orthopaedic prosthetic devices, implants and grafts

1061

6590

1.69

50.61

4.2

3.3

103.30

89.77

ng/l

1.98

900

5516

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2515

14534

1.40

50.36

4.0

3.6

102.02

93.50

ng/l

3.19

2124

12180

2232

14715

1.42

50.33

4.0

4.4

99.47

97.38

ng/l

0.36

1925

12878

Seborrhoeic keratosis

1042

6456

1.69

50.24

5.6

3.4

110.60

89.13

ng/l

7.04

925

5427

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

434

2048

2.27

50.08

4.7

3.6

95.92

83.03

ng/l

1.69

385

1759

Conductive and sensorineural hearing loss

3513

18643

1.33

49.97

3.7

3.9

91.54

92.39

ng/l

0.19

2920

16055

Other infectious diseases

412

1912

2.33

49.87

7.3

3.8

136.43

92.81

ng/l

4.24

355

1638

Dipeptidyl peptidase 4 (DPP-4) inhibitors

554

2865

2.06

49.83

4.9

3.9

118.54

93.33

ng/l

5.24

469

2429

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

612

2928

1.96

49.80

5.8

4.9

75.24

73.67

ng/l

0.15

555

2721

Chronic rhinitis, nasopharyngitis and pharyngitis

1316

8587

1.58

49.77

3.8

4.0

83.55

90.32

ng/l

2.02

1155

7482

Familial hypercholesterolemia

685

3784

1.90

49.72

5.5

3.3

115.34

90.19

ng/l

5.57

588

3168

Decubitus ulcer and pressure area

317

1321

2.64

49.64

7.8

3.4

147.15

92.38

ng/l

8.30

273

1106

Ovarian cyst

1629

6310

1.53

49.62

3.5

3.3

83.92

79.73

ng/l

0.67

1407

5458

Kela-code for severe mental illness

1463

9763

1.54

49.55

3.2

4.1

84.00

91.88

ng/l

2.21

1226

8528

Dental caries 1, only avohilmo

3745

14707

1.33

49.41

3.7

4.1

90.17

92.91

ng/l

0.93

3192

12706

Hyperplasia of prostate

1360

4992

1.60

49.37

5.0

4.7

114.58

107.11

ng/l

1.15

1183

4382

Transient ischemic attack

2349

14155

1.41

49.30

3.9

3.7

101.15

92.82

ng/l

3.17

2021

11952

Other local infections of skin and subcutaneous tissue

472

2311

2.18

49.30

7.3

4.1

118.65

88.27

ng/l

4.75

422

2014

Trochanteric bursitis

666

3667

1.92

49.24

3.5

85.37

86.81

ng/l

0.15

585

3106

Basal cell carcinoma, including avohilmo

2607

15167

1.39

49.21

4.1

3.6

102.77

93.43

ng/l

3.84

2198

12737

Basal cell carcinoma

2553

14986

1.39

49.17

4.1

3.6

103.35

93.47

ng/l

4.11

2154

12582

Other and unspecified local infections of skin and subcutaneous tissue

452

2183

2.21

49.06

7.5

4.1

120.93

87.70

ng/l

5.23

406

1900

Allergic asthma (mode), excluding more controls

862

4978

1.75

48.92

3.5

3.4

79.27

77.11

ng/l

0.31

781

4352

Substance abuse

2211

15244

1.41

48.69

3.8

4.4

95.76

96.41

ng/l

0.09

1899

13371

Immunodeficiencies

280

1113

2.79

48.63

5.1

4.0

86.62

80.52

ng/l

0.57

260

995

Cardiomyopathy, other and unspecified

376

1694

2.38

48.59

5.0

3.6

126.41

81.83

ng/l

11.24

340

1465

Abnormal weight loss

456

2229

2.21

48.45

3.7

4.1

78.63

91.82

ng/l

2.51

390

1917

Systemic lupus erythematosus

229

826

3.13

48.39

5.6

3.4

90.59

79.12

ng/l

1.32

211

730

Pulmonary heart disease, diseases of pulmonary circulation

1421

9506

1.55

48.30

4.1

3.7

105.18

92.60

ng/l

4.32

1218

8033

Persistent mood disorders

832

4896

1.77

48.20

3.6

3.7

89.92

87.83

ng/l

0.23

704

4205

Endocarditis

194

635

3.41

48.15

8.2

3.4

170.82

80.30

ng/l

10.15

175

553

Poisoning by drugs, medicaments and biological substances

901

5410

1.72

48.00

3.3

4.0

90.05

86.92

ng/l

0.32

777

4805

Enlarged lymph nodes

646

3537

1.90

47.82

3.9

3.7

77.63

87.04

ng/l

2.13

564

3053

Benign neoplasm: Ascending colon

645

3563

1.93

47.75

4.8

3.8

110.69

94.36

ng/l

3.54

569

3003

Background retinopathy and retinal vascular changes

155

452

4.06

47.36

8.5

3.7

145.28

86.20

ng/l

6.24

144

395

Localized swelling, mass and lump of skin and subcutaneous tissue

1320

8725

1.56

47.30

4.0

3.9

84.94

89.53

ng/l

1.26

1180

7483

Hypopituitarism

309

1293

2.56

47.14

4.9

4.6

85.66

77.34

ng/l

0.52

273

1185

Sensorineural hearing loss

3343

17964

1.33

47.10

3.6

3.9

92.38

93.09

ng/l

0.15

2763

15437

Persons with potential health hazards related to communicable diseases

1337

8762

1.55

47.09

7.0

4.2

109.28

82.45

ng/l

11.97

1192

7853

Hyperkinetic disorders, excluding more controls

300

1190

2.55

47.03

5.0

4.5

69.30

68.26

ng/l

0.07

267

1131

Nonalcoholic fatty liver disease

431

2078

2.22

47.03

3.5

4.0

80.98

84.05

ng/l

0.32

380

1826

2320

15178

1.40

46.98

4.0

4.3

99.84

96.71

ng/l

0.61

2000

13286

Disorders of conjunctiva

3385

21865

1.32

46.79

4.0

3.9

84.41

87.59

ng/l

1.21

2948

18976

Fall on same level involving ice and snow

2373

17475

1.39

46.77

3.9

92.95

89.52

ng/l

0.85

2072

15074

Dental caries 3, only avohilmo

3900

15519

1.31

46.59

3.7

4.1

90.03

92.38

ng/l

0.75

3322

13427

Rheumatism, unspecified

683

3853

1.87

46.54

3.0

3.5

77.39

85.49

ng/l

2.50

590

3273

Osteonecrosis

313

1338

2.57

46.43

5.3

3.6

109.27

88.04

ng/l

2.07

272

1161

Cervicalgia

883

5335

1.72

46.40

3.4

3.9

81.91

91.92

ng/l

2.73

789

4547

Voice disturbances

1169

7577

1.60

46.18

3.6

3.7

80.27

89.27

ng/l

2.58

1028

6520

Benign neoplasm: Sigmoid colon

842

5057

1.75

46.05

4.6

3.8

98.30

95.07

ng/l

0.42

745

4294

Intestinal stricture

1340

8953

1.55

45.90

4.9

3.8

108.26

92.61

ng/l

3.48

1158

7573

Other medical care

1631

11031

1.48

45.87

3.7

2.7

100.63

80.32

ng/l

9.31

1406

9288

Cervical disc disorders

1507

10287

1.51

45.87

3.5

4.1

83.72

94.97

ng/l

4.96

1329

8874

Special screening examination for infectious and parasitic diseases

712

2973

1.83

45.81

3.2

3.7

76.88

84.56

ng/l

1.41

621

2672

Use of pramipexole

1022

6458

1.66

45.51

5.4

3.6

111.22

90.58

ng/l

5.59

864

5451

Abnormal involuntary movements

610

3350

1.92

45.46

3.6

3.9

88.98

88.91

ng/l

0.01

531

2880

Artificial opening status

285

1182

2.65

45.18

5.9

3.3

113.93

83.02

ng/l

2.42

263

1034

Spondylolisthesis/Spondylolysis

791

4687

1.76

44.94

3.6

3.9

82.34

92.88

ng/l

2.46

687

4028

Hyperaldosteronism

173

557

3.56

44.77

5.8

3.4

109.93

83.08

ng/l

2.94

156

491

Seropositive rheumatoid arthritis

1092

6994

1.61

44.67

3.3

3.4

84.24

88.39

ng/l

0.51

955

5912

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

134

366

4.23

44.58

10.8

4.3

103.51

67.62

ng/l

3.68

127

339

Chronic sinusitis

1730

12179

1.45

44.37

3.7

3.9

83.29

91.33

ng/l

3.13

1510

10561

Allergic asthma (mode)

862

5116

1.70

44.24

3.5

79.27

79.79

ng/l

0.06

781

4468

DVT of lower extremities

862

5258

1.71

44.07

4.7

3.6

107.05

93.24

ng/l

3.05

760

4465

Other complications of surgical and medical care, not elsewhere classified

450

2258

2.12

43.97

4.4

3.5

96.81

82.41

ng/l

2.15

405

1944

Vascular disorders of the intestines

343

1559

2.38

43.75

6.0

3.5

128.70

95.33

ng/l

4.70

307

1305

Diseases of the myoneural junction and muscle

562

3049

1.95

43.71

4.2

4.0

96.44

93.02

ng/l

0.30

469

2617

Budesonide

553

2970

1.95

43.70

3.8

3.6

86.35

87.49

ng/l

0.11

487

2569

Other or unspecified ileus, impaction or obstruction

780

4636

1.75

43.68

4.7

3.6

103.15

93.22

ng/l

1.60

660

3906

Other diseases of lip and oral mucosa

687

3947

1.82

43.66

4.4

3.2

93.42

84.17

ng/l

1.37

588

3353

Phobic anxiety disorders

448

2230

2.08

43.64

4.1

82.38

78.21

ng/l

0.36

400

2037

Other symptoms and signs involving the digestive system and abdomen

757

4472

1.77

43.59

3.8

3.3

88.93

83.25

ng/l

0.68

623

3840

Abnormalities of gait and mobility

574

3148

1.94

43.38

4.3

4.1

98.78

94.20

ng/l

0.46

499

2683

Open wound of lower leg

638

3598

1.86

43.33

5.5

4.0

112.90

91.43

ng/l

2.49

565

3063

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

583

3217

1.92

43.02

5.1

3.6

120.09

99.98

ng/l

2.65

504

2629

Lung transplant status

146

7.31

42.93

8.0

5.2

115.44

85.96

ng/l

1.69

133

Lung transplantation

146

7.30

42.92

8.0

5.2

115.44

85.96

ng/l

1.69

133

Benign neoplasm: Rectum, anus and anal canal

855

5248

1.70

42.73

4.4

3.8

100.49

95.14

ng/l

0.90

744

4424

Inflammatory bowel disease

1240

8254

1.54

42.71

4.0

4.1

87.71

90.31

ng/l

0.38

1108

7239

Poisoning by medicine

799

4796

1.72

42.70

3.4

4.1

91.70

86.70

ng/l

0.52

693

4267

Pulmonary embolism

1281

8614

1.54

42.54

4.1

3.6

102.57

92.90

ng/l

2.57

1099

7273

Other and unspecified disorders of skin and subcutaneous tissue

344

1588

2.35

42.43

5.1

3.5

103.35

86.54

ng/l

2.01

282

1368

Nontoxic diffuse goitre

202

732

3.12

42.42

3.2

3.3

65.17

86.12

ng/l

4.41

170

624

Sequelae of cerebrovascular disease

1540

9393

1.48

42.40

4.6

3.7

107.48

95.26

ng/l

4.22

1289

7876

Subjective visual disturbances

1026

6588

1.62

42.19

3.6

3.7

89.50

87.86

ng/l

0.21

914

5634

Other diseases of pericardium

226

864

2.87

42.19

6.4

3.4

145.95

81.46

ng/l

6.26

203

748

Complications of cardiac and vascular prosthetic devices, implants and grafts

142

422

3.95

42.10

12.7

3.6

191.51

87.58

ng/l

9.73

124

364

Pulmonary heart disease

1281

8633

1.54

42.09

4.1

3.6

102.57

93.36

ng/l

2.37

1099

7289

Non-allergic asthma (mode), excluding more controls

780

4628

1.73

42.03

3.8

3.3

90.47

79.27

ng/l

2.35

689

3964

Speech and linguistic disorders, excluding more controls

299

1209

2.44

42.01

8.0

4.7

70.37

73.04

ng/l

0.26

279

1123

Generalized anxiety disorder

526

2806

1.94

41.97

3.1

3.8

73.25

78.51

ng/l

0.90

470

2507

Other pleural conditions

492

2598

2.02

41.73

5.6

3.8

128.27

97.64

ng/l

5.72

430

2219

Leiomyoma of uterus

2004

8126

1.42

41.67

3.4

3.3

82.95

79.74

ng/l

0.93

1704

7006

Visual impairment including blindness (binocular or monocular)

355

1671

2.30

41.64

6.2

3.9

125.47

91.25

ng/l

3.99

302

1398

Other and unspecified drugs and medicaments

402

1982

2.17

41.54

4.7

3.8

97.79

86.60

ng/l

1.20

356

1709

Umbilical hernia

1037

6688

1.60

41.53

5.7

4.2

112.90

95.64

ng/l

4.31

911

5828

Phlebitis and thrombophlebitis (not including DVT)

970

6179

1.63

41.37

5.1

3.6

109.56

90.06

ng/l

5.72

839

5287

Sleep disorders

816

4972

1.70

41.34

4.1

4.0

89.02

87.09

ng/l

0.21

710

4362

In situ neoplasms

1573

11065

1.47

41.31

4.2

3.5

101.10

89.65

ng/l

4.00

1343

9373

Benign neoplasm: Stomach

504

2702

2.00

41.23

4.0

3.7

95.53

91.40

ng/l

0.40

439

2283

Procreative management

1206

6744

1.55

41.17

5.2

4.4

78.98

86.98

ng/l

2.02

1103

5976

Melanocytic naevi of trunk

507

2708

1.97

41.13

6.7

3.8

106.22

87.01

ng/l

3.63

465

2379

Benign neoplasm: Rectum

759

4571

1.74

40.98

4.5

3.8

100.54

95.37

ng/l

0.80

668

3853

Hallux valgus (acquired)

1480

7386

1.49

40.93

3.0

3.4

77.24

86.49

ng/l

4.81

1251

6292

Emotionally unstable personality disorder

428

2152

2.07

40.77

3.0

3.8

76.74

77.38

ng/l

0.05

377

1938

Injuries to the shoulder and upper arm

3457

22848

1.29

40.47

3.9

4.0

90.84

92.26

ng/l

0.34

2991

19703

Disorders of ocular muscles, binocular movement, accommodation and refraction

1794

12810

1.42

40.44

4.5

4.0

85.10

86.83

ng/l

0.27

1551

11245

Erosion of teeth, including avohilmo

743

4286

1.73

40.36

6.3

3.2

102.01

78.84

ng/l

5.21

642

3783

Other disorders of eyelid

1972

13975

1.40

40.25

3.7

3.6

93.40

91.51

ng/l

0.37

1684

11793

Nail disorders

385

1888

2.17

40.19

6.2

4.0

120.68

82.58

ng/l

5.83

339

1654

COPD-related respiratory insufficiency

550

3046

1.91

40.16

5.8

3.9

132.37

100.23

ng/l

7.04

460

2593

Vitamin B12 deficiency anaemia

527

2880

1.94

40.09

4.2

3.5

106.91

90.35

ng/l

2.59

435

2407

Substance use, excluding alcohol

713

4225

1.74

40.08

4.0

4.2

92.12

91.49

ng/l

0.05

601

3749

Parodontitis, under 40 years, or operation codes

277

1178

2.44

39.91

9.8

4.0

121.70

79.26

ng/l

4.37

258

1088

SLE, ICD10

213

820

2.92

39.82

5.6

3.4

88.75

77.31

ng/l

1.29

196

727

SLE, strict definition

213

820

2.92

39.82

5.6

3.4

88.75

77.31

ng/l

1.29

196

727

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1025

6641

1.58

39.82

3.2

4.0

82.44

85.97

ng/l

0.48

876

5910

Corns and callosities

350

1668

2.26

39.78

7.1

3.6

137.66

85.78

ng/l

7.26

314

1424

Diseases of external ear

1361

9391

1.49

39.46

4.5

4.0

98.19

90.76

ng/l

1.57

1118

8116

Abnormal results of function studies

394

1967

2.13

39.20

5.0

4.2

102.83

88.03

ng/l

1.98

356

1720

Filling of root of tooth

180

639

3.16

39.12

10.9

3.9

133.18

82.48

ng/l

5.79

174

569

Urticaria and erythema

1433

9995

1.47

38.97

4.2

3.9

85.75

85.63

ng/l

0.01

1253

8717

Other crystal arthropathies

135

410

3.90

38.93

4.8

3.8

98.43

97.06

ng/l

0.05

107

341

Crystal arthropathies, rheuma endpoint

135

410

3.90

38.93

4.8

3.8

98.43

96.28

ng/l

0.08

107

341

Retinal detachments and breaks

1486

10459

1.46

38.91

5.2

3.6

111.82

90.32

ng/l

9.68

1283

8943

Other endocrine disorders

268

1106

2.52

38.81

6.9

5.4

73.31

65.97

ng/l

0.53

226

1022

Parodontitis, under 40 years

274

1177

2.41

38.60

9.7

4.0

120.95

79.29

ng/l

4.20

255

1087

Benign neoplasm: Descending colon

331

1566

2.29

38.53

4.8

3.7

107.05

94.33

ng/l

1.40

304

1315

Opening and dilatation of root channel of tooth

281

1237

2.43

38.36

8.2

3.8

114.67

82.23

ng/l

4.56

261

1105

Pain and other conditions associated with female genital organs and menstrual cycle

721

4155

1.71

38.05

3.1

3.4

69.26

76.68

ng/l

1.77

613

3679

Other congenital malformations of the digestive system

243

1007

2.63

38.00

10.0

5.6

88.50

73.02

ng/l

1.63

235

920

Fitting and adjustment of other devices

1442

9411

1.47

37.87

3.8

2.7

96.16

82.90

ng/l

5.09

1171

7824

Diseases of salivary glands

767

4710

1.69

37.83

4.1

3.2

88.96

83.15

ng/l

0.89

664

4044

Enthesopathies of lower limb, excluding foot

859

5421

1.64

37.78

3.7

4.1

84.50

91.43

ng/l

1.44

752

4711

Mixed hyperlipidaemia

201

766

2.87

37.74

4.9

3.4

129.46

89.98

ng/l

3.23

167

667

Pruritus

501

2746

1.93

37.68

6.4

3.5

118.65

85.33

ng/l

7.02

446

2330

Dental pulpitis 4, only avohilmo

4799

20485

1.24

37.49

3.6

4.0

89.24

90.05

ng/l

0.21

4121

17803

Trigger finger

604

3499

1.80

37.37

4.7

3.9

94.40

90.55

ng/l

0.39

518

3034

Unspecified acute lower respiratory infection

591

3399

1.81

37.34

5.5

4.0

106.69

90.54

ng/l

2.52

528

2974

Myocarditis

173

606

3.02

37.25

4.1

2.1

94.87

59.91

ng/l

4.98

156

523

Other diseases of blood and blood-forming organs, wide

931

6027

1.60

37.14

4.9

3.8

96.73

90.23

ng/l

1.14

817

5180

Other disorders of veins

1659

11995

1.42

36.92

3.6

90.49

86.69

ng/l

0.99

1385

10278

Suicide or other Intentional self-harm

897

5746

1.61

36.86

3.3

4.0

85.67

87.62

ng/l

0.20

761

5097

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

207

5.36

36.77

9.2

4.2

162.23

94.31

ng/l

3.81

183

Open wound of ankle and foot

412

2131

2.03

36.73

7.3

4.3

131.70

90.87

ng/l

6.99

358

1881

Fracture of shoulder and upper arm

1507

10728

1.44

36.72

4.1

3.9

93.91

90.91

ng/l

0.51

1285

9166

Disorders of psychological development

419

2002

2.01

36.72

7.1

5.1

68.29

73.44

ng/l

0.77

386

1843

Cyst of kidney

339

1649

2.22

36.71

7.2

3.4

126.37

89.95

ng/l

7.23

299

1416

Other disorders of bone

751

4621

1.68

36.68

4.2

3.8

85.12

85.93

ng/l

0.08

661

4058

Nontoxic single thyroid nodule

351

1725

2.18

36.66

2.9

3.5

63.58

88.15

ng/l

11.23

287

1473

Pleural effusion

672

4040

1.74

36.57

5.5

3.8

120.29

98.56

ng/l

5.16

572

3419

Extrapyramidal and movement disorders

1566

11250

1.43

36.53

3.2

3.8

85.39

92.80

ng/l

2.14

1325

9570

COPD

1892

11503

1.39

36.49

4.2

3.9

107.97

95.66

ng/l

4.21

1587

9807

Coronary revascularization (ANGIO or CABG)

1952

10051

1.39

36.42

5.2

3.6

129.17

88.91

ng/l

34.81

1703

8452

Migraine with aura

839

5307

1.62

36.25

2.8

3.8

67.58

82.59

ng/l

10.24

769

4670

Other diseases of pancreas

353

1747

2.17

36.25

5.6

4.0

111.23

93.29

ng/l

2.15

300

1501

Mouth breathing

1564

11223

1.43

36.16

4.1

4.5

94.63

92.15

ng/l

0.39

1370

9912

Migraine without aura

677

4063

1.71

36.12

3.6

4.0

75.78

78.57

ng/l

0.36

606

3641

Later onset COPD, excluding more controls

909

4555

1.62

36.11

3.9

3.4

113.94

92.51

ng/l

4.99

756

3790

Congenital malformations and deformations of the musculoskeletal system

373

1865

2.10

36.08

5.5

5.0

64.52

71.84

ng/l

1.16

348

1700

Pyogenic arthritis

300

1392

2.29

36.07

6.3

3.7

112.25

91.17

ng/l

2.27

257

1190

Multiple myeloma

166

596

3.21

35.94

3.6

99.02

92.36

ng/l

0.31

150

514

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

166

596

3.21

35.94

3.6

99.02

92.36

ng/l

0.31

150

514

Irregular menses

1762

10419

1.40

35.91

3.7

3.3

80.16

76.61

ng/l

0.87

1563

9121

Squamous cell neoplasms and carcinomas of the skin

583

3400

1.81

35.83

5.1

3.5

120.09

98.15

ng/l

3.06

504

2817

Leiomyoma of uterus

2781

12257

1.32

35.64

3.3

3.2

82.42

80.32

ng/l

0.67

2329

10534

Other enthesopathies

1174

8024

1.50

35.61

3.3

3.9

81.95

89.53

ng/l

2.19

1020

6968

Superficial injury of lower leg

969

6372

1.57

35.60

4.5

3.8

98.76

86.77

ng/l

2.63

835

5474

Non-allergic asthma (mode)

780

4833

1.65

35.54

3.8

3.4

90.47

82.64

ng/l

1.33

689

4131

Parodontitis, operation under 40 years and operation codes

257

1114

2.39

35.52

9.9

4.0

121.81

78.97

ng/l

4.19

238

1028

Other extrapyramidal and movement disorders in other diseases

964

6357

1.57

35.47

3.5

3.8

88.48

91.55

ng/l

0.45

829

5416

Drug-induced hypoglycaemia without coma

110

310

4.13

35.21

7.5

3.9

124.40

82.44

ng/l

3.43

273

Postprocedural disorders of digestive system, not elsewhere classified

194

759

2.87

35.19

5.5

3.8

88.05

86.34

ng/l

0.06

174

658

Syphilis

150

511

3.30

35.13

8.0

4.0

142.53

85.43

ng/l

5.27

135

458

Abnormal findings on diagnostic imaging of other body structures

582

3409

1.80

35.09

4.3

3.7

93.53

88.07

ng/l

0.63

506

2901

Other and unspecified myopathies

397

2072

2.04

35.01

4.0

100.84

96.69

ng/l

0.29

323

1775

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1619

11737

1.41

34.90

3.7

4.5

97.58

97.87

ng/l

0.03

1395

10314

Panic disorder

491

2719

1.86

34.86

3.4

3.8

80.98

78.65

ng/l

0.26

426

2437

Other benign neoplasms of skin

1577

11430

1.42

34.82

4.5

3.7

98.74

90.62

ng/l

2.00

1349

9774

Inflammatory diseases of female pelvic organs

2498

14508

1.32

34.71

3.3

76.55

79.35

ng/l

0.96

2123

12493

Delirium, not induced by alcohol and other psychoactive substances

507

2859

1.87

34.69

3.7

105.76

99.59

ng/l

0.62

413

2424

Keratitis

1360

9606

1.45

34.63

4.6

3.9

99.36

89.87

ng/l

2.61

1183

8301

Primary biliary cholangitis (PBC)

144

487

3.39

34.50

3.6

2.9

83.22

79.33

ng/l

0.18

131

424

Adenocarcinoma and Papillary adenocarcinoma of kidney

219

5.05

34.26

9.2

4.1

162.23

89.20

ng/l

4.30

196

Parodontitis, under 40 years and operation codes

254

1113

2.36

34.25

9.9

4.0

121.00

79.01

ng/l

4.01

235

1027

Haemorrhage, not elsewhere classified

196

777

2.77

34.24

8.3

3.5

150.77

90.26

ng/l

6.05

174

654

Other abnormal uterine and vaginal bleeding

1075

5155

1.54

34.11

3.1

3.2

79.35

81.82

ng/l

0.44

858

4399

Haemorrhoids and perianal venous thrombosis

1191

8234

1.49

34.08

3.6

3.5

86.01

91.02

ng/l

1.29

1018

6962

Mental and behavioural disorders due to alcohol

1855

13425

1.37

34.07

3.8

4.4

97.82

97.41

ng/l

0.05

1589

11798

Neovascular glaucoma

222

936

2.60

34.07

7.0

3.7

139.88

90.29

ng/l

4.44

194

805

Other chronic obstructive pulmonary disease

1811

11148

1.38

34.05

4.2

3.9

108.78

96.05

ng/l

4.20

1515

9501

Dental pulpitis 1, only avohilmo

4777

20595

1.23

33.92

3.5

4.1

88.43

90.39

ng/l

0.65

4094

17911

Epilepsy

1192

8227

1.48

33.78

4.0

4.2

87.03

89.95

ng/l

0.45

1015

7155

COPD related to multimorbidity

1628

10002

1.41

33.76

4.2

3.9

111.34

98.06

ng/l

4.59

1356

8449

Glaucoma secondary to other eye disorders

222

941

2.58

33.66

7.0

4.0

139.88

92.97

ng/l

4.03

194

814

Ulcerative colitis

934

6172

1.56

33.49

4.1

87.35

90.24

ng/l

0.39

833

5399

Other diseases of stomach and duodenum

312

1520

2.20

33.48

5.1

3.8

102.24

93.36

ng/l

0.87

283

1293

Polymyalgia rheumatica

632

3841

1.74

33.43

3.2

3.4

82.15

94.31

ng/l

3.08

532

3146

Coronary artery bypass grafting

1153

6019

1.50

33.41

5.3

3.7

135.16

92.29

ng/l

21.98

1005

5023

Asthma and allergy, excluding more controls

437

2333

1.91

33.38

3.3

3.4

76.07

72.32

ng/l

0.44

392

2067

Spondyloarthritis

704

4366

1.67

33.34

4.2

3.7

101.24

91.73

ng/l

1.06

619

3747

Glaucoma

2435

16587

1.32

33.17

4.1

3.7

99.00

92.46

ng/l

2.23

2026

14047

Other embolism and thrombosis

567

3347

1.77

33.05

5.4

3.6

109.27

91.97

ng/l

2.40

500

2843

Duodenal ulcer

474

2658

1.87

32.98

5.1

3.8

125.46

99.61

ng/l

3.31

406

2249

Acquired absence of limb

156

5.64

32.91

12.5

3.7

205.12

80.47

ng/l

4.95

135

Excessive attrition of teeth

1501

5803

1.43

32.85

5.2

3.2

88.38

80.80

ng/l

2.18

1309

5079

5-aminosalicylic acid

754

4765

1.63

32.85

3.9

86.17

87.89

ng/l

0.17

669

4163

Iridocyclitis

907

5991

1.56

32.84

4.9

3.8

98.11

90.18

ng/l

1.25

811

5161

Disorders of muscles

409

2195

1.95

32.65

3.9

4.1

84.93

93.11

ng/l

0.91

357

1897

Other respiratory disorders and diseases

857

5609

1.58

32.60

5.2

3.8

121.81

96.17

ng/l

4.48

717

4743

Other diseases of the respiratory system

857

5609

1.58

32.60

5.2

3.8

121.81

96.17

ng/l

4.48

717

4743

Immunodeficiency with predominantly antibody defects

154

556

3.11

32.58

5.7

4.1

84.91

77.97

ng/l

0.48

147

499

Transport accidents

1640

10655

1.39

32.57

4.1

4.0

89.90

88.00

ng/l

0.32

1450

9402

Alcohol use disorder, ICD-based

1488

10778

1.41

32.54

3.6

4.4

96.83

97.42

ng/l

0.07

1285

9468

Benign neoplasm: Descending colon

331

1672

2.14

32.48

4.8

3.8

107.05

93.60

ng/l

1.49

304

1444

Carcinoma in situ of skin of other and unspecified parts of face

392

2099

2.01

32.44

5.2

3.3

124.76

95.80

ng/l

3.49

334

1701

Other chronic obstructive pulmonary disease, including avohilmo

2214

14152

1.33

32.16

4.0

3.9

102.95

96.01

ng/l

2.01

1865

12106

Scoliosis

359

1855

2.03

32.16

3.8

4.0

75.12

80.84

ng/l

0.62

312

1587

Benign neoplasm: Caecum

463

2611

1.88

32.15

4.4

3.7

102.32

95.33

ng/l

0.75

398

2189

Meniscus derangement

2153

11215

1.34

32.07

3.6

3.7

88.28

90.59

ng/l

0.50

1851

9677

Acquired absence of organs, not elsewhere classified

228

4.60

31.96

10.9

3.3

156.72

75.29

ng/l

3.33

202

Crohn disease

501

2876

1.81

31.93

4.2

4.1

90.80

85.70

ng/l

0.43

449

2541

Eating disorder

288

1373

2.18

31.68

4.1

3.8

75.88

68.25

ng/l

0.62

256

1261

Benign neoplasm: Rectum, anus and anal canal

855

5640

1.58

31.58

4.4

3.8

100.49

94.75

ng/l

0.99

744

4795

Amiodarone users

454

2559

1.88

31.53

4.4

4.1

124.19

100.17

ng/l

5.78

408

2193

Carcinoma in situ of skin of upper limb, including shoulder

150

550

3.18

31.53

6.5

3.4

127.33

91.80

ng/l

1.99

132

468

Other and unspecified coagulation defects

230

1016

2.44

31.51

5.2

3.8

103.07

80.99

ng/l

1.80

209

901

Acute suppurative otitis media

809

4881

1.58

31.41

6.6

4.2

91.77

80.90

ng/l

1.76

730

4381

Fissure and fistula of anal and rectal regions

913

6088

1.54

31.39

3.6

3.8

90.74

89.37

ng/l

0.14

781

5262

Asthma and allergy

436

2373

1.87

31.36

3.2

3.5

75.97

74.98

ng/l

0.09

391

2104

Cholangitis (primary sclerosing, PSC)

290

1410

2.20

31.28

5.6

4.1

95.59

92.33

ng/l

0.23

264

1220

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

225

4.70

31.17

2.1

3.8

44.30

77.08

ng/l

9.21

199

Other disorders of bladder

481

2756

1.83

31.14

4.2

4.1

105.21

97.96

ng/l

0.58

379

2360

Other disorders starting during childhood or adolecense, excluding more controls

172

635

2.75

31.11

9.7

5.5

71.81

58.19

ng/l

1.66

167

606

ILD, hospital admission 2, with pulmonary infections

410

2244

1.93

31.11

4.5

3.6

112.29

91.13

ng/l

2.44

356

1896

Primary gonarthrosis, bilateral

2198

14855

1.32

31.09

3.2

3.8

85.71

93.66

ng/l

4.56

1860

12596

Urticaria

1128

7856

1.47

31.09

4.2

3.9

85.65

84.19

ng/l

0.17

990

6866

Carcinoma in situ of skin of trunk

177

708

2.83

30.98

5.5

3.7

127.17

98.35

ng/l

1.79

157

595

Problems related to lifestyle

365

1915

1.98

30.98

4.0

3.8

95.46

86.01

ng/l

0.74

318

1706

Infection of intervertebral disc (pyogenic)

253

4.35

30.86

5.5

4.0

138.41

87.45

ng/l

1.73

216

Melanocytic naevi, other sites/unspecified

318

1601

2.10

30.85

6.8

3.8

124.40

85.25

ng/l

4.93

286

1401

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

227

1013

2.45

30.75

5.6

3.8

129.69

95.56

ng/l

3.51

202

863

Eating disorders

357

1863

1.98

30.59

4.4

3.8

88.35

73.26

ng/l

1.56

315

1689

Organic, including symptomatic, mental disorders

2106

11667

1.33

30.48

3.2

3.8

91.72

97.73

ng/l

2.15

1682

9816

Personal history of other diseases and conditions

407

2215

1.90

30.45

5.5

2.9

88.01

63.83

ng/l

4.89

369

1980

Valvular operations

550

3285

1.74

30.43

4.7

3.8

123.79

83.41

ng/l

10.83

476

2799

Conjunctivitis

2915

20317

1.27

30.43

4.0

3.9

81.57

85.97

ng/l

2.00

2559

17660

Benign neoplasm: Adrenal gland

336

1742

2.06

30.41

4.1

3.8

99.93

92.91

ng/l

0.66

299

1491

Benign neoplasm: Rectum

759

4929

1.61

30.23

4.5

3.9

100.54

95.95

ng/l

0.67

668

4200

Invasive ventilation

329

1695

2.07

30.19

6.2

4.3

121.34

92.09

ng/l

3.85

284

1484

Ascites

324

1660

2.08

30.18

6.4

3.6

125.44

91.39

ng/l

5.14

295

1418

Type 1 diabetes, strict definition, subgroup 1

264

1241

2.21

30.07

7.4

5.0

106.67

65.46

ng/l

5.64

245

1168

Other coagulation defects

315

1599

2.09

30.01

4.8

3.8

104.40

86.38

ng/l

1.67

280

1403

Nonorganic sleeping disorders

676

4262

1.64

29.97

4.1

4.0

87.59

85.71

ng/l

0.18

585

3743

Alcoholic liver disease

395

2161

1.92

29.92

4.0

4.2

97.14

99.59

ng/l

0.18

344

1879

Schizophrenia or delusion

1148

8074

1.45

29.88

3.3

4.1

85.56

91.17

ng/l

1.05

958

7075

Other symptoms and signs involving the circulatory and respiratory systems

276

1335

2.19

29.85

5.0

3.8

92.34

84.99

ng/l

0.57

237

1143

Carcinoma in situ of skin of upper limb, including shoulder

150

567

3.08

29.81

6.5

3.7

127.33

97.77

ng/l

1.39

132

480

Sequelae of other external causes

255

1203

2.28

29.79

5.1

3.8

125.13

87.63

ng/l

3.26

239

1058

Other shoulder lesions

371

1990

1.95

29.71

3.7

4.1

81.37

89.60

ng/l

1.03

325

1732

Disorders of lacrimal system and orbit in diseases classified elsewhere

151

568

2.99

29.69

2.8

3.5

52.40

80.62

ng/l

9.99

136

509

Conjunctivitis (acute, non atopic)

1038

7164

1.48

29.53

4.9

4.1

89.14

85.45

ng/l

0.58

925

6293

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

572

3472

1.70

29.50

3.3

4.0

86.54

82.49

ng/l

0.33

492

3112

Superficial injury of head

887

5964

1.53

29.43

3.5

4.0

92.82

89.33

ng/l

0.48

736

5146

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

185

769

2.65

29.43

5.5

3.5

133.24

91.81

ng/l

4.35

163

653

Other respiratory diseases principally affecting the interstitium

756

4933

1.59

29.39

5.1

3.8

119.92

97.51

ng/l

2.98

662

4152

Schizophrenia, schizotypal and delusional disorders

1150

8117

1.45

29.35

3.3

4.1

85.35

91.03

ng/l

1.07

957

7115

Anosmia

256

3.86

29.27

2.9

2.3

74.13

73.93

ng/l

0.01

215

Covid-19 suspected case

729

4700

1.59

29.25

5.2

3.8

93.91

84.37

ng/l

1.57

609

4154

Cirrhosis of liver, NAS

242

1131

2.32

29.21

6.3

4.0

121.20

93.85

ng/l

2.57

217

984

Other degenerative diseases of the nervous system

1048

5482

1.49

29.18

2.9

3.7

87.61

92.04

ng/l

0.80

839

4653

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1917

9524

1.34

29.08

2.6

3.3

75.32

81.51

ng/l

3.10

1646

8067

Respiratory insufficiency

339

1779

2.00

28.99

4.1

3.5

111.83

94.39

ng/l

2.19

270

1510

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1916

9523

1.34

28.99

2.6

3.3

75.34

81.51

ng/l

3.08

1645

8066

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1149

8136

1.45

28.98

4.5

4.0

91.79

89.97

ng/l

0.23

979

7077

Insomnia

578

3539

1.69

28.98

4.0

84.82

85.73

ng/l

0.09

507

3103

Lichen simplex chronicus and prurigo

301

1528

2.11

28.92

5.3

3.7

116.03

89.13

ng/l

3.11

262

1317

Unstable angina pectoris

1624

10062

1.37

28.90

4.4

3.6

115.01

92.27

ng/l

11.72

1401

8418

Small fibre neuropathy

154

594

2.91

28.87

6.5

3.9

108.90

88.81

ng/l

1.08

135

519

Coxarthrosis, primary

2538

17485

1.28

28.86

3.6

3.8

89.32

94.21

ng/l

1.80

2136

14824

Graves ophthalmopathy, strict

138

504

3.11

28.84

2.9

3.5

52.78

81.05

ng/l

8.29

126

446

Nonischemic cardiomyopathy

250

1184

2.26

28.83

6.4

3.9

125.38

87.09

ng/l

4.20

230

1040

Pain associated with micturition

488

2874

1.78

28.74

4.2

3.6

84.81

85.67

ng/l

0.07

416

2444

Heartburn

416

2339

1.86

28.66

3.7

3.6

91.89

88.00

ng/l

0.28

351

2002

Carcinoma in situ of skin of trunk

177

736

2.71

28.62

5.5

3.7

127.17

100.12

ng/l

1.55

157

623

Type 1 diabetes, strict definition

276

1345

2.13

28.60

7.3

5.1

106.75

64.76

ng/l

6.23

256

1268

Viral pneumonia (known virus, not influenza)

137

501

3.08

28.45

7.9

4.5

123.21

79.80

ng/l

4.16

122

446

Other sleep disorders

425

2410

1.84

28.39

4.3

4.1

96.13

91.36

ng/l

0.48

367

2106

Other and unspecified nonorganic psychotic disorders

650

4114

1.62

28.22

3.1

4.2

82.25

87.55

ng/l

0.60

548

3663

Other eating disorders

187

786

2.50

28.17

4.3

4.0

77.09

64.20

ng/l

0.74

160

722

Diplopia

537

3266

1.72

28.04

3.8

92.00

90.87

ng/l

0.08

474

2792

Aortic aneurysm

841

5560

1.53

27.81

5.1

3.8

114.56

96.37

ng/l

4.37

722

4708

Spondylopathies (FG)

484

2858

1.75

27.76

3.6

3.8

85.90

87.87

ng/l

0.15

425

2503

Graves ophthalmopathy

149

577

2.90

27.74

2.9

3.6

52.59

81.07

ng/l

9.55

135

514

Disorders of vestibular function (Vertigo)

1949

14988

1.32

27.58

3.4

3.7

83.36

89.92

ng/l

2.95

1627

12774

Other congenital malformations

350

1891

1.94

27.46

5.2

4.8

90.74

73.54

ng/l

1.81

322

1707

Impingement syndrome of shoulder

943

6511

1.49

27.40

3.6

4.0

81.57

93.44

ng/l

3.76

840

5656

Carcinoma in situ of skin of other and unspecified parts of face

392

2216

1.89

27.38

5.2

3.3

124.76

96.19

ng/l

3.36

334

1826

Other epidermal thickening

217

996

2.36

27.36

5.2

3.7

114.52

83.97

ng/l

3.17

199

867

Mental retardation, excluding more controls

170

685

2.62

27.30

6.1

5.4

71.71

66.94

ng/l

0.33

156

646

Injuries to unspecified part of trunk, limb or body region

412

2349

1.84

27.30

5.1

4.2

105.25

89.36

ng/l

1.77

356

2043

Post-traumatic stress disorder

252

1211

2.16

27.29

3.5

3.7

78.33

72.49

ng/l

0.47

223

1107

Combinations of oral blood glucose lowering drugs

1047

7383

1.46

27.22

3.7

3.9

90.64

92.42

ng/l

0.25

913

6349

Crohn's disease NAS

269

1336

2.13

27.15

4.6

4.4

96.96

82.27

ng/l

1.04

243

1201

Otitis externa

831

5613

1.52

27.08

4.9

4.0

97.41

88.57

ng/l

1.44

713

4900

Other general symptoms and signs

210

939

2.35

26.93

3.7

4.1

71.57

75.72

ng/l

0.47

178

838

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

11.52

26.93

8.2

1.3

143.66

59.82

ng/l

2.75

Nonsuppurative otitis media

758

4314

1.55

26.89

5.8

4.2

87.01

81.70

ng/l

0.69

681

3814

Adhesive capsulitis of shoulder

672

4349

1.60

26.88

4.5

3.9

92.83

91.83

ng/l

0.09

602

3737

Other interventions on the root canals of the tooth

104

335

3.49

26.88

10.2

4.3

132.36

82.42

ng/l

3.28

307

Other postsurgical states

279

1413

2.10

26.88

5.0

3.1

92.94

77.77

ng/l

1.13

255

1234

Other specified/unspecified necrotizing vasculopathies

298

3.76

26.76

9.2

3.7

151.66

81.81

ng/l

2.90

266

Abnormal serum enzyme levels

1093

7686

1.44

26.75

4.6

4.5

97.57

102.76

ng/l

0.85

996

6664

Suppurative and unspecified otitis media

1166

7403

1.42

26.73

5.5

4.1

90.41

84.76

ng/l

0.83

1034

6546

Traumatic subdural haemorrhage

487

2871

1.73

26.55

4.2

3.8

112.72

98.86

ng/l

1.64

396

2432

Hepatic failure, not elsewhere classified

183

793

2.52

26.54

5.3

3.8

99.01

89.24

ng/l

0.58

162

698

Coeliac disease

508

3088

1.71

26.54

4.2

4.0

91.52

83.94

ng/l

0.80

431

2670

Emergency coronary revascularization (for ACS)

2259

12796

1.29

26.47

5.0

3.8

128.30

95.07

ng/l

28.55

1967

10741

Benign neoplasm: Caecum

463

2765

1.77

26.40

4.4

3.8

102.32

94.92

ng/l

0.80

398

2334

Speech and linguistic disorders

319

1619

1.97

26.39

8.0

5.3

68.36

71.48

ng/l

0.35

299

1502

1281

8320

1.40

26.37

3.6

3.4

105.99

95.46

ng/l

2.36

1022

6884

Internal derangement of knee

1319

9669

1.39

26.36

3.8

88.67

89.34

ng/l

0.09

1104

8414

Varicose veins

2695

16399

1.26

26.35

3.6

91.06

90.08

ng/l

0.21

2287

13978

Anterior Iridocyclitis

790

5317

1.53

26.29

5.0

3.9

97.85

90.97

ng/l

0.89

704

4588

Diseases of inner ear

2235

17327

1.29

26.29

3.5

3.7

84.86

91.37

ng/l

2.98

1870

14817

Sulfasalazine

1071

7620

1.44

26.25

3.3

3.6

80.88

87.59

ng/l

1.01

947

6571

Disorders of orbit

216

1006

2.31

26.22

3.6

3.8

65.32

83.60

ng/l

3.27

193

882

Rheumatoid arthritis, including avohilmo

1597

12127

1.35

26.14

3.4

3.6

82.85

89.63

ng/l

1.59

1389

10337

Mixed and other personality disorders

290

1496

2.02

26.09

3.4

4.0

94.11

81.08

ng/l

1.01

250

1355

Heart failure and hypertrophic cardiomyopathy

113

393

3.33

26.06

5.6

3.8

127.14

90.00

ng/l

3.10

107

346

Benign neoplasm of urinary organs

225

1069

2.28

26.06

5.5

3.5

104.18

89.59

ng/l

1.33

202

915

Renal cell carcinoma of kidney

185

813

2.49

26.06

5.5

3.8

133.24

100.39

ng/l

2.74

163

695

COPD, hospital admission 2, with asthma infections

1284

8034

1.40

25.96

4.3

3.9

114.30

98.06

ng/l

4.18

1067

6790

Disorders of refraction and accommodation

934

6474

1.47

25.92

4.9

4.1

81.70

83.53

ng/l

0.21

803

5736

ILD, hospital admissions 3, with pneumonia sepsis

354

1965

1.90

25.86

4.5

3.4

107.03

90.46

ng/l

2.02

306

1660

Manic episode

143

556

2.78

25.85

3.3

3.9

85.61

78.71

ng/l

0.25

129

500

Infections with a predominantly sexual mode of transmission

968

6768

1.46

25.84

4.8

3.8

89.74

82.98

ng/l

1.31

866

6019

Intestinal adhesions without obstruction

356

1978

1.90

25.83

4.7

3.7

100.54

91.41

ng/l

0.65

295

1665

Dermatophytosis

518

3189

1.69

25.82

5.5

4.0

112.22

93.78

ng/l

2.79

465

2763

Acute and subacute iridocyclitis

740

4933

1.55

25.80

5.1

3.8

99.03

90.16

ng/l

1.21

659

4259

Cervicobrachial syndrome

821

5582

1.51

25.79

3.3

3.9

77.30

90.22

ng/l

4.48

746

4816

Chronic laryngitis and laryngotracheitis

568

3576

1.65

25.74

3.6

3.7

76.17

91.92

ng/l

4.27

481

3071

Schizoaffective disorder

297

1555

2.00

25.71

3.1

3.9

88.01

80.46

ng/l

0.44

253

1390

Other hammer toe(s) (acquired)

768

4843

1.54

25.69

3.2

83.93

88.63

ng/l

0.86

648

4031

Paracetamol of NSAID medication

700

2249

1.60

25.65

4.2

5.6

84.97

94.59

ng/l

1.90

631

2025

Ingrowing nail

237

1152

2.19

25.54

6.6

4.1

119.95

82.65

ng/l

3.98

208

1030

Arterial embolism and thrombosis

268

1363

2.09

25.53

6.0

3.4

141.33

92.36

ng/l

4.02

233

1145

Oesophageal varices

197

897

2.38

25.40

5.6

4.2

98.28

91.76

ng/l

0.37

179

791

Benign neoplasm: Kidney

179

786

2.50

25.36

5.4

3.5

103.50

88.39

ng/l

1.12

159

680

Hyperfunction of pituitary gland

189

839

2.38

25.34

4.7

3.3

89.38

72.67

ng/l

0.85

162

754

Pericarditis

162

675

2.58

25.34

7.3

3.6

127.41

79.88

ng/l

4.12

149

592

Systemic lupus erythematosus, unspecified

167

712

2.58

25.28

5.0

3.5

83.39

77.46

ng/l

0.53

153

634

Cardiodefibrillation

1468

11062

1.36

25.22

4.3

3.9

114.43

97.06

ng/l

8.26

1258

9378

Alcohol-induced chronic pancreatitis

253

1264

2.12

25.21

5.5

4.6

117.26

98.57

ng/l

1.26

214

1133

Acute posthaemorrhagic anaemia

178

779

2.48

25.17

7.6

3.3

162.36

86.16

ng/l

7.07

151

677

Hydrocele

409

2372

1.78

25.16

6.5

4.8

128.66

105.57

ng/l

2.78

371

2072

Ulcerative colitis, NAS

519

3210

1.67

25.12

4.1

89.92

87.72

ng/l

0.18

457

2821

Oter anti-inflammatory and antirheumatic agents, non-steroids

1039

4046

1.46

25.11

3.6

5.6

94.16

118.09

ng/l

8.02

877

3507

Gonarthrosis, primary, with knee surgery

2381

15567

1.27

25.09

3.2

3.8

84.10

94.17

ng/l

8.16

2014

13179

Extreme obesity with alveolar hypoventilation

198

910

2.36

24.98

4.3

3.7

121.02

88.86

ng/l

3.35

161

804

Clear cell adenocarcinoma of kidney

227

1106

2.23

24.84

5.6

3.9

129.69

95.66

ng/l

3.39

202

960

Other inflammation of eyelid

532

3331

1.66

24.78

3.9

83.89

89.57

ng/l

0.64

454

2846

Pulmonary oedema

107

369

3.27

24.72

8.9

3.8

199.09

97.31

ng/l

2.51

100

316

Metatarsalgia

387

2229

1.81

24.72

3.6

3.8

82.83

86.63

ng/l

0.38

342

1925

COPD, hospital admissions

1819

11953

1.31

24.69

4.2

3.9

108.19

96.72

ng/l

3.56

1519

10169

Benign neoplasm: Adrenal gland

336

1869

1.91

24.62

4.1

4.0

99.93

91.60

ng/l

0.83

299

1602

Type of accident

1050

7537

1.43

24.61

4.4

4.0

90.36

89.68

ng/l

0.07

898

6537

Cerebral palsy and other paralytic syndromes

454

2734

1.73

24.59

3.8

4.1

81.86

88.17

ng/l

0.80

401

2371

Paget disease

100

6.49

24.54

2.8

3.7

72.02

90.69

ng/l

0.97

Seborrhoeic dermatitis

378

2170

1.82

24.44

4.9

4.0

101.70

91.11

ng/l

0.88

328

1882

Acute pharyngitis

457

2728

1.71

24.40

5.6

4.3

80.34

82.88

ng/l

0.25

418

2473

Other and unspecified nerve root and plexus disorders, also in other diseases

679

4498

1.55

24.36

3.0

3.9

77.64

90.96

ng/l

3.10

602

3908

Magnesium deficiency

9.15

24.36

4.2

4.3

103.10

91.44

ng/l

0.21

Melanocytic naevi, other sites/unspecified

318

1737

1.93

24.34

6.8

3.9

124.40

85.06

ng/l

4.90

286

1536

Other inflammatory liver diseases

288

1529

2.00

24.24

3.8

92.40

89.38

ng/l

0.25

253

1326

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

156

652

2.58

24.24

6.8

6.3

99.34

67.86

ng/l

2.03

148

617

Fibroblastic disorders

896

6276

1.46

24.18

3.9

4.0

94.52

95.84

ng/l

0.16

782

5377

Other disorders of eye and adnexa

545

3449

1.64

24.17

4.6

3.9

91.05

84.78

ng/l

0.84

493

2979

Fall on and from stairs and steps

977

6961

1.44

24.06

3.9

3.8

90.24

90.52

ng/l

0.03

820

5961

Superficial injury of hip and thigh

589

3798

1.61

24.04

4.0

3.7

102.80

91.86

ng/l

1.34

487

3193

Allergic purpura

151

627

2.61

23.97

6.4

4.2

115.88

81.84

ng/l

2.30

137

560

Other bursopathies

517

3243

1.65

23.80

4.0

3.9

92.53

94.94

ng/l

0.21

448

2767

Redundant prepuce, phimosis and paraphimosis

594

3813

1.59

23.73

5.3

5.2

117.50

104.15

ng/l

1.38

534

3420

Other diseases of jaws

268

1394

2.02

23.71

3.9

3.3

84.86

82.67

ng/l

0.15

231

1220

Xerosis cutis

321

3.45

23.69

4.3

3.7

101.36

84.93

ng/l

0.90

283

COPD, early/later onset

1824

12029

1.31

23.62

4.2

3.9

108.66

96.67

ng/l

3.83

1525

10235

Follow-up examination after treatment for malignant neoplasms

407

2407

1.76

23.57

3.4

3.3

93.37

92.20

ng/l

0.09

353

2012

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1392

8517

1.36

23.49

2.4

3.2

71.94

82.00

ng/l

6.52

1199

7172

Stomatitis and related lesions

313

1717

1.90

23.45

4.5

3.3

90.33

83.48

ng/l

0.68

273

1498

Other disorders of nervous system

286

1534

1.98

23.39

5.4

3.9

96.57

91.04

ng/l

0.41

243

1339

Pneumonia due to other infectious organisms, not elsewhere classified

149

622

2.60

23.37

6.3

3.5

106.42

81.10

ng/l

2.63

132

545

Viral pneumonia (unknown virus, not influenza)

263

1370

2.02

23.26

7.0

4.2

113.36

88.64

ng/l

2.75

236

1215

Faecal incontinence

423

2550

1.75

23.25

3.5

3.1

90.63

85.76

ng/l

0.36

333

2134

Other enthesopathy of foot (+metatarsalgia)

405

2403

1.76

23.24

3.6

3.8

82.41

86.39

ng/l

0.43

359

2075

Other/unspecified enthesopathies of lower limb, excluding foot

282

1503

1.97

23.21

3.0

4.1

74.83

86.20

ng/l

2.10

246

1310

Other symptoms and signs involving the urinary system

392

2308

1.77

23.15

5.2

4.0

105.14

92.94

ng/l

1.12

353

1989

Secondary parkinsonism, excluding more controls

118

442

2.90

23.06

2.7

3.4

77.65

91.01

ng/l

0.76

383

Pneumocystosis

103

366

3.26

22.95

7.2

4.2

113.44

82.74

ng/l

2.42

325

IBD patients in KELA-register

784

5415

1.48

22.68

4.1

4.2

86.59

89.53

ng/l

0.35

707

4796

Otitis media, unspecified

389

2102

1.76

22.64

5.9

4.3

68.25

73.88

ng/l

1.00

350

1885

Other and unspecified effects of external causes

940

6720

1.43

22.49

4.4

4.0

88.85

86.34

ng/l

0.32

819

5910

Other and unspecified mood [affective] disorders

233

1173

2.06

22.42

3.2

3.9

81.74

75.14

ng/l

0.67

207

1057

Osteonecrosis due to drugs

270

3.67

22.34

4.2

3.6

70.62

76.65

ng/l

0.26

241

Coronary angioplasty

1507

8870

1.33

22.30

4.7

3.6

125.29

89.61

ng/l

23.47

1304

7449

Flat foot [pes planus] (acquired)

392

2335

1.75

22.28

3.4

3.5

79.98

85.91

ng/l

0.51

333

1998

Superficial injury of abdomen, lower back and pelvis

542

3488

1.60

22.23

4.3

4.0

94.42

88.02

ng/l

0.67

464

3028

Other diseases of oesophagus

397

2374

1.75

22.23

4.2

3.7

102.42

94.92

ng/l

0.55

330

2007

Glucosamine medication

2212

14218

1.27

22.21

3.0

3.6

82.77

92.18

ng/l

5.76

1832

11963

Malnutrition

122

480

2.87

22.21

5.0

5.2

86.63

77.31

ng/l

0.43

104

431

Vascular diseases of the intestine

185

868

2.30

22.18

6.1

3.4

135.23

92.56

ng/l

3.43

166

731

Other specified and unspecified personality disorders

322

1811

1.85

22.18

3.9

84.30

80.81

ng/l

0.33

284

1625

Emotional disorders starting during childhood or adolecense, excluding more controls

133

522

2.59

21.99

5.2

4.8

67.22

57.88

ng/l

0.55

118

498

Endometriosis

1387

6220

1.35

21.98

3.3

3.2

76.48

80.14

ng/l

1.08

1191

5373

Cholangitis (primary sclerosing, PSC), with reimbursement 202

100

356

3.13

21.79

8.1

4.7

95.70

78.21

ng/l

0.81

325

Juvenile arthritis (FINNGEN)

181

841

2.26

21.75

5.7

4.9

103.89

69.65

ng/l

1.13

168

764

Cramp and spasm

204

999

2.18

21.75

3.5

4.3

89.48

86.72

ng/l

0.14

175

890

Amenorrhoea

227

1145

2.06

21.72

3.8

3.5

80.28

72.19

ng/l

0.71

204

1035

Papulosquamous disorders

1498

11567

1.32

21.69

3.9

87.93

90.34

ng/l

0.44

1269

10013

Carcinoma in situ of skin

353

2070

1.81

21.66

4.8

3.4

114.45

93.26

ng/l

2.76

292

1703

Left ventricular outflow tract obstruction (LVOTO), broad definition

369

2179

1.76

21.58

6.6

4.7

131.22

87.89

ng/l

5.88

339

1965

Type1 diabetes, definitions combined, early onset

242

1248

2.01

21.57

8.2

5.7

113.82

70.29

ng/l

5.26

222

1172

Other and unspecified urticaria

725

4991

1.49

21.57

4.4

3.9

83.54

83.19

ng/l

0.03

630

4359

TMD related operations

582

3836

1.56

21.44

4.2

3.9

82.38

84.86

ng/l

0.25

513

3386

Sicca syndrome [Sjögren]

398

2414

1.73

21.43

3.1

3.3

76.89

82.85

ng/l

0.68

339

2031

Calculus of lower urinary tract

221

1120

2.10

21.39

4.5

4.4

97.04

104.96

ng/l

0.43

197

982

Polyp of the female genital tract

1337

5861

1.36

21.37

3.4

3.3

79.03

81.62

ng/l

0.57

1148

5043

Impotence

195

943

2.18

21.27

7.0

4.9

131.30

105.14

ng/l

1.67

176

835

Unspecified misadventure during surgical and medical care

239

1250

2.04

21.25

5.2

3.8

109.68

91.00

ng/l

1.51

221

1097

Sequelae of injuries, of poisoning and of other consequences of external causes

838

5938

1.45

21.25

3.7

4.1

85.32

91.70

ng/l

1.22

730

5207

Familial hypercholesterolemia, with ischemic heart disease

404

2462

1.72

21.24

5.6

3.5

120.10

90.73

ng/l

4.17

345

2052

Overexertion and strenuous or repetitive movements

371

2207

1.75

21.11

3.9

4.0

85.98

87.98

ng/l

0.13

339

1948

Benign neoplasm of urinary organs

225

1158

2.09

21.11

5.5

3.7

104.18

91.66

ng/l

1.01

202

1003

Lesion of ulnar nerve

500

3203

1.61

21.02

4.0

95.21

94.33

ng/l

0.06

430

2782

Acute gastritis

320

1835

1.83

20.93

4.1

3.8

99.12

92.42

ng/l

0.56

272

1550

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

519

3365

1.60

20.89

3.5

3.9

84.34

95.96

ng/l

1.90

436

2829

Mental and behavioural disorders due to tobacco

322

1851

1.82

20.84

5.2

4.0

101.74

88.93

ng/l

1.11

282

1637

Blepharochalasis

1221

9243

1.36

20.79

3.5

3.6

88.82

91.10

ng/l

0.39

1032

7826

Childhood asthma (age<16), excluding more controls

315

1397

1.82

20.78

5.4

3.9

75.18

70.79

ng/l

0.31

283

1284

COPD, hospital admissions 3, with asthma pneumonia sepsis

1058

6639

1.39

20.74

4.3

3.9

116.56

99.76

ng/l

3.61

873

5611

Smoking dependency

322

1854

1.82

20.73

5.2

4.0

101.74

89.38

ng/l

1.06

282

1632

Migraine without aura and triptan purchases

500

3207

1.60

20.66

3.5

3.9

72.65

78.00

ng/l

0.90

451

2884

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

356

3.07

20.65

8.5

5.5

113.06

70.73

ng/l

1.61

331

Paralytic ileus

170

793

2.29

20.58

5.2

3.9

126.67

97.99

ng/l

0.75

154

679

Temporomandibular joint disorders, including avohilmo

1405

10804

1.32

20.54

3.5

3.7

74.82

82.95

ng/l

3.09

1217

9505

Other Crohn's disease

254

1363

1.95

20.49

4.8

4.1

94.87

81.81

ng/l

1.18

230

1222

Traction detachment of retina

154

4.42

20.41

10.6

3.6

230.11

83.27

ng/l

4.00

133

Drug-induced osteoporosis

269

3.52

20.40

4.3

3.1

78.25

73.37

ng/l

0.29

240

Benign paroxysmal vertigo

1166

8789

1.36

20.39

3.6

83.91

89.98

ng/l

1.74

956

7491

Benign neoplasm: Skin of other and unspecified parts of face

434

2716

1.66

20.38

4.5

3.6

105.48

91.05

ng/l

1.34

354

2276

Other and unspecified tonsillitis

952

5849

1.40

20.36

5.2

4.3

84.70

86.63

ng/l

0.23

869

5270

Total colectomy

180

862

2.23

20.36

5.7

4.1

114.99

85.22

ng/l

1.63

164

766

Total colectomy operation

180

862

2.23

20.36

5.7

4.1

114.99

85.22

ng/l

1.63

164

766

Acute and transient psychotic disorders

425

2640

1.66

20.34

3.5

4.0

90.75

86.57

ng/l

0.28

357

2324

Other/unspecified synovitis and tenosynovitis

439

2750

1.65

20.34

4.4

3.9

87.60

90.26

ng/l

0.21

373

2369

Carcinoma in situ of skin of ear and external auricular canal

247

3.55

20.28

6.6

4.0

130.14

107.57

ng/l

0.97

210

Moderate visual impairment, binocular

159

730

2.37

20.28

6.6

3.7

144.78

89.30

ng/l

3.40

132

604

Postmenopausal bleeding

1258

5204

1.36

20.27

3.0

3.2

79.35

83.13

ng/l

0.97

1064

4438

Necrobiosis lipoidica, not elsewhere classified

5.50

20.26

7.9

3.4

115.87

75.55

ng/l

1.38

Retinal vascular occlusion

505

3288

1.60

20.13

5.9

3.5

124.25

94.82

ng/l

5.95

432

2755

Inflammatory bowel disease, strict (require KELA)

784

5541

1.45

20.10

4.1

4.2

86.59

89.63

ng/l

0.37

707

4909

Benign neoplasm: Kidney

179

867

2.25

20.06

5.4

3.6

103.50

86.70

ng/l

1.30

159

752

Artificial joint operation, meniscal resection

3721

21090

1.19

19.86

3.4

4.0

85.02

94.62

ng/l

7.07

3209

18099

Other disorders of conjunctiva

570

3816

1.55

19.86

4.6

3.8

100.42

93.62

ng/l

0.71

474

3243

Psoriasis

1042

7747

1.37

19.78

4.1

4.0

86.77

91.67

ng/l

0.95

881

6737

Disturbance of activity and attention

284

1566

1.84

19.78

4.9

5.0

66.87

67.72

ng/l

0.06

254

1469

Other mental disorders due to brain damage and dysfunction and to physical disease

470

3024

1.62

19.76

3.5

3.7

86.07

97.47

ng/l

2.09

388

2557

913

6312

1.41

19.64

3.4

3.3

98.86

95.52

ng/l

0.43

716

5204

Childhood asthma (age<16)

315

1423

1.79

19.60

5.4

4.0

75.18

72.88

ng/l

0.14

283

1310

Noninflammatory disorders of female genital tract

1674

6585

1.30

19.60

3.4

3.3

77.55

78.68

ng/l

0.21

1426

5704

Superficial injury of thorax

542

3593

1.55

19.56

4.2

4.0

95.57

93.53

ng/l

0.18

467

3111

Pure hyperglyceridaemia

102

388

2.86

19.46

5.7

3.6

128.88

88.74

ng/l

2.52

339

Seronegative rheumatoid arthritis

467

3004

1.61

19.45

3.2

3.4

77.58

87.07

ng/l

1.96

409

2534

Disorders of breast

1932

14436

1.26

19.42

3.1

3.3

75.36

80.49

ng/l

2.59

1667

12352

Methotrexate

567

3803

1.54

19.36

3.3

3.4

75.34

85.37

ng/l

2.68

501

3254

Other arterial embolism and thrombosis

137

601

2.47

19.36

7.6

3.8

154.43

95.68

ng/l

2.57

124

516

Benign neoplasm: Small intestine

192

967

2.14

19.27

5.1

3.7

119.74

91.78

ng/l

2.60

162

830

Urethral stricture

214

1110

2.03

19.26

4.2

4.3

120.36

106.50

ng/l

0.62

187

964

Strabismus

948

6960

1.39

19.25

4.4

4.1

86.96

85.57

ng/l

0.13

831

6087

Retinal vascular disorders

508

3345

1.58

19.23

5.9

3.5

123.72

94.91

ng/l

5.79

435

2802

Aortic valve malfunction, age under 60 years

333

1979

1.75

19.10

6.8

4.6

137.58

89.79

ng/l

6.02

308

1775

Other follicular disorders

250

1367

1.91

19.04

5.5

3.9

116.35

83.51

ng/l

3.44

227

1228

Herpesviral [herpes simplex] infections

435

2769

1.63

18.95

4.6

3.7

89.20

84.66

ng/l

0.46

369

2399

Atopic dermatitis

1871

12824

1.26

18.90

3.8

3.9

76.92

83.29

ng/l

2.97

1642

11356

Other juvenile arthritis

156

724

2.27

18.88

5.8

5.0

107.43

66.54

ng/l

1.18

144

661

Agoraphobia

107

421

2.68

18.72

3.0

4.1

70.97

75.28

ng/l

0.26

391

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1163

8824

1.34

18.72

4.0

84.65

84.21

ng/l

0.06

1018

7824

conjunctival haemorrhage

322

1918

1.77

18.66

5.0

3.9

103.73

91.96

ng/l

1.22

271

1630

Adverse effects, not elsewhere classified

686

4806

1.46

18.63

4.7

4.0

89.35

83.55

ng/l

0.83

599

4188

Certain conditions originating in the perinatal period

279

1396

1.83

18.59

8.0

5.2

63.57

64.75

ng/l

0.13

265

1303

Malignant neoplasm of breast, HER2-negative

2113

12677

1.25

18.54

2.6

3.3

75.71

82.84

ng/l

4.36

1803

10691

Alcohol abuse, main dg, excluding more controls

447

2868

1.60

18.51

3.3

4.4

91.05

94.75

ng/l

0.31

379

2573

Discitis, unspecified

332

3.03

18.51

5.4

4.1

140.58

88.91

ng/l

2.72

284

Other or ill-defined heart diseases

198

1012

2.05

18.51

6.7

3.6

122.12

79.16

ng/l

3.72

178

877

Atopic dermatitis, strict definition with reimbursement

935

6682

1.38

18.43

4.4

4.1

77.70

80.12

ng/l

0.39

827

5979

Disorders of purine and pyrimidine metabolism

5.29

18.41

7.9

3.1

108.74

81.35

ng/l

1.06

Alcohol dependence

911

6706

1.39

18.38

3.5

4.5

98.03

99.43

ng/l

0.13

779

5927

Crohn's disease of small intestine

247

1364

1.89

18.27

4.1

95.32

83.13

ng/l

0.77

219

1226

Dental caries 2 and operation codes

2696

17903

1.21

18.27

5.1

3.9

87.32

86.72

ng/l

0.12

2392

15732

Acne

278

1581

1.80

18.25

6.7

4.3

110.07

70.52

ng/l

4.77

257

1442

Fenamates

670

3133

1.48

18.16

2.9

5.6

81.61

111.55

ng/l

15.45

573

2746

Malignant neoplasm of breast

2159

12770

1.24

18.16

2.6

3.3

75.53

82.86

ng/l

4.68

1841

10778

Hypertrophic cardiomyopathy

185

939

2.11

18.10

5.7

4.1

117.88

90.68

ng/l

3.07

171

820

Other disorders of patella

564

3823

1.51

18.08

3.1

3.7

75.56

86.20

ng/l

1.84

496

3363

Orchitis and epididymitis

290

1682

1.78

18.01

5.8

4.9

113.45

105.03

ng/l

0.58

247

1485

Ulcer of oesophagus

283

1640

1.81

17.97

4.2

3.9

117.28

100.77

ng/l

1.23

243

1397

Neuralgia and neuritis, unspecified

206

1084

2.00

17.87

3.5

3.7

82.14

87.35

ng/l

0.24

177

940

Polyglandular dysfunction, other/unspecified

25.50

17.85

2.4

3.6

64.60

81.14

ng/l

—

Dental caries 2

2748

18117

1.20

17.85

5.1

3.9

87.87

86.71

ng/l

0.26

2435

15913

Impacted cerumen

407

2597

1.64

17.84

4.3

4.0

95.83

92.75

ng/l

0.20

290

2232

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

326

1970

1.74

17.82

5.7

3.7

116.96

87.97

ng/l

3.26

276

1692

Thyrotoxicosis with toxic single thyroid nodule

180

3.90

17.78

3.8

3.2

68.88

75.97

ng/l

0.25

162

Collagenous colitis

366

2278

1.68

17.77

4.5

3.7

85.37

87.64

ng/l

0.19

316

1952

Other/unspecified crystal arthropathies

134

4.62

17.76

4.7

3.5

100.51

85.77

ng/l

0.37

116

Fracture at wrist and hand level

1146

8760

1.33

17.76

4.6

4.3

93.82

92.31

ng/l

0.15

1006

7675

Other hearing loss

1107

8300

1.34

17.74

3.8

3.7

105.82

96.60

ng/l

1.49

881

6987

Early onset COPD

822

6000

1.40

17.71

4.5

4.1

103.57

94.10

ng/l

1.53

704

5206

Unspecified urinary incontinence

391

2479

1.65

17.67

3.2

3.4

83.08

84.65

ng/l

0.12

293

2062

Superficial injury of wrist and hand

644

4507

1.46

17.53

4.1

4.2

89.55

86.42

ng/l

0.32

558

3979

Follicular adenocarcinoma of thyroid gland

130

4.55

17.49

2.6

3.9

44.88

82.04

ng/l

5.10

121

Colonic or urogenital fistula

987

7423

1.36

17.44

3.7

4.0

90.62

92.02

ng/l

0.16

845

6431

Abscess of anal and rectal regions

281

1632

1.78

17.42

5.6

4.3

118.18

90.33

ng/l

2.67

251

1447

Diseases of spleen

373

2.84

17.34

5.3

3.8

112.10

83.04

ng/l

1.32

330

Rash and other nonspecific skin eruption

396

2524

1.63

17.33

4.5

4.0

95.92

88.25

ng/l

0.74

357

2160

Other specified/unspecified systemic involvement of connective tissue

252

1430

1.86

17.32

3.5

80.25

80.16

ng/l

0.01

232

1229

Benign neoplasm: Endocrine pancreas

127

4.65

17.31

4.6

4.1

89.02

85.39

ng/l

0.11

107

Carcinoma in situ of skin

353

2200

1.69

17.30

4.8

3.6

114.45

95.85

ng/l

2.18

292

1843

Hyperkinetic disorders

303

1771

1.73

17.30

5.1

5.3

68.90

68.66

ng/l

0.02

270

1658

Presence of other devices

862

6361

1.39

17.26

4.4

3.1

104.73

87.17

ng/l

4.47

760

5359

Mixed connective tissue disease

276

1610

1.80

17.24

3.2

3.5

83.85

81.58

ng/l

0.13

251

1392

Monoarthritis, not elsewhere classified

175

882

2.09

17.21

4.3

3.8

90.99

86.00

ng/l

0.27

150

765

Acute bronchiolitis

224

1093

1.92

17.19

8.6

5.8

79.35

63.39

ng/l

1.47

210

1016

Anankastic personality disorder

145

681

2.25

17.17

3.0

3.8

78.85

78.39

ng/l

0.02

127

613

Carcinoma in situ of skin of ear and external auricular canal

273

3.20

17.16

6.6

4.8

130.14

110.17

ng/l

0.79

234

Thyroiditis

286

1686

1.77

17.09

3.1

3.6

77.72

83.42

ng/l

0.56

247

1444

Other chondrocalcinosis

276

3.23

17.03

4.6

3.7

96.93

87.49

ng/l

0.36

245

Fall involving bed

156

765

2.22

17.01

4.4

4.0

114.04

91.64

ng/l

1.29

130

645

Protozoal diseases

134

618

2.36

17.01

6.3

3.9

111.93

84.09

ng/l

2.33

124

549

Fentanyl

375

2365

1.64

16.96

4.9

3.5

123.01

94.11

ng/l

2.69

315

1961

Chronic hepatitis, not elsewhere classified

156

762

2.20

16.95

3.7

3.5

85.38

80.90

ng/l

0.26

143

676

Striking against or struck by other objects

1042

7915

1.34

16.92

4.2

4.5

90.18

92.24

ng/l

0.18

900

7005

Other (seronegative) rheumatoid arthritis, wide

778

5680

1.41

16.92

3.4

3.5

79.12

89.75

ng/l

3.21

669

4799

Progressive vascular leukoencephalopathy

173

884

2.13

16.89

2.9

3.1

90.85

97.44

ng/l

0.44

145

716

Polyarteritis nodosa

133

4.34

16.83

7.8

3.3

124.71

76.31

ng/l

1.85

117

Astigmatism

238

1335

1.86

16.81

5.3

4.7

74.40

77.24

ng/l

0.21

206

1194

Crohn's disease of large intestine

194

1021

1.99

16.77

4.8

4.2

95.38

82.39

ng/l

0.92

177

926

Cushing syndrome

201

3.53

16.72

3.5

2.9

94.41

67.61

ng/l

1.95

176

Prurigo nodularis

130

598

2.38

16.70

5.8

3.5

120.89

83.38

ng/l

2.52

114

517

Follicular cysts of skin and subcutaneous tissue

641

4532

1.45

16.67

4.8

3.9

106.38

91.04

ng/l

2.67

570

3928

Leisure time condition

634

4475

1.45

16.66

4.3

3.9

90.06

90.46

ng/l

0.03

530

3873

Alcohol-induced acute pancreatitis

139

652

2.27

16.62

5.5

4.5

106.93

93.70

ng/l

0.89

123

582

Bronchiectasis

346

2165

1.68

16.59

3.8

3.7

87.29

90.68

ng/l

0.32

283

1824

Disorders of oesophagus in diseases classified elsewhere

106

448

2.61

16.55

5.1

3.6

116.00

85.63

ng/l

1.92

381

Diseases of middle ear and mastoid

1922

12868

1.24

16.53

5.0

4.0

94.10

87.50

ng/l

1.54

1698

11283

Oesophagitis

223

1238

1.90

16.46

5.1

4.0

99.57

93.21

ng/l

0.39

198

1067

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1066

8186

1.33

16.43

3.3

3.5

83.35

89.12

ng/l

0.80

934

6949

Other symptoms and signs involving the nervous and musculoskeletal systems

1521

12180

1.27

16.42

3.4

3.9

84.30

88.35

ng/l

0.91

1298

10566

Obsessive-compulsive disorder

185

960

1.99

16.41

4.1

4.2

83.16

74.35

ng/l

0.61

166

879

Otitis externa, unspecified

381

2433

1.62

16.41

5.2

4.2

89.64

86.31

ng/l

0.28

342

2144

Unknown and unspecified causes of morbidity

258

1490

1.79

16.38

4.5

3.7

110.88

85.85

ng/l

2.32

230

1283

Abdominal aortic aneurysm (AAA)

363

2274

1.63

16.31

5.2

3.8

118.50

102.71

ng/l

1.85

307

1916

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

192

999

1.97

16.29

9.3

5.9

77.55

62.49

ng/l

1.51

185

951

Disorder of pancreatic internal secretion, other and/or unspecified

156

4.03

16.28

6.6

3.8

94.29

74.32

ng/l

1.02

142

Other/unspecified seropositive rheumatoid arthritis

1084

8356

1.33

16.24

3.3

3.5

83.85

89.24

ng/l

0.73

950

7091

Right bundle-branch block

150

732

2.18

16.22

4.6

3.3

96.77

82.51

ng/l

0.91

118

630

Granulomatous disorders of skin and subcutaneous tissue

124

564

2.37

16.18

5.6

3.6

97.17

76.70

ng/l

1.53

109

501

Vasculitis limited to skin, not elsewhere classified

130

605

2.34

16.18

5.3

3.5

98.09

82.00

ng/l

1.14

116

525

Recurring oral aphthae, including avohilmo

521

3572

1.51

16.16

3.9

79.54

85.90

ng/l

1.04

439

3067

Benign neoplasm: Small intestine

192

1030

2.00

16.14

5.1

3.8

119.74

89.10

ng/l

3.04

162

885

Other diseases of biliary tract

345

2169

1.66

16.10

4.8

3.7

102.55

89.75

ng/l

1.50

299

1826

Benign neoplasm: Endocrine pancreas

134

4.39

16.10

4.6

3.9

89.02

81.16

ng/l

0.28

119

Thoracic aortic aneurysm

463

3101

1.54

16.09

5.4

3.9

114.21

96.04

ng/l

2.31

401

2674

Reactive arthropathies, FINNGEN

250

1441

1.80

16.04

3.8

3.9

94.16

86.59

ng/l

0.54

228

1251

Thrombocytopenia, unspecified

277

1650

1.76

16.01

5.9

4.2

103.83

92.45

ng/l

1.04

242

1438

Cervicocranial syndrome

392

2535

1.60

15.98

3.4

3.8

79.03

88.69

ng/l

1.70

353

2168

Colectomy operation

653

4679

1.44

15.95

4.4

3.8

108.48

94.41

ng/l

2.17

580

3968

Carcinoma in situ of skin of scalp and neck

117

527

2.45

15.90

5.9

3.7

131.95

99.37

ng/l

1.07

446

Osteopathy in diseases classified elsewhere

149

4.10

15.90

9.5

3.6

104.55

71.54

ng/l

1.36

130

Suppurative and necrotic conditions of lower respiratory tract

209

1150

1.91

15.89

5.2

4.3

113.72

100.62

ng/l

0.79

189

1012

Psychotic depression

215

1190

1.87

15.78

3.9

4.2

92.50

85.52

ng/l

0.31

181

1054

Carcinoma in situ of skin of lower limb, including hip

113

507

2.50

15.69

5.4

3.6

103.41

92.62

ng/l

0.66

429

Seropositive rheumatoid arthritis, wide

1091

8459

1.32

15.66

3.3

3.5

84.24

89.29

ng/l

0.67

955

7176

Ankylosing spondylitis

299

1819

1.70

15.65

3.9

4.3

87.04

94.22

ng/l

0.50

264

1615

Left bundle-branch block

268

1590

1.76

15.63

3.4

3.2

95.29

81.11

ng/l

1.90

226

1345

Polyarteritis nodosa and related conditions

298

2.95

15.62

6.9

3.8

110.87

76.10

ng/l

2.04

269

Glaucoma suspect

1434

11501

1.27

15.57

4.0

3.6

94.63

91.64

ng/l

0.50

1205

9750

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

118

4.50

15.52

6.0

4.6

60.71

84.69

ng/l

1.56

102

Migraine with aura and triptan purchases

460

3093

1.52

15.46

2.6

3.9

64.47

78.32

ng/l

7.12

418

2754

Attention to artificial openings

156

787

2.10

15.45

5.9

3.0

103.72

82.03

ng/l

1.51

141

683

Memory loss

387

2527

1.60

15.44

3.1

3.7

90.51

95.60

ng/l

0.60

325

2133

Abnormal findings in nipple discharge synovial fluid wound secretions

317

2.86

15.44

6.8

4.0

107.49

80.51

ng/l

1.13

287

Radiculopathy

613

4363

1.44

15.42

3.6

3.8

92.90

95.08

ng/l

0.19

528

3677

Carcinoma in situ of skin of lower limb, including hip

113

511

2.48

15.41

5.4

3.4

103.41

85.98

ng/l

1.33

429

Coxibs

1141

4674

1.32

15.38

2.8

5.7

83.45

115.61

ng/l

24.25

980

4079

Hyperhidrosis

114

508

2.37

15.37

2.7

3.7

64.79

78.97

ng/l

1.84

450

Ovarian dysfunction

197

1067

1.90

15.36

3.1

2.7

90.06

65.86

ng/l

0.77

177

954

Hypermobility syndrome

181

958

1.97

15.35

2.9

3.5

64.64

73.50

ng/l

1.37

159

859

Psoriatic and enteropathic arthropathies

386

2508

1.58

15.34

3.7

3.8

83.72

87.99

ng/l

0.43

329

2184

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

549

3832

1.47

15.30

3.4

3.3

70.39

77.51

ng/l

1.62

474

3325

Inflammatory disease of uterus

474

3219

1.51

15.27

3.1

3.4

73.48

77.34

ng/l

0.63

418

2801

Hyperprolactinaemia

119

541

2.31

15.25

4.4

3.1

97.18

71.41

ng/l

0.86

102

490

Abrasion of teeth

937

5214

1.35

15.20

3.8

3.2

80.25

82.88

ng/l

0.40

798

4551

Other strabismus

747

5485

1.39

15.19

4.3

4.0

80.61

83.44

ng/l

0.30

653

4833

ILD, hospital admissions

570

4026

1.46

15.18

4.3

3.8

104.89

96.93

ng/l

0.81

495

3395

Adrenogenital disorders

5.07

15.07

6.8

3.7

162.04

76.32

ng/l

1.86

Other disorders of optic [2nd] nerve and visual pathways

248

1459

1.78

15.03

5.5

4.1

106.77

84.89

ng/l

1.55

222

1283

Benign neoplasm: Liver/bile ducts

106

466

2.45

14.98

4.1

3.6

84.16

81.59

ng/l

0.12

422

Mental retardation

170

893

2.01

14.96

6.1

6.4

71.71

70.27

ng/l

0.08

156

837

Reactive arthropathies

306

1896

1.67

14.96

4.2

3.7

93.97

87.61

ng/l

0.49

274

1639

Deficiency of other B group vitamins

104

456

2.48

14.89

3.5

3.6

81.34

87.62

ng/l

0.35

398

Monoamine oxidase A inhibitors

448

3030

1.52

14.86

3.4

4.0

85.35

92.71

ng/l

1.03

372

2606

Olecranon bursitis

214

1208

1.85

14.85

5.4

4.7

110.14

102.97

ng/l

0.30

191

1070

Psoriasis vulgaris

647

4678

1.42

14.84

4.4

4.1

91.42

93.93

ng/l

0.24

545

4079

Benign neoplasm: Skin of eyelid, including canthus

577

4099

1.45

14.83

3.7

3.5

86.16

90.83

ng/l

0.60

494

3441

Drug-induced adrenocortical insufficiency

410

2.60

14.79

4.5

3.6

75.34

76.98

ng/l

0.07

368

Ptosis of eyelid

433

2923

1.54

14.73

4.3

3.8

98.05

94.41

ng/l

0.30

388

2461

Benign neoplasm: Liver

401

2.56

14.72

3.8

3.7

77.66

81.90

ng/l

0.24

365

Retinal detachment with retinal break

480

3301

1.50

14.72

5.2

3.7

111.80

93.25

ng/l

2.74

419

2807

Neuroendocrine tumor and carcinoma of pancreas

123

4.31

14.66

6.0

3.8

60.71

83.96

ng/l

1.46

109

Barrett oesophagus

188

1029

1.93

14.63

4.0

4.1

102.27

95.25

ng/l

0.32

165

889

Other disorders of the musculoskeletal system and connective tissue

554

3918

1.46

14.62

3.4

3.8

93.19

92.36

ng/l

0.04

490

3336

Other/unspecified rheumatoid arthritis

525

3684

1.47

14.57

3.9

3.5

88.67

89.99

ng/l

0.06

448

3077

Anorexia (incl.atypical)

195

1073

1.88

14.56

4.3

3.8

91.83

73.65

ng/l

1.41

173

973

Disorders of endocrine glands in diseases classified elsewhere

8.89

14.56

13.6

4.6

111.74

55.17

ng/l

0.60

Congenital malformations of the circulatory system

494

3308

1.49

14.55

5.8

4.8

80.05

81.94

ng/l

0.21

451

2956

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

244

1436

1.76

14.53

5.2

3.1

95.52

72.49

ng/l

3.61

223

1303

Cardiac murmurs and other cardiac sounds

332

2087

1.62

14.52

5.2

4.3

86.35

75.15

ng/l

1.43

299

1815

Assault

370

2408

1.57

14.50

3.6

4.5

91.74

87.98

ng/l

0.26

328

2200

Superficial injury of ankle and foot

369

2404

1.58

14.48

5.1

4.1

95.23

80.56

ng/l

1.57

337

2162

Crohn disease (strict definition, require KELA, min 2 HDR)

213

1209

1.83

14.48

4.2

87.00

81.29

ng/l

0.38

192

1095

Algoneurodystrophy

135

662

2.16

14.47

3.9

3.7

92.31

79.00

ng/l

0.49

127

598

Acne vulgaris

214

1212

1.81

14.42

6.1

4.4

108.79

71.02

ng/l

3.63

200

1115

Injury of unspecified body region

290

1796

1.68

14.42

5.4

4.1

106.89

88.87

ng/l

1.55

252

1564

Other and unspecified visual disturbances

358

2329

1.59

14.42

3.8

94.32

87.06

ng/l

0.56

321

1993

Benign neoplasm: Skin of other and unspecified parts of face

434

2944

1.53

14.35

4.5

3.7

105.48

91.22

ng/l

1.31

354

2497

Atopic dermatitis, strict definition

884

6588

1.33

14.30

4.4

4.3

77.24

79.00

ng/l

0.26

792

5926

Other disorders starting during childhood or adolescence

175

930

1.94

14.28

9.7

6.2

71.19

59.11

ng/l

1.46

170

883

Special screening examination for neoplasms

156

807

2.02

14.23

6.6

3.8

119.27

96.34

ng/l

1.13

132

699

Hypothyroidism due to medicaments and other exogenous substances

228

3.18

14.22

3.9

3.2

78.54

74.13

ng/l

0.17

204

Emotional disorders and disorders of social functioning with onset specific to childhood

153

773

2.02

14.17

5.2

5.7

69.72

60.99

ng/l

0.56

137

737

Mental disorders, not otherwise specified

265

1605

1.70

14.17

4.2

3.9

80.05

78.90

ng/l

0.09

235

1442

Benign neoplasm: Pituitary gland, craniopharyngeal duct

187

1030

1.90

14.17

4.5

3.9

75.54

86.55

ng/l

1.62

165

915

Other noninfective disorders of lymphatic vessels and lymph nodes

157

821

2.04

14.16

5.9

3.4

112.77

83.32

ng/l

2.28

138

708

Other interstitial pulmonary diseases

570

4078

1.44

14.14

4.3

3.8

104.89

96.68

ng/l

0.85

495

3439

Bulimia nervosa (incl. atypical)

107

480

2.33

14.11

3.7

3.4

77.10

66.45

ng/l

0.93

436

Restless leg syndrome

464

3200

1.50

14.11

3.3

3.7

87.30

88.97

ng/l

0.15

400

2724

Cholecystitis

521

3665

1.46

14.10

4.3

3.7

102.44

94.01

ng/l

1.09

456

3077

Acetic acid derivatives and related substances

1141

4632

1.30

13.97

3.3

5.7

87.41

115.89

ng/l

16.21

974

4043

Injuries to the neck

715

5303

1.37

13.89

3.8

4.0

86.57

88.80

ng/l

0.21

619

4653

Hyphaema and other vascular disorders of iris and ciliary body

401

2.52

13.87

7.1

3.6

134.30

85.96

ng/l

2.71

352

Crohn disease (strict definition, require KELA)

214

1233

1.80

13.83

4.1

4.2

87.00

81.11

ng/l

0.40

192

1113

Myositis

119

569

2.24

13.77

4.0

80.52

87.34

ng/l

0.34

103

499

Interstitial lung disease endpoints

570

4101

1.43

13.70

4.3

3.8

104.89

96.90

ng/l

0.81

495

3456

Interstitial lung disease

570

4101

1.43

13.70

4.3

3.8

104.89

96.90

ng/l

0.81

495

3456

Correction of physiology of bite - demanding therapy visit

244

1463

1.73

13.69

4.1

3.7

79.57

79.25

ng/l

0.02

209

1301

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

226

1326

1.77

13.69

4.3

4.2

86.32

81.51

ng/l

0.32

203

1191

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1925

15812

1.21

13.69

3.5

3.7

78.07

84.68

ng/l

3.35

1670

13777

ILD, hospital admissions 1, main diag only

510

3605

1.46

13.62

4.3

3.8

108.20

96.01

ng/l

1.34

444

3043

Preparation and fitting of bite rail to mouth

448

3082

1.49

13.60

4.3

3.9

83.73

83.31

ng/l

0.03

402

2729

Mental retardation, wide definition

174

951

1.93

13.58

6.0

6.2

71.53

70.51

ng/l

0.06

160

891

Tobacco use

185

1030

1.88

13.55

4.2

4.1

95.57

89.15

ng/l

0.28

168

914

Female genital prolapse

1233

5649

1.28

13.53

2.9

3.2

77.31

82.22

ng/l

1.56

1029

4837

Benign neoplasm of meninges

395

2665

1.54

13.51

3.9

3.4

89.12

87.80

ng/l

0.12

338

2229

Inflammatory diseases of the central nervous system

295

1862

1.64

13.50

4.2

4.1

85.19

86.26

ng/l

0.07

256

1625

Plantar fascial fibromatosis

352

2312

1.57

13.50

3.2

3.8

80.48

87.56

ng/l

0.91

311

2003

Other and unspecified disorders of vitreous body

1580

12939

1.24

13.46

3.5

3.6

86.22

87.85

ng/l

0.33

1356

11037

Other specified/unspecified bacterial intestinal infections

256

1566

1.71

13.46

5.0

3.6

92.81

87.65

ng/l

0.39

223

1356

Other disorders of iris and ciliary body

118

568

2.23

13.43

6.6

3.7

123.06

87.46

ng/l

2.34

105

494

Other and unspecified rosacea

316

2037

1.61

13.30

4.6

3.6

92.56

85.87

ng/l

0.64

278

1764

Carcinoma in situ of skin of scalp and neck

117

568

2.26

13.30

5.9

4.1

131.95

107.43

ng/l

0.69

487

Non-follicular lymphoma, hilmo, excluding all cancers

348

2293

1.57

13.28

3.7

3.9

88.47

97.09

ng/l

0.89

295

1934

Achilles tendinitis

353

2327

1.56

13.27

4.1

4.2

90.73

96.19

ng/l

0.44

316

2038

TMD related pain

138

705

2.07

13.24

3.6

3.4

66.81

74.93

ng/l

0.60

120

628

Macular pucker

574

4169

1.42

13.16

4.4

3.6

98.84

93.65

ng/l

0.52

481

3519

Benign neoplasm: Liver/bile ducts

106

493

2.31

13.16

4.1

3.6

84.16

80.86

ng/l

0.15

445

Allergic conjunctivitis

2015

16706

1.20

13.12

3.5

3.8

77.79

84.66

ng/l

3.81

1752

14572

Parkinson's disease, excluding more controls

459

3112

1.47

13.11

2.9

3.8

87.49

96.13

ng/l

0.72

367

2633

Deviated nasal septum

1100

8711

1.28

13.11

3.6

4.4

88.48

99.51

ng/l

3.70

975

7613

Papilloedema, unspecified

436

2.39

13.07

5.1

4.2

113.38

80.41

ng/l

1.07

395

Other and unspecified vasculitis limited to skin

114

550

2.24

13.03

5.7

3.6

102.02

83.41

ng/l

1.23

103

478

Benign neoplasm: Cerebral meninges

359

2397

1.56

12.96

3.9

3.3

89.66

86.51

ng/l

0.30

305

2005

Postprocedural musculoskeletal disorders, not elsewhere classified

288

1835

1.64

12.94

3.3

3.8

101.28

92.43

ng/l

0.30

259

1574

Amputation of thigh

127

637

2.13

12.94

9.1

3.6

183.95

103.97

ng/l

4.65

105

544

Other disorders of cornea

355

2362

1.56

12.94

4.2

3.8

94.82

88.06

ng/l

0.71

301

2016

Ocular pain

291

1852

1.63

12.92

4.2

3.8

89.32

81.49

ng/l

0.67

259

1621

Ulcerative enterocolitis

125

623

2.12

12.83

4.8

4.0

105.65

83.76

ng/l

1.04

114

558

Cerebral cysts

195

1120

1.81

12.83

5.1

4.1

95.90

84.92

ng/l

0.72

169

995

Benign lipomatous neoplasm

1012

7969

1.29

12.82

3.7

3.8

87.04

92.00

ng/l

0.98

854

6821

Rosacea

402

2747

1.51

12.78

4.7

3.6

89.94

85.99

ng/l

0.39

356

2374

Fracture of skull and facial bones

679

5067

1.36

12.73

4.3

4.4

90.35

94.53

ng/l

0.46

592

4459

Vasomotor and allergic rhinitis

1242

9859

1.26

12.73

3.7

4.2

75.92

87.81

ng/l

6.22

1093

8680

Mucosal proctocolitis

398

2714

1.50

12.63

3.8

4.1

87.10

89.67

ng/l

0.21

364

2422

Alzheimer disease, excluding more controls

654

3221

1.39

12.60

2.8

3.6

90.76

95.50

ng/l

0.61

508

2667

Open wound of forearm

305

1972

1.59

12.56

4.3

4.1

95.72

91.99

ng/l

0.19

253

1719

Abnormal blood-pressure reading, without diagnosis

175

982

1.87

12.55

4.3

3.8

82.58

80.40

ng/l

0.12

153

844

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

196

1132

1.78

12.49

2.9

4.5

83.37

86.34

ng/l

0.14

164

1044

Hyperosmolality and hypernatraemia

255

2.85

12.48

3.3

83.96

84.62

ng/l

0.02

217

Specific development disorders of scholastic skills

139

715

2.00

12.44

8.0

5.6

62.68

64.78

ng/l

0.15

130

681

Dermatitis due to substances taken internally

211

1253

1.76

12.41

5.2

3.9

101.03

83.71

ng/l

1.43

185

1093

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

4.58

12.40

8.5

3.4

117.25

79.70

ng/l

0.79

Social phobias

215

1275

1.73

12.38

4.0

4.2

83.52

76.83

ng/l

0.47

196

1173

Early complications of trauma

158

864

1.92

12.35

5.0

4.1

112.24

88.67

ng/l

1.07

128

769

!Aliquae complicationes praecoces traumatis

158

864

1.92

12.35

5.0

4.1

112.24

88.67

ng/l

1.07

128

769

Degenerative macular diseases

494

3539

1.44

12.31

4.1

3.3

106.12

92.34

ng/l

1.85

395

2947

Single delivery by forceps and vacuum extractor

192

1987

0.58

12.30

2.6

4.3

64.33

79.07

ng/l

3.22

175

1804

Pre-eclampsia or eclampsia

717

5427

1.35

12.26

4.6

3.3

91.16

77.07

ng/l

3.12

617

4742

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

412

2845

1.48

12.22

4.3

4.1

110.82

105.41

ng/l

0.38

339

2382

Other abnormalities of plasma proteins

325

2.61

12.21

6.2

3.7

159.80

81.64

ng/l

2.68

288

Varicella [chickenpox]

147

786

1.94

12.18

8.0

4.9

94.58

82.63

ng/l

0.87

142

717

Pyothorax

158

869

1.91

12.18

5.1

4.3

110.10

100.90

ng/l

0.42

146

763

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

242

2.90

12.14

5.4

3.8

123.06

94.39

ng/l

1.28

205

Ganglion

686

5164

1.35

12.14

3.5

3.8

79.31

87.25

ng/l

1.83

606

4499

Testicular hypofunction

434

2.29

12.12

4.8

4.4

107.72

87.62

ng/l

0.63

396

Oxicams

968

4295

1.30

12.11

3.2

5.7

84.80

118.19

ng/l

21.51

840

3741

Congenital malformations of heart and great arteries

434

2941

1.47

12.07

6.2

5.0

80.34

81.16

ng/l

0.08

394

2637

Benign neoplasm: Liver

439

2.32

12.03

3.8

3.5

77.66

79.93

ng/l

0.12

396

Specific development disorders of speech and language

201

1139

1.76

12.03

8.1

5.5

71.99

71.83

ng/l

0.01

187

1051

Corneal ulcer

594

4386

1.38

12.02

5.2

3.9

106.43

90.01

ng/l

2.75

524

3813

Other disorders of electrolyte and fluid balance, not elsewhere classified

165

3.33

12.00

3.4

2.5

96.86

83.40

ng/l

0.38

140

Somnolence, stupor and coma

165

924

1.87

11.93

4.9

4.0

105.96

93.66

ng/l

0.69

144

816

Use of antiglaucoma preparations and miotics

344

2322

1.54

11.86

4.9

3.4

107.38

94.89

ng/l

1.30

291

1921

Other and unspecified injuries of head

229

1408

1.69

11.82

3.5

4.0

86.93

89.97

ng/l

0.18

199

1227

Mental and behavioural disorders due to sedatives or hypnotics

219

1328

1.70

11.80

2.9

4.1

85.32

84.11

ng/l

0.07

177

1197

Cardiomyopathy in other diseases

107

4.12

11.77

3.6

2.7

114.94

83.42

ng/l

1.10

Nummular dermatitis

293

1911

1.59

11.75

4.7

3.9

99.81

91.35

ng/l

0.73

244

1650

Testicular dysfunction

104

499

2.18

11.72

4.6

4.5

104.43

91.98

ng/l

0.38

456

Other disorders of white blood cells

214

1298

1.72

11.72

5.4

4.0

96.71

90.44

ng/l

0.45

189

1134

Hidradenitis suppurativa

120

610

2.06

11.61

4.8

3.9

109.33

77.78

ng/l

1.53

110

551

Scleritis and episcleritis

215

1306

1.71

11.61

4.5

3.6

91.41

80.16

ng/l

0.82

191

1159

Malignant melanoma, excluding all cancers (controls excluding all cancers)

605

4513

1.37

11.60

4.1

3.8

105.37

95.33

ng/l

1.29

517

3787

Benign neoplasm of thyroid gland

147

806

1.94

11.59

2.9

3.4

67.15

83.24

ng/l

2.30

127

700

Other and unspecified acquired haemolytic anaemias

191

3.13

11.59

6.5

4.1

125.07

86.57

ng/l

1.11

169

Pre-eclampsia

648

4884

1.35

11.45

4.4

3.2

90.45

75.70

ng/l

3.07

556

4276

Folate deficiency anaemia

154

3.36

11.41

2.8

3.7

97.72

82.67

ng/l

0.39

139

Infective dermatitis

399

2784

1.47

11.40

4.8

3.8

103.21

91.00

ng/l

1.35

329

2399

Other and unspecified vascular occlusions

368

2537

1.50

11.38

6.1

3.5

127.42

93.05

ng/l

5.76

315

2117

Other noninflammatory disorders of vulva and perineum

321

2149

1.54

11.32

3.9

3.2

85.08

79.17

ng/l

0.60

274

1853

Other female pelvic inflammatory diseases

620

4665

1.36

11.26

3.2

76.41

79.91

ng/l

0.55

501

3985

Other factor of the environment

239

2.80

11.24

6.1

3.8

130.20

80.51

ng/l

1.64

218

Melanocytic naevi of lower limb, including hip

156

876

1.86

11.23

6.0

3.8

101.69

82.15

ng/l

1.18

144

773

Other and unspecified epidermal thickening

114

580

2.09

11.22

6.2

3.9

124.68

79.33

ng/l

3.01

104

511

L02BG Aromatase inhibitors

1191

9727

1.25

11.22

2.4

3.3

70.23

82.33

ng/l

9.57

1032

8189

Kyphosis

301

2.60

11.18

4.4

4.1

79.77

81.20

ng/l

0.05

263

Other specified/unspecified soft tissue disorders

199

1199

1.73

11.17

3.4

86.57

89.18

ng/l

0.17

174

1002

Benign neoplasm: Skin of trunk

156

879

1.86

11.13

5.6

3.7

95.28

85.64

ng/l

0.61

134

769

Viral hepatitis

224

1387

1.66

11.11

4.3

96.46

85.83

ng/l

0.88

200

1251

Other disorders of pigmentation

182

1075

1.78

11.11

3.8

3.6

97.27

81.81

ng/l

1.20

168

925

Giant cell arteritis

186

1110

1.78

11.07

3.5

94.75

92.80

ng/l

0.09

165

924

Speech disturbances, not elsewhere classified

326

2206

1.53

11.06

4.4

3.9

97.85

95.54

ng/l

0.13

267

1874

Secondary thrombocytopenia

248

2.76

11.03

5.2

3.6

112.18

74.80

ng/l

2.18

224

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

559

4146

1.37

11.00

4.1

4.2

87.87

90.10

ng/l

0.20

503

3663

Inflammatory diseases of prostate (prostatitis)

364

2510

1.48

10.98

4.0

4.7

97.20

104.26

ng/l

0.64

318

2216

Tooth eruption problems

352

2382

1.49

10.96

7.8

4.4

81.76

71.38

ng/l

1.41

338

2189

Injuries to the wrist and hand

3667

23629

1.13

10.95

4.0

91.23

89.39

ng/l

0.45

3187

20605

Coxarthrosis, primary, with hip surgery

1833

14778

1.19

10.94

3.4

3.7

88.80

94.80

ng/l

1.91

1538

12464

Congenital iodine-deficiency syndrome/hypothyroidism

133

720

1.96

10.92

4.2

3.5

115.96

85.53

ng/l

1.40

107

614

Other keratitis

356

2450

1.49

10.92

5.5

3.9

105.63

86.53

ng/l

2.39

321

2130

Symptoms and signs involving emotional state

109

549

2.09

10.91

3.7

4.4

82.07

80.27

ng/l

0.06

499

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

497

3625

1.40

10.89

4.0

4.3

87.78

89.78

ng/l

0.16

444

3216

Sequelae of injuries of lower limb

312

2095

1.53

10.86

3.9

4.0

86.60

86.01

ng/l

0.04

279

1841

Myopia

371

2573

1.47

10.85

4.9

4.0

87.86

78.43

ng/l

0.96

311

2290

Erythema intertrigo

104

520

2.14

10.83

4.7

3.7

103.51

83.17

ng/l

1.58

447

Radial styloid tenosynovitis [de Quervain]

190

1138

1.73

10.80

3.3

3.6

78.00

82.65

ng/l

0.31

163

995

Other autoimmune haemolytic anaemias

251

2.74

10.80

5.4

3.7

102.18

83.28

ng/l

0.80

223

Superficial injury of forearm

305

2040

1.53

10.78

4.2

87.24

84.05

ng/l

0.24

261

1802

Subacute thyroiditis

134

728

1.93

10.76

3.3

3.7

73.19

84.28

ng/l

1.09

115

631

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1464

10722

1.22

10.76

3.1

3.9

91.92

93.24

ng/l

0.18

1252

9061

Tinnitus

820

6447

1.30

10.68

3.5

3.9

83.93

90.92

ng/l

1.67

705

5589

Otalgia

286

1898

1.56

10.65

3.4

4.3

72.32

80.92

ng/l

1.57

259

1666

Dissociative [conversion] disorders

125

664

1.96

10.64

3.2

3.6

72.25

73.88

ng/l

0.11

103

603

Secondary parkinsonism

118

621

2.02

10.60

2.7

4.0

77.65

96.55

ng/l

1.29

542

Agranulocytosis

406

2886

1.45

10.60

5.0

3.9

96.34

86.84

ng/l

1.07

363

2482

Malignant immunoproliferative diseases

201

2.96

10.58

4.8

3.8

97.96

87.49

ng/l

0.29

176

Gangrene, not elsewhere classified

151

3.30

10.52

13.5

3.6

165.14

81.71

ng/l

3.34

130

Lactose intolerance

113

584

2.03

10.52

3.7

3.3

87.69

77.38

ng/l

0.53

518

Palmar fascial fibromatosis [Dupuytren]

526

3898

1.38

10.52

4.2

102.14

101.08

ng/l

0.08

452

3324

Other prurigo

236

2.76

10.51

5.5

3.4

140.31

75.99

ng/l

3.04

210

Other bacterial agents as the cause of diseases classified to other chapters

219

2.85

10.49

8.8

3.6

131.63

75.52

ng/l

3.03

200

Other and unspecified mononeuropathies, also in other diseases

124

666

1.97

10.41

4.7

3.5

103.53

85.92

ng/l

1.03

100

578

Paraplegia, diplegia of upper limbs

452

2.20

10.41

3.7

3.9

68.41

84.87

ng/l

1.18

400

Synovial cyst of popliteal space [Baker]

271

1787

1.57

10.41

3.5

3.9

83.09

93.78

ng/l

1.15

231

1506

Sleep disorders, other/unspecified

115

600

2.00

10.40

4.4

3.9

105.86

76.44

ng/l

1.06

546

Ulcerative colitis (strict definition, require KELA)

511

3773

1.38

10.39

4.0

4.2

87.62

90.08

ng/l

0.21

457

3340

Delivery

1246

8000

0.81

10.38

2.9

3.5

76.28

83.50

ng/l

2.89

1052

6802

Parkinson's disease, strict definition, excluding more controls

415

2909

1.43

10.33

2.8

3.8

83.05

96.32

ng/l

2.32

332

2455

Disorders of optic nerve and visual pathways

320

2184

1.51

10.33

4.9

4.1

99.59

84.61

ng/l

1.21

284

1915

Wet age-related macular degeneration

692

5262

1.32

10.32

3.6

3.3

110.94

95.23

ng/l

2.48

556

4314

Other infective otitis externa

215

1348

1.66

10.31

5.0

4.0

100.40

88.63

ng/l

0.72

184

1186

Spontaneous rupture of synovium and tendon

292

1960

1.54

10.29

3.9

4.0

83.89

95.21

ng/l

1.60

243

1661

Benign neoplasm: Pituitary gland, craniopharyngeal duct

187

1134

1.72

10.27

4.5

3.9

75.54

87.08

ng/l

1.55

165

1000

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

217

1362

1.64

10.26

4.1

106.95

80.89

ng/l

1.81

191

1212

Diseases of tongue

237

1523

1.61

10.25

4.3

3.2

89.71

85.53

ng/l

0.30

208

1293

Sacroiliitis, not elsewhere classified

139

772

1.86

10.24

3.4

4.1

70.31

81.08

ng/l

0.65

124

694

Secondary parkinsonism+Parkinsonism in other disease

119

636

1.99

10.22

2.7

3.9

77.35

95.82

ng/l

1.27

552

R07AX Other respiratory system products

+∞

10.19

5.2

9.2

50.30

48.80

ng/l

—

Benign neoplasm of thyroid gland

147

841

1.85

10.15

2.9

3.4

67.15

80.94

ng/l

1.81

127

735

Hallux rigidus

501

3710

1.38

10.14

2.9

3.5

79.91

91.03

ng/l

3.08

424

3161

Pneumonitis due to solids and liquids

280

1869

1.54

10.13

3.9

94.65

98.56

ng/l

0.27

227

1591

Other viral hepatitis

184

1113

1.70

10.05

4.7

4.3

98.21

83.59

ng/l

1.14

168

1011

Other localized connective tissue disorders

481

2.15

10.04

8.4

3.1

136.61

75.16

ng/l

4.30

429

Benign neoplasm of eye and adnexa

352

2464

1.47

10.03

3.8

3.6

92.60

89.85

ng/l

0.20

295

2089

Other and unspecified psoriasis

236

1524

1.60

10.00

4.6

4.0

94.60

91.23

ng/l

0.18

202

1341

Other symptoms and signs involving general sensations and perceptions

152

879

1.81

10.00

2.7

4.0

77.12

87.29

ng/l

0.88

122

769

Pneumonia derived septicemia

133

740

1.89

9.98

7.1

4.5

115.81

87.82

ng/l

1.64

118

646

Temporal arteritis

166

990

1.78

9.97

3.4

3.5

93.10

91.61

ng/l

0.06

149

824

Other and unspecified injuries of lower leg

240

1555

1.59

9.92

4.0

91.65

82.05

ng/l

0.90

214

1369

Malignant neoplasm of breast, HER-positive

1380

11408

1.21

9.91

2.4

3.3

71.97

82.65

ng/l

7.58

1187

9619

Endometriosis of pelvic peritoneum

504

3692

1.37

9.89

3.2

3.4

70.21

79.75

ng/l

3.45

443

3259

Panniculitis affecting regions of neck and back

139

784

1.85

9.89

4.0

4.1

85.21

87.85

ng/l

0.16

122

685

Recurrent dislocation of patella

137

765

1.84

9.88

3.9

70.65

70.84

ng/l

0.01

126

693

Mental and behavioural disorders due to opioids

104

532

2.02

9.87

3.2

4.5

81.15

82.24

ng/l

0.04

491

Complications of other internal prosthetic devices, implants and grafts

156

915

1.79

9.81

5.0

3.4

103.26

84.54

ng/l

1.66

142

785

Complications following infusion, transfusion and therapeutic injection

312

2.43

9.80

8.0

3.5

108.16

72.11

ng/l

1.94

275

Lung diseases due to external agents

478

3533

1.38

9.80

4.0

3.9

93.47

99.41

ng/l

0.74

397

2999

Benign neoplasm: Other and unspecified parts of small intestine

392

2.28

9.78

4.3

3.5

123.49

82.17

ng/l

2.08

338

Lesion of lateral popliteal nerve

170

1019

1.73

9.75

4.3

4.0

82.24

93.24

ng/l

0.98

156

894

Encephalitis

113

602

1.98

9.74

3.8

4.2

79.64

81.11

ng/l

0.07

539

Arterial embolism and thrombosis of lower extremity artery

137

775

1.86

9.72

4.9

3.7

138.04

92.00

ng/l

1.85

115

657

Benign neoplasm: Other and unspecified parts of small intestine

393

2.27

9.72

4.3

3.4

123.49

82.87

ng/l

2.01

344

Somnolence

232

2.65

9.70

4.1

4.3

105.56

77.75

ng/l

0.82

211

Bacterial, viral and other infectious agents

264

1754

1.54

9.70

6.7

4.5

108.93

87.20

ng/l

2.59

227

1576

Non-follicular lymphoma

348

2450

1.47

9.68

3.7

4.0

88.47

96.52

ng/l

0.80

295

2094

Brachial plexus disorders

278

1867

1.53

9.67

2.6

3.5

70.92

79.28

ng/l

1.34

256

1659

Allergic urticaria

275

1847

1.53

9.64

3.8

3.9

89.60

78.57

ng/l

0.73

245

1621

Other and unspecified mental retardation

387

2.27

9.62

4.7

7.0

60.16

59.44

ng/l

0.03

369

Single spontaneous delivery

1245

7982

0.82

9.62

2.9

3.5

75.34

83.56

ng/l

3.81

1057

6786

Disease of hard tissues of teeth, NOS

186

2.87

9.61

9.5

3.1

127.88

71.40

ng/l

1.91

163

COPD, hospital admissions 1, only main diagnosis

1267

8978

1.22

9.61

4.2

3.9

108.89

98.62

ng/l

2.45

1048

7573

Benign neoplasm: Skin of eyelid, including canthus

577

4406

1.34

9.58

3.7

3.6

86.16

91.49

ng/l

0.71

494

3744

Chondrocostal junction syndrome [Tietze]

151

884

1.80

9.58

2.9

3.4

73.84

80.28

ng/l

0.67

141

769

Psoriatic arthropathies

320

2215

1.48

9.58

3.7

81.56

88.54

ng/l

0.83

271

1928

Crossbite

226

1347

1.60

9.57

9.3

5.3

69.00

68.25

ng/l

0.06

207

1259

Other/unspecified reactive arthropathies

226

1459

1.60

9.57

3.9

4.1

94.53

84.75

ng/l

0.69

206

1278

Other noninflammatory disorders of uterus, except cervix

914

5010

1.27

9.56

3.2

84.71

83.30

ng/l

0.22

749

4257

Corneal scars and opacities

110

586

1.99

9.55

5.4

3.6

114.63

82.99

ng/l

1.92

507

Hypertrophic disorders of skin

190

1178

1.67

9.51

3.8

88.66

77.93

ng/l

0.53

168

1037

Hypotension due to drugs

298

2.45

9.50

3.8

113.71

88.73

ng/l

0.99

259

Other specified and unspecified disorders of eye and adnexa

154

908

1.78

9.49

5.3

3.7

95.68

86.41

ng/l

0.73

147

787

D07AA Corticosteroids, weak (group I)

480

3559

1.37

9.49

3.9

4.4

79.33

80.82

ng/l

0.12

436

3151

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

496

3708

1.37

9.48

3.3

3.9

85.59

95.22

ng/l

1.33

425

3129

Other peripheral vascular diseases

277

1873

1.52

9.45

4.0

3.4

91.12

83.43

ng/l

0.65

242

1599

Biological medication for rheuma

466

3446

1.38

9.45

3.5

4.2

76.09

83.63

ng/l

0.49

430

3069

Sequelae of injuries of upper limb

320

2224

1.48

9.43

3.6

4.0

88.62

89.39

ng/l

0.05

275

1957

Other and unspecified disorders of white blood cells

159

948

1.76

9.43

5.1

3.8

89.46

86.84

ng/l

0.14

139

832

Lifestyle-related condition

224

2.68

9.43

6.1

3.9

135.02

81.56

ng/l

1.57

202

Disorders of adrenal gland, other and/or unspecified

4.04

9.42

4.9

2.8

82.33

72.00

ng/l

0.21

Correction of physiology of bite - very demanding therapy visit

108

573

1.98

9.42

3.6

3.7

66.58

78.37

ng/l

0.82

516

Other aneurysm

195

1223

1.66

9.41

6.8

3.7

111.11

92.08

ng/l

2.15

177

1058

Other and unspecified follicular disorders

132

745

1.85

9.40

5.9

3.9

121.17

84.58

ng/l

2.84

119

668

Burns and corrosions

411

2985

1.40

9.35

4.0

4.5

88.03

89.73

ng/l

0.13

354

2671

Secondary right heart disease

168

1020

1.73

9.34

4.0

3.9

129.09

93.33

ng/l

3.09

142

866

Adenomyosis (Endometriosis of uterus)

506

3806

1.36

9.31

3.1

3.2

77.47

82.74

ng/l

1.08

446

3281

Medicines for HER+ breast cancer

1431

11797

1.20

9.24

2.5

3.3

72.08

82.60

ng/l

7.73

1237

9952

Other disorders of the genitourinary system

515

3898

1.36

9.21

3.9

3.3

88.31

85.70

ng/l

0.26

421

3252

Ankylosing spondylitis, ICD10

283

1930

1.50

9.20

3.8

4.2

86.87

89.29

ng/l

0.13

252

1720

Melanoma in situ

161

972

1.74

9.20

3.7

3.6

95.93

92.77

ng/l

0.17

133

825

ILD-related respiratory insufficiency

132

755

1.85

9.18

5.3

3.9

119.89

96.83

ng/l

1.49

119

650

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

149

881

1.78

9.15

4.8

3.5

88.05

85.62

ng/l

0.14

125

764

Entropion and trichiasis of eyelid

320

2243

1.47

9.15

3.9

3.6

100.47

98.22

ng/l

0.16

277

1878

Diffuse large B-cell lymphoma, helper endpoint

167

1018

1.72

9.13

4.5

3.6

85.73

91.95

ng/l

0.38

140

868

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

167

1018

1.72

9.13

4.5

3.6

85.73

91.95

ng/l

0.38

140

868

Amblyopia ex anopsia

153

909

1.75

9.13

6.1

5.0

62.05

74.77

ng/l

2.58

131

821

Artificial joint re-operation

286

1970

1.51

9.12

3.8

3.6

96.77

92.29

ng/l

0.13

244

1656

Giant cell arteritis with polymyalgia rheumatica

166

1015

1.73

9.12

3.4

3.5

93.10

91.03

ng/l

0.09

149

850

Benign neoplasm of mouth and pharynx

367

2633

1.43

9.11

3.9

3.8

87.57

92.57

ng/l

0.47

313

2233

Benign neoplasm: Duodenum

112

612

1.96

9.10

5.3

3.7

115.35

91.21

ng/l

1.55

533

therapeutic use

127

721

1.87

9.07

5.4

3.2

88.90

84.74

ng/l

0.15

106

621

Malignant immunoproliferative diseases

218

2.72

9.05

4.8

4.1

97.96

88.02

ng/l

0.27

195

Complications of genitourinary prosthetic devices, implants and grafts

102

540

2.00

9.03

6.9

3.3

140.94

79.01

ng/l

2.99

475

Pneumonia due to Streptococcus pneumoniae

141

821

1.78

9.00

4.8

3.8

99.56

84.27

ng/l

0.96

119

715

Juvenile rheumatoid arthirtis

367

2.20

8.97

4.3

4.2

110.24

71.51

ng/l

0.44

330

Benign neoplasm of meninges

395

2884

1.41

8.97

3.9

3.4

89.12

87.15

ng/l

0.18

338

2422

Chronic diseases of tonsils and adenoids

2837

15906

1.14

8.96

4.0

4.1

80.66

89.05

ng/l

4.87

2565

13923

Other diseases of blood and blood-forming organs

242

1613

1.55

8.94

4.4

3.9

91.23

92.23

ng/l

0.06

206

1403

Cholera

179

1118

1.68

8.92

3.6

3.1

80.47

80.64

ng/l

0.01

172

947

Additional codes for the location of defect, injury or illness

201

1287

1.62

8.91

4.6

3.9

77.28

87.44

ng/l

1.06

178

1127

Primary coxarthrosis, bilateral

1098

9110

1.23

8.90

3.4

3.7

91.66

94.68

ng/l

0.43

915

7651

Iridocyclitis in diseases classified elsewhere

378

2.21

8.88

4.4

4.3

93.43

81.97

ng/l

0.57

336

Other encephalitis

104

557

1.97

8.86

4.0

4.1

80.33

80.47

ng/l

0.01

499

Blindness or visual impairment, binocular

3.81

8.85

7.4

4.3

111.17

75.66

ng/l

0.93

Chronic iridocyclitis

181

1133

1.66

8.83

4.2

3.9

71.83

87.26

ng/l

1.88

160

989

Other ulcerative colitis

186

1170

1.64

8.81

4.8

4.1

88.21

84.81

ng/l

0.14

164

1056

Pre-eclampsia or poor fetal growth

885

7154

1.25

8.81

4.5

3.3

88.00

75.59

ng/l

3.30

769

6335

Atypical facial pain

189

1197

1.64

8.80

2.7

3.5

71.05

81.88

ng/l

1.32

159

1038

1688

0.52

8.80

3.4

4.3

110.49

104.92

ng/l

0.17

1468

Unspecified lump in breast

602

4679

1.32

8.80

2.9

3.2

79.71

81.11

ng/l

0.18

532

3950

Chondropathies

489

3686

1.35

8.80

3.6

4.0

81.62

87.66

ng/l

1.06

428

3230

Other abnormal findings in urine

334

2.30

8.79

4.3

3.9

103.54

86.40

ng/l

0.54

296

Phakomatoses, not elsewhere classified

220

2.61

8.73

4.8

4.9

111.67

69.47

ng/l

0.82

202

Melanocytic naevi of upper limb, including shoulder

476

2.05

8.73

4.7

3.9

96.66

84.22

ng/l

0.61

425

Medical abortion

2467

11785

1.15

8.72

3.2

3.3

78.19

80.26

ng/l

0.57

2128

10083

Infective bursitis

107

582

1.93

8.68

4.4

4.5

107.68

93.94

ng/l

0.52

514

Other condition

436

3239

1.37

8.68

4.8

4.1

91.25

89.12

ng/l

0.16

391

2823

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

854

6908

1.25

8.68

3.6

4.2

83.26

88.30

ng/l

0.77

759

6106

Other disorders of bone density and structure

497

2.01

8.66

3.7

75.13

80.75

ng/l

0.24

449

Other otitis externa (chronic)

227

1503

1.56

8.65

4.7

4.0

107.64

86.27

ng/l

1.68

181

1320

Melanocytic naevi of upper limb, including shoulder

478

2.04

8.63

4.7

3.8

96.66

79.92

ng/l

0.93

430

Other orthopaedic follow-up care

193

1233

1.62

8.61

3.8

2.8

81.73

78.09

ng/l

0.25

172

1049

Other retinal artery occlusion

102

551

1.97

8.59

5.8

3.8

128.59

97.96

ng/l

1.30

477

Alcohol abuse, main dg

447

3337

1.36

8.56

3.3

4.4

91.05

93.88

ng/l

0.23

379

2972

Other/unspecified enthesopathies, not elsewhere classified

299

2092

1.47

8.56

3.9

3.8

97.85

92.56

ng/l

0.31

252

1788

Melanocytic naevi of lower limb, including hip

156

950

1.71

8.53

6.0

3.7

101.69

80.79

ng/l

1.31

144

835

Lichen simplex chronicus

132

770

1.80

8.51

5.2

3.7

102.73

83.08

ng/l

1.27

116

679

Disorder of thyroid, unspecified

254

2.47

8.50

2.6

3.0

69.41

81.63

ng/l

0.75

224

Benign neoplasm: Cerebral meninges

359

2606

1.42

8.49

3.9

3.4

89.66

86.95

ng/l

0.25

305

2199

Other pulmonary heart/vessel disease

179

1132

1.65

8.47

4.0

125.87

92.72

ng/l

3.01

152

956

Emotional disorders starting during childhood or adolescence

134

774

1.76

8.46

5.2

6.1

67.60

60.73

ng/l

0.38

119

738

Assault by bodily force

202

1306

1.58

8.42

3.4

4.4

90.02

81.96

ng/l

0.47

182

1192

Injury of intra-abdominal organs

453

2.04

8.40

5.4

4.4

100.01

84.36

ng/l

0.79

409

Hypersomnia

268

2.40

8.37

2.6

3.7

71.47

72.70

ng/l

0.05

245

Other disorders of penis

263

1802

1.49

8.35

5.6

5.4

117.33

100.05

ng/l

0.99

232

1619

Bell's palsy

383

2808

1.39

8.34

4.1

3.8

94.99

90.44

ng/l

0.36

323

2406

Benign neoplasm: Duodenum

112

630

1.90

8.34

5.3

3.7

115.35

86.61

ng/l

2.04

551

Status epilepticus

129

752

1.79

8.29

4.4

4.3

92.59

91.17

ng/l

0.05

110

664

Alzheimer’s disease (Atypical or mixed), excluding more controls

264

1565

1.50

8.27

2.4

3.4

98.65

101.20

ng/l

0.14

183

1283

Follow-up care involving plastic surgery

146

882

1.73

8.26

3.9

2.6

70.41

73.28

ng/l

0.20

112

764

Hypertrophy of breast in women and men

648

5117

1.29

8.25

3.4

3.5

77.86

81.79

ng/l

0.64

557

4453

Convalescence

187

1199

1.61

8.25

4.7

2.7

81.77

75.19

ng/l

0.53

159

1027

Iron deficiency

320

2.23

8.23

4.1

79.05

72.16

ng/l

0.30

287

Oesophageal obstruction

136

808

1.76

8.23

3.6

3.7

94.62

97.53

ng/l

0.11

112

693

Other nutritional anaemias

208

2.62

8.22

6.0

3.7

108.10

79.73

ng/l

0.89

183

Dislocation, sprain and strain of joints and ligaments at neck level

424

3160

1.36

8.22

3.4

4.0

76.58

84.39

ng/l

1.15

369

2812

Unspecified protein-energy malnutrition

123

3.29

8.20

3.3

3.6

100.93

71.11

ng/l

0.67

108

Personal history of risk-factors, not elsewhere classified

201

2.60

8.19

3.6

3.3

83.12

65.00

ng/l

0.77

177

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

115

649

1.84

8.19

8.2

5.1

74.15

66.71

ng/l

0.43

104

596

Other benign neoplasms of connective and other soft tissue

321

2295

1.43

8.17

3.9

3.8

92.36

88.60

ng/l

0.23

275

1972

Oral leukoplakia and related diseases, including avohilmo

316

2258

1.44

8.16

3.8

86.40

91.31

ng/l

0.46

266

1935

Heterophoria

255

1748

1.50

8.15

3.5

4.0

81.64

78.49

ng/l

0.13

205

1547

Benign neoplasm of major salivary glands

330

2374

1.43

8.14

3.8

3.7

92.03

92.35

ng/l

0.02

277

2011

215

1418

1.54

8.14

3.2

76.17

72.49

ng/l

0.20

190

1298

Benign neoplasm: Rectosigmoid junction

155

958

1.69

8.10

3.9

3.6

93.16

91.18

ng/l

0.11

131

820

Other and unspecified nail disorders

441

2.05

8.06

5.5

3.2

125.50

75.58

ng/l

1.89

394

Acute alcohol intoxication

771

6229

1.25

7.99

3.7

4.5

98.54

97.60

ng/l

0.08

644

5481

Paralytic strabismus

247

1696

1.50

7.93

4.4

3.9

111.20

92.53

ng/l

0.91

218

1467

Acute laryngitis and tracheitis

311

2180

1.43

7.92

5.5

4.2

79.10

77.88

ng/l

0.06

277

1975

Embedded teeth, including avohilmo

226

1517

1.52

7.91

6.6

4.2

92.38

74.90

ng/l

1.83

216

1378

Cerebral aneurysm, nonruptured

308

2203

1.44

7.91

5.5

3.7

96.09

88.04

ng/l

0.71

272

1889

Other drug-induced secondary parkinsonism

201

2.64

7.90

3.1

3.8

94.03

80.84

ng/l

0.29

179

Melanocytic naevi of other and unspecified parts of face

195

1275

1.58

7.89

4.5

3.6

82.85

85.19

ng/l

0.17

181

1106

Toxic effects of substances chiefly nonmedicinal as to source

339

2460

1.41

7.86

3.7

4.3

92.24

88.26

ng/l

0.21

301

2172

Myocardial infarction, with ST-elevation

598

4709

1.29

7.85

5.0

3.9

128.89

100.54

ng/l

6.86

527

3974

Bullous disorders

215

1441

1.55

7.85

4.4

3.8

123.83

92.02

ng/l

2.38

184

1241

Dystonia

198

1303

1.57

7.84

2.6

3.7

69.76

82.31

ng/l

2.45

176

1139

Autoimmune thyroiditis

341

2.17

7.84

2.7

4.0

57.72

79.85

ng/l

3.77

306

Episcleritis

174

1111

1.62

7.83

4.6

3.6

96.71

80.16

ng/l

1.07

153

983

Exposure to other and unspecified inanimate mechanical forces

210

1396

1.55

7.83

5.4

4.5

86.18

84.28

ng/l

0.11

194

1248

Short Achilles tendon (acquired)

106

595

1.87

7.82

3.4

3.6

79.92

84.51

ng/l

0.21

523

Polycystic ovarian syndrome

120

693

1.77

7.80

2.9

2.8

99.47

63.15

ng/l

0.66

104

625

Bronchitis, not specified as acute or chronic

283

1995

1.45

7.79

5.0

4.0

113.55

93.18

ng/l

1.75

240

1710

Disorders of iron metabolism

225

2.46

7.78

5.3

3.2

90.93

82.83

ng/l

0.24

199

Other bursitis of hip

483

1.98

7.77

2.9

3.4

90.78

84.25

ng/l

0.31

422

Cysts of oral region, not elsewhere classified

138

833

1.71

7.77

7.0

3.3

132.32

84.53

ng/l

1.80

124

735

Alcoholic gastritis

257

2.36

7.76

3.8

4.6

100.76

92.52

ng/l

0.24

227

Hypertrophic scar

170

1081

1.62

7.76

3.8

3.7

87.76

77.02

ng/l

0.48

150

956

Acute alcohol intoxication, ICD10

564

4410

1.30

7.75

3.5

4.5

93.45

95.27

ng/l

0.14

464

3931

Wide developmental disorders, excluding more controls

383

2.05

7.74

4.4

5.9

50.66

59.80

ng/l

1.27

369

Post-traumatic wound infection, not elsewhere classified

511

1.93

7.70

5.3

4.0

113.70

81.86

ng/l

0.93

454

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

221

2.49

7.67

4.2

3.4

82.26

74.06

ng/l

0.25

201

Car occupant injured in other and unspecified transport accidents

553

4320

1.30

7.66

4.1

4.0

86.81

88.02

ng/l

0.11

487

3792

Pregnancy hypertension

1306

10026

1.19

7.65

4.4

3.2

88.58

76.03

ng/l

4.61

1149

8785

Anomalies of dental arch relationship, including avohilmo

554

3882

1.30

7.64

6.7

4.1

79.08

78.46

ng/l

0.06

482

3461

Retinal haemorrhage

102

573

1.89

7.62

4.3

3.5

114.26

85.71

ng/l

1.22

496

Congenital malformations of cardiac septa

237

1574

1.50

7.57

5.8

5.6

76.70

73.03

ng/l

0.35

211

1450

Other and unspecified injuries of ankle and foot

130

778

1.73

7.56

3.7

4.1

81.47

76.72

ng/l

0.29

110

702

Lactose intolerance, other/unspecified

520

1.91

7.56

3.5

3.2

79.58

75.24

ng/l

0.23

460

Behavioural disorders, excluding more controls

232

2.36

7.54

4.5

4.6

103.73

67.41

ng/l

1.04

224

Other misadventures during surgical and medical care

452

1.99

7.53

6.0

3.9

99.60

82.22

ng/l

0.53

404

Other and unspecified abdominal hernia

159

1008

1.65

7.51

5.2

3.5

116.06

89.34

ng/l

1.28

137

875

Tumor necrosis factor alpha inhibitors

407

3061

1.35

7.49

3.4

4.2

77.68

81.64

ng/l

0.19

374

2723

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

324

2356

1.41

7.49

3.3

4.1

82.85

98.46

ng/l

2.41

274

1993

Hypermetropia

234

1607

1.50

7.47

5.9

4.4

78.29

77.98

ng/l

0.02

209

1426

Event of undetermined intent

184

1202

1.57

7.45

3.9

4.5

97.23

83.75

ng/l

0.87

162

1072

Other overlap syndromes

412

2.04

7.43

3.4

3.7

95.88

79.01

ng/l

0.37

363

Recurring oral aphthae

173

1121

1.60

7.41

4.5

3.9

80.40

82.34

ng/l

0.12

148

997

Benign neoplasm: Skin of trunk

156

987

1.64

7.40

5.6

3.7

95.28

83.74

ng/l

0.78

134

867

Unspecified/other endometriosis

251

1745

1.47

7.40

3.5

3.3

69.43

76.59

ng/l

1.19

220

1544

Pneumococcal septicemia

124

741

1.75

7.39

6.2

4.6

108.59

85.38

ng/l

1.22

109

654

Eosinophilic disease (BM)

256

2.32

7.38

5.8

4.1

117.58

83.10

ng/l

1.79

228

Organ-limited amyloidosis

4.11

7.38

7.7

2.7

165.29

94.05

ng/l

1.35

Combined immunodeficiencies

232

2.43

7.38

4.7

3.4

96.05

79.94

ng/l

0.64

208

Other predominantly sexually transmitted diseases, not elsewhere classified

452

3455

1.33

7.37

4.2

3.7

81.61

79.18

ng/l

0.24

410

3082

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

117

690

1.78

7.36

4.3

3.8

107.67

89.76

ng/l

1.24

104

599

Allergic contact dermatitis

437

3332

1.34

7.36

3.7

3.5

84.91

81.52

ng/l

0.23

363

2893

Postzoster neuralgia

325

2.18

7.33

4.1

3.3

96.16

87.72

ng/l

0.41

280

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

110

638

1.81

7.33

3.5

3.7

82.95

94.50

ng/l

0.83

548

Presbycusis

528

4116

1.30

7.32

3.4

106.92

97.36

ng/l

1.11

381

3397

severe traumatic brain injury, does not include concussion

729

5922

1.25

7.30

4.1

4.0

107.76

98.98

ng/l

1.18

595

5015

Anorexia

298

2.21

7.26

3.6

3.9

80.05

76.70

ng/l

0.10

264

Use of biperiden

179

1172

1.58

7.26

3.5

4.0

84.78

86.75

ng/l

0.11

151

1040

Other other unspecified disorders of the circulatory system

145

908

1.67

7.24

4.5

3.9

119.05

87.32

ng/l

1.91

127

789

Benign neoplasm: Choroid

210

1426

1.53

7.23

3.5

92.56

88.64

ng/l

0.21

176

1221

Other and unspecified diseases of blood and blood-forming organs

102

582

1.85

7.23

5.3

3.9

103.21

86.59

ng/l

0.88

512

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

147

923

1.66

7.21

3.4

3.6

79.84

90.27

ng/l

0.76

119

791

Asthma and opportunity respiratory infection

187

1245

1.57

7.16

4.0

3.5

86.80

92.57

ng/l

0.46

164

1056

Benign neoplasm of breast

441

3387

1.33

7.16

3.1

3.2

76.11

81.79

ng/l

0.79

377

2856

All dysplastic lesions of the vulva

161

1035

1.62

7.16

5.1

3.1

102.29

74.48

ng/l

2.18

143

896

Lateral epicondylitis

401

3032

1.35

7.15

2.7

4.1

75.09

90.14

ng/l

3.67

350

2662

Male infertility

106

607

1.79

7.15

7.3

5.6

145.88

100.61

ng/l

1.59

573

Diffuse large B-cell lymphoma

167

1085

1.60

7.13

4.5

3.9

85.73

95.78

ng/l

0.67

140

933

Myeloproliferative diseases

303

2204

1.41

7.12

3.5

3.8

88.52

94.10

ng/l

0.55

261

1872

Perforation of tympanic membrane

332

2446

1.39

7.12

4.4

3.9

90.72

87.26

ng/l

0.29

289

2112

Melanoma in situ

161

1040

1.62

7.11

3.7

3.6

95.93

92.96

ng/l

0.15

133

894

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

120

717

1.74

7.10

4.1

4.2

86.47

80.53

ng/l

0.31

110

648

Congenital deformities of feet

459

1.93

7.09

4.7

4.4

74.76

70.76

ng/l

0.12

418

Lymphoid leukaemia

195

1309

1.54

7.09

4.1

4.3

90.03

91.42

ng/l

0.08

172

1121

Bruxism

376

2.05

7.08

3.9

3.6

64.57

73.95

ng/l

0.76

339

Vascular dementia

307

2160

1.41

7.07

3.1

3.4

103.67

103.81

ng/l

0.01

230

1785

Other specified disorders of muscle

106

614

1.80

7.05

4.0

4.1

90.44

86.96

ng/l

0.12

534

Pathological resorption of teeth

547

1.84

7.03

5.1

3.3

97.32

81.23

ng/l

0.94

484

Benign neoplasm: Parotid gland

257

1820

1.45

7.02

3.5

3.8

88.90

91.46

ng/l

0.18

216

1554

Urethritis and urethral syndrome

433

1.96

7.00

3.6

3.5

77.56

78.35

ng/l

0.03

375

Polyarthritis, unspecified

128

782

1.70

6.98

4.2

3.8

91.04

87.47

ng/l

0.17

116

682

Alcohol withdrawal state with delirium

206

1400

1.51

6.96

3.5

4.6

84.40

103.11

ng/l

2.39

181

1251

Oral lichen ruber planus wide, hypothyreosis or thyroxin

221

1532

1.50

6.95

3.0

3.4

80.60

83.92

ng/l

0.22

168

1301

Oral leukoplakia and related diseases

211

1448

1.51

6.93

3.9

87.06

91.78

ng/l

0.37

182

1256

Personal history of malignant neoplasm

143

902

1.65

6.93

4.1

3.0

86.00

72.00

ng/l

1.10

123

778

Trigeminal neuralgia

202

1371

1.52

6.93

3.3

3.4

78.85

84.49

ng/l

0.49

164

1179

Superficial injury of shoulder and upper arm

348

2593

1.37

6.91

3.6

4.2

87.44

91.39

ng/l

0.29

303

2240

Excessive vomiting in pregnancy

240

1680

1.46

6.91

3.3

3.2

71.51

73.13

ng/l

0.15

204

1487

Crohn disease (strict definition, all UC cases excluded)

154

985

1.61

6.90

3.9

4.3

79.30

82.40

ng/l

0.18

140

894

Other specified and unspecified retinal disorders

134

834

1.68

6.88

5.9

3.7

106.19

87.35

ng/l

0.89

119

722

Hemiplegia

177

1170

1.56

6.88

3.5

4.0

85.08

89.00

ng/l

0.25

146

1028

Gastrojejunal ulcer

232

2.35

6.87

5.3

4.1

113.94

89.80

ng/l

0.57

201

Supervision of normal pregnancy

372

2828

0.74

6.87

2.5

3.6

62.97

77.01

ng/l

5.57

346

2554

Secondary and unspecified malignant neoplasm of lymph nodes

284

2056

1.42

6.86

3.4

4.0

79.79

93.61

ng/l

2.01

238

1778

Volvulus

568

1.83

6.85

4.4

3.7

96.92

90.84

ng/l

0.22

494

Focal epilepsy

689

5602

1.25

6.84

3.9

4.2

81.42

89.76

ng/l

1.77

590

4873

Adalimumab

255

1809

1.44

6.83

3.4

4.1

84.12

80.56

ng/l

0.10

236

1630

509

1.87

6.82

3.6

3.9

90.41

81.15

ng/l

0.39

464

Other specified and unspecified disorders of conjunctiva

183

2.55

6.81

5.8

3.8

99.54

76.25

ng/l

0.49

163

Benign neoplasm of eye and adnexa

352

2640

1.37

6.80

3.8

92.60

91.18

ng/l

0.10

295

2261

Unspecified event, undetermined intent

488

1.89

6.80

4.8

4.6

98.90

82.66

ng/l

0.81

446

Other neurotic disorders

171

1127

1.57

6.76

2.9

3.7

90.84

85.93

ng/l

0.28

141

973

Spinal instabilities

100

577

1.81

6.75

3.6

4.1

70.58

84.18

ng/l

1.18

515

Sudden idiopathic hearing loss

344

2574

1.37

6.73

4.1

4.0

102.21

92.40

ng/l

0.59

289

2217

Ulcerative proctitis

184

1231

1.53

6.72

4.0

84.37

85.63

ng/l

0.07

169

1107

Inguinal hernia

1995

11894

1.14

6.72

4.7

4.3

98.19

98.25

ng/l

0.01

1744

10279

Congenital malformations of the musculoskeletal system, not elsewhere classified

267

2.22

6.71

5.8

4.1

64.90

69.71

ng/l

0.21

246

Emphysema

229

1602

1.47

6.70

3.9

91.46

98.43

ng/l

0.64

189

1371

Lesion of radial nerve

127

784

1.68

6.67

3.9

3.7

102.87

87.55

ng/l

0.65

100

688

Delivery, wide proxy

1066

6689

0.84

6.67

2.9

3.4

78.15

83.63

ng/l

1.54

911

5648

Endocrine disorders, other/unspecified

377

2.01

6.65

2.7

3.2

94.86

76.49

ng/l

0.40

333

Open wound of wrist and hand

1284

10949

1.17

6.65

4.1

4.4

92.93

94.53

ng/l

0.21

1112

9659

Acute generalized exanthematous pustulosis

162

1061

1.58

6.65

5.3

3.8

107.40

84.62

ng/l

1.60

141

932

Traumatic subarachnoid haemorrhage

107

632

1.75

6.61

4.2

3.5

109.24

93.11

ng/l

0.74

545

Other specified/unspecified inflammatory spondylopathies

135

845

1.64

6.61

3.1

3.9

84.59

81.41

ng/l

0.17

115

752

Pilonidal cyst

214

1477

1.47

6.60

5.7

4.4

104.68

83.60

ng/l

1.68

195

1355

Other disorders of breast

442

3434

1.31

6.60

3.3

3.2

73.91

80.30

ng/l

1.17

386

2929

Disorders of myoneural junction and muscle in diseases classified elsewhere

181

2.56

6.56

6.5

3.4

113.42

82.26

ng/l

0.98

158

Other specified/unspecified dorsopathies

124

764

1.68

6.56

3.3

3.8

96.27

85.88

ng/l

0.33

112

659

Schizophrenia

466

3640

1.30

6.55

3.2

4.2

90.05

93.04

ng/l

0.19

383

3230

Medial epicondylitis

129

803

1.66

6.54

3.4

4.0

84.00

85.84

ng/l

0.08

110

718

Multifocal fibrosclerosis

151

2.74

6.52

4.1

3.2

77.74

87.62

ng/l

0.47

130

Implicit parasitic Sepsis

3.42

6.52

5.2

3.3

100.89

85.05

ng/l

0.42

Carrier of infectious disease

459

1.89

6.49

5.1

4.0

92.96

79.96

ng/l

0.75

411

Oligomenorrhoea

112

673

1.72

6.48

3.1

77.55

71.37

ng/l

0.37

100

594

Adenocarcinoma of pancreas

650

0.35

6.46

3.6

3.9

137.56

94.45

ng/l

1.00

563

Dissection of aorta

110

661

1.73

6.45

5.0

3.8

131.46

97.90

ng/l

1.33

565

Disorders of speech understanding and production

141

884

1.62

6.41

7.6

5.5

67.74

68.70

ng/l

0.05

131

814

Pemphigoid

109

658

1.75

6.39

3.8

124.04

93.08

ng/l

1.52

560

Benign lipomatous neoplasm

1012

8596

1.19

6.39

3.7

3.8

87.04

91.28

ng/l

0.78

854

7395

Generalized skin eruption due to drugs and medicaments

144

928

1.61

6.38

5.7

3.9

113.14

84.11

ng/l

2.01

126

821

Benign neoplasm: Skin, unspecified

136

864

1.63

6.38

5.6

3.8

99.69

89.04

ng/l

0.68

120

748

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

238

1690

1.44

6.38

4.2

3.6

105.50

95.40

ng/l

0.83

213

1429

Premature rupture of membranes

331

3237

0.74

6.34

2.8

3.6

61.00

76.68

ng/l

5.86

292

2916

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1511

10297

1.16

6.33

3.6

3.9

94.13

94.93

ng/l

0.12

1325

8677

Visual field defects

284

2085

1.40

6.32

4.5

4.0

109.48

91.48

ng/l

1.50

244

1789

Other and unspecified iridocyclitis

144

929

1.60

6.32

4.3

3.8

85.35

84.27

ng/l

0.05

131

816

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

468

3683

1.29

6.31

4.2

3.8

104.38

95.80

ng/l

0.83

404

3093

Allergic rhinitis

901

7502

1.20

6.30

3.6

4.3

73.28

82.44

ng/l

3.26

798

6696

Pulmonary eosinophilia, not elsewhere classified

255

2.23

6.30

3.6

3.2

91.15

79.33

ng/l

0.46

222

Anogenital herpesviral [herpes simplex] infection

158

1037

1.56

6.29

4.3

3.5

72.50

74.29

ng/l

0.15

140

936

Congenital malformations of the respiratory system

438

1.92

6.28

6.9

5.2

75.86

69.25

ng/l

0.37

405

Other/unspecified disorders of vestibular function

146

949

1.60

6.27

3.7

3.6

91.24

90.44

ng/l

0.03

128

815

Mild mental retardation

501

1.83

6.26

7.9

5.2

80.60

71.12

ng/l

0.45

467

Sacrococcygeal disorders, not elsewhere classified

102

605

1.75

6.25

2.7

3.6

69.96

80.27

ng/l

1.17

534

Collapsed vertebra, not elsewhere classified

179

2.52

6.23

4.0

3.2

78.77

82.24

ng/l

0.11

147

Systemic sclerosis (FG)

533

1.81

6.22

3.7

3.6

79.18

85.08

ng/l

0.36

459

Benign neoplasm: Oesophagus

243

2.25

6.21

4.6

3.6

111.99

83.11

ng/l

1.02

213

Autism spe, excluding more controls

233

2.21

6.21

3.4

5.6

53.32

65.13

ng/l

1.14

222

Other and unspecified corneal deformities and disorders

116

715

1.69

6.20

4.2

3.7

85.35

83.88

ng/l

0.07

631

Family history of malignant neoplasm

308

2293

1.37

6.19

3.4

2.8

74.22

72.18

ng/l

0.19

267

2000

Aneurysms, operations, SAH

567

4574

1.26

6.19

5.0

3.5

99.18

89.88

ng/l

1.35

498

3886

Injury of urinary and pelvic organs

380

1.96

6.17

5.1

4.4

106.49

84.77

ng/l

0.81

345

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1477

11301

1.15

6.17

4.4

3.2

88.97

76.32

ng/l

5.21

1307

9854

Other and unspecified glaucoma

259

1885

1.42

6.16

4.2

3.6

98.33

95.50

ng/l

0.17

212

1577

Retinal breaks without detachment

521

4167

1.27

6.15

4.1

3.6

85.88

89.53

ng/l

0.49

445

3585

Salpingitis and oophoritis

645

5280

1.24

6.15

3.7

3.3

82.94

79.98

ng/l

0.33

557

4554

Chronic conjunctivitis

113

695

1.70

6.11

3.8

4.0

74.33

77.67

ng/l

0.24

105

616

Benign neoplasm: Anus and anal canal

104

628

1.73

6.05

3.8

3.6

89.92

88.94

ng/l

0.04

541

Multiple delivery

147

2205

0.65

6.05

3.2

4.1

75.49

83.79

ng/l

0.65

128

1952

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

194

2.41

6.03

4.0

3.8

76.48

81.92

ng/l

0.18

170

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

266

2.17

6.03

3.4

3.9

100.53

89.37

ng/l

0.25

235

Melanocytic naevi of other and unspecified parts of face

195

1353

1.48

6.03

4.5

3.6

82.85

84.49

ng/l

0.11

181

1181

Other disorders of carbohydrate metabolism

3.39

6.03

7.6

3.7

92.79

77.14

ng/l

0.34

Malignant neoplasm of small intestine

495

1.84

6.02

4.8

4.1

115.05

89.99

ng/l

1.50

432

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

129

823

1.63

6.00

3.4

3.8

81.85

93.39

ng/l

0.99

111

695

Other superficial mycoses

384

1.93

5.98

6.3

4.1

122.35

81.79

ng/l

1.11

350

Single delivery by caesarean section

333

2544

0.75

5.98

3.3

4.3

76.40

79.14

ng/l

0.18

298

2305

Unspecified visual impairment (binocular)

315

2.06

5.98

4.3

4.6

120.69

77.34

ng/l

1.84

284

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

151

2.62

5.97

4.6

3.7

93.63

82.25

ng/l

0.22

131

Adenocarcinoma and ductal carcinoma of pancreas

809

0.44

5.97

2.9

3.7

121.43

94.55

ng/l

0.77

696

Childhood allergy (age < 16)

309

1893

1.36

5.97

5.1

5.6

63.34

67.38

ng/l

0.41

284

1770

Juvenile Open Angle Glaucoma

103

2.98

5.97

7.4

3.4

147.00

79.10

ng/l

0.92

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

195

2.40

5.96

4.0

3.7

76.48

84.71

ng/l

0.32

171

Other and specified injuries of hip and thigh

488

1.83

5.96

5.8

3.7

103.06

87.78

ng/l

0.46

414

L04AC Interleukin inhibitors

141

917

1.58

5.94

4.0

68.91

82.16

ng/l

2.13

133

825

Benign neoplasm: Rectosigmoid junction

155

1035

1.56

5.93

3.9

3.7

93.16

94.27

ng/l

0.05

131

889

Benign neoplasm: Oesophagus

248

2.20

5.91

4.6

3.7

111.99

86.52

ng/l

0.86

218

Chronic viral hepatitis

137

885

1.58

5.90

5.0

4.4

107.43

84.79

ng/l

1.54

123

806

Dementia, including avohilmo

1681

10252

1.14

5.90

2.9

3.7

89.97

99.21

ng/l

3.97

1310

8583

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

262

2.17

5.90

3.3

3.5

84.09

85.28

ng/l

0.04

229

Benign neoplasm of major salivary glands

330

2507

1.35

5.89

3.8

3.9

92.03

93.28

ng/l

0.09

277

2147

Other fall from one level to another

660

5432

1.23

5.86

4.2

4.5

83.47

90.54

ng/l

1.28

581

4798

Mixed conductive and sensorineural hearing loss

426

3349

1.30

5.86

3.9

3.8

99.08

93.08

ng/l

0.51

353

2848

Vulvovaginal ulceration/inflammation in other diseases

164

1104

1.52

5.86

4.1

3.4

72.31

72.55

ng/l

0.02

143

988

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

579

1.74

5.85

4.2

4.1

89.03

80.89

ng/l

0.30

523

Atopic conjunctivitis

141

922

1.57

5.82

4.2

4.1

76.46

75.94

ng/l

0.03

125

829

Ectropion of eyelid

145

957

1.57

5.82

4.5

3.8

119.84

103.51

ng/l

0.90

130

787

Contusion of other and unspecified parts of foot

140

913

1.57

5.82

4.6

4.4

81.02

77.02

ng/l

0.21

127

831

Convergent concomitant strabismus

170

1155

1.51

5.81

4.4

4.1

73.22

76.69

ng/l

0.24

159

1043

Enteropathic arthropathies

431

1.86

5.81

3.2

4.3

87.57

83.69

ng/l

0.11

388

Benign neoplasm of mouth and pharynx

367

2834

1.32

5.81

3.9

87.57

90.54

ng/l

0.24

313

2433

Hodgkin lymphoma

520

1.78

5.79

3.7

4.2

88.41

87.47

ng/l

0.03

464

Appendectomy

2172

18813

1.12

5.79

4.0

3.9

87.05

88.54

ng/l

0.24

1904

16437

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

211

1492

1.44

5.79

3.7

3.8

84.37

84.23

ng/l

0.01

188

1326

Crowding of teeth, including avohilmo

232

1370

1.42

5.78

9.2

4.8

69.90

64.20

ng/l

0.57

217

1274

Burns and corrosions of external body surface, specified by site

307

2311

1.35

5.76

3.9

4.8

86.73

89.77

ng/l

0.22

262

2069

Other disorders of thyroid

306

2.06

5.76

2.6

3.2

69.30

79.23

ng/l

0.59

271

Intracranial and intraspinal abscess and granuloma

217

2.27

5.76

5.7

3.9

99.36

81.29

ng/l

0.46

198

Other congenital malformations of limb(s)

128

2.68

5.76

5.0

5.7

78.84

64.49

ng/l

0.21

119

Other melanin hyperpigmentation

548

1.77

5.73

4.0

3.3

98.56

82.54

ng/l

0.85

472

Complications of labour and delivery

1814

11369

0.88

5.72

3.1

3.4

75.53

78.80

ng/l

1.07

1580

9832

Encephalopathy

185

2.38

5.72

5.0

3.8

117.72

92.15

ng/l

0.51

159

Abscess of lung

285

2.08

5.70

5.4

4.5

107.68

86.17

ng/l

0.62

252

Congenital malformations of genital organs

271

1993

1.38

5.70

4.8

4.2

76.31

69.39

ng/l

0.57

244

1811

Other specified/unspecified disorders of bone/cartilage

546

1.75

5.68

4.7

3.7

78.92

83.09

ng/l

0.20

489

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

612

0.38

5.68

3.6

3.4

137.56

92.14

ng/l

1.07

529

Benign leiomyoma with endometriosis

581

4752

1.24

5.66

3.2

81.86

83.23

ng/l

0.18

480

3986

Malignant neoplasm of bronchus and lung

415

4910

0.78

5.65

2.8

3.9

84.09

102.00

ng/l

4.59

360

4108

Contusion of ankle

111

691

1.65

5.65

5.2

4.1

86.44

78.22

ng/l

0.47

101

625

Other nonscarring hair loss

180

2.39

5.62

5.0

3.8

93.30

73.91

ng/l

0.60

158

Malignant melanoma

499

4020

1.26

5.60

4.2

3.8

106.53

94.69

ng/l

1.36

430

3423

Other acute viral hepatitis

219

2.23

5.59

3.7

4.2

85.58

86.26

ng/l

0.02

200

Prolonged pregnancy

193

2486

0.70

5.57

2.2

3.7

64.96

77.75

ng/l

3.09

180

2261

Ulcerative colitis (strict definition, all Crohn cases excluded)

408

3206

1.29

5.56

3.7

4.2

85.83

89.84

ng/l

0.33

364

2851

Pustular psoriasis

164

1122

1.51

5.54

3.5

3.7

74.62

83.51

ng/l

1.15

140

975

Hereditary hypogammaglobulinemia

3.44

5.52

3.4

4.9

76.59

83.58

ng/l

0.21

Open bite

145

965

1.54

5.51

7.5

5.1

66.86

67.11

ng/l

0.02

139

899

Lymphoid leukaemia

195

1380

1.46

5.51

4.1

4.3

90.03

90.54

ng/l

0.03

172

1203

Embolic stroke with flimmer

559

1.73

5.50

4.3

3.4

120.20

90.66

ng/l

2.06

471

Cluster headache, strict

603

1.69

5.49

3.6

3.9

72.96

78.66

ng/l

0.37

553

Other disorders of binocular movement

417

1.85

5.48

4.4

4.0

86.56

70.80

ng/l

0.76

378

Vascular syndromes of brain in cerebrovascular disorders

166

1142

1.50

5.48

4.5

3.7

109.02

98.37

ng/l

0.60

152

983

Perineal laceration during delivery

208

2577

0.71

5.47

2.4

3.6

56.62

73.73

ng/l

5.31

191

2326

Adult respiratory distress syndrome

249

2.13

5.44

7.6

4.1

146.54

88.08

ng/l

2.41

222

Chorioretinal inflammation

592

1.70

5.43

5.0

3.7

87.53

80.41

ng/l

0.42

527

Dental caries 2, only avohilmo

2515

18018

1.11

5.41

4.1

4.0

82.50

87.16

ng/l

1.84

2207

15869

Disorder of the sleep-wake schedule

311

1.99

5.41

4.2

5.0

84.03

73.55

ng/l

0.33

285

Caught, crushed, jammed or pinched in or between objects

139

922

1.55

5.39

4.1

4.6

87.94

81.80

ng/l

0.33

123

834

Other complications of labour and delivery, not elsewhere classified

109

1644

0.63

5.38

2.7

3.5

52.28

72.77

ng/l

5.63

1489

Examination and encounter for administrative purposes

121

780

1.59

5.34

4.0

98.06

98.22

ng/l

0.00

108

660

Burns and corrosions of multiple and unspecified body regions

414

1.84

5.31

4.8

91.45

85.71

ng/l

0.18

379

Third [oculomotor] nerve palsy

409

1.86

5.31

5.7

4.1

151.78

85.91

ng/l

1.30

365

Other injuries of lower limb, level unspecified

153

2.47

5.28

4.6

3.9

94.84

80.01

ng/l

0.54

141

Postmenopausal atrophic vaginitis

993

5133

1.18

5.25

3.0

3.2

76.01

82.60

ng/l

2.36

853

4412

Other diseases of peritoneum

163

1127

1.49

5.25

4.6

3.4

93.23

84.38

ng/l

0.62

138

975

Central retinal artery occlusion

508

1.76

5.23

4.5

4.0

115.46

96.54

ng/l

0.93

441

Postprocedural disorders of nervous system

196

1397

1.43

5.22

2.6

3.8

60.05

75.78

ng/l

5.63

176

1257

Injury of other and unspecified intrathoracic organs

192

1367

1.44

5.20

3.8

4.3

88.52

97.30

ng/l

0.65

166

1209

Injury of eye and orbit

386

3039

1.29

5.20

4.6

4.4

93.88

92.31

ng/l

0.11

343

2709

Hypertrichosis

336

1.91

5.19

4.7

3.7

94.77

70.87

ng/l

1.01

306

Pyoderma

411

1.84

5.18

4.8

4.0

84.14

79.50

ng/l

0.16

364

Benign neoplasm: Choroid

210

1524

1.42

5.18

3.5

3.6

92.56

90.29

ng/l

0.11

176

1321

Haemangioma and lymphangioma, any site

273

2058

1.35

5.17

3.9

4.0

86.12

86.28

ng/l

0.01

239

1775

Other/unspecified soft tissue disorders related to use, overuse and pressure

592

1.68

5.16

2.7

3.7

83.77

83.83

ng/l

0.00

528

Human immunodeficiency virus [HIV] disease

316

1.95

5.15

2.1

4.3

73.75

87.61

ng/l

1.06

291

Melanoma in situ of upper limb, including shoulder

143

2.53

5.15

2.6

3.5

84.19

82.43

ng/l

0.06

123

Dislocation, sprain and strain of joint and ligaments of hip

132

881

1.55

5.10

4.2

3.6

96.72

89.58

ng/l

0.34

120

753

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

762

0.47

5.10

2.9

3.5

121.43

91.80

ng/l

0.89

657

Prepatellar bursitis

128

846

1.55

5.07

5.3

4.8

145.99

97.81

ng/l

0.99

115

749

Portal vein thrombosis

305

1.97

5.07

5.8

4.0

91.86

80.32

ng/l

0.38

274

Haemoglobinuria due to haemolysis from other external causes

22.13

5.07

13.6

3.4

149.14

62.40

ng/l

—

Other lesions of median nerve

111

715

1.62

5.07

4.4

3.2

104.91

88.69

ng/l

0.84

597

Spondylopathies in diseases classified elsewhere

257

2.08

5.05

3.2

3.7

119.12

84.27

ng/l

1.10

222

Other and unspecified types of non-Hodgkin lymphoma, hilmo

147

1006

1.51

5.02

3.4

3.7

79.84

91.90

ng/l

0.88

119

869

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

397

3155

1.28

5.02

3.5

3.7

81.96

90.38

ng/l

1.40

338

2702

Intermittent heterotropia

170

1191

1.46

5.02

5.6

5.0

78.64

71.78

ng/l

0.41

154

1084

Other benign neoplasms of connective and other soft tissue

321

2487

1.32

5.01

3.9

92.36

89.05

ng/l

0.20

275

2158

592

1.66

5.00

12.6

8.1

51.58

51.78

ng/l

0.02

579

Mature T/NK-cell lymphomas, hilmo

286

2.01

4.99

3.4

4.1

100.53

86.98

ng/l

0.32

257

Pustulosis palmaris et plantaris

148

1015

1.51

4.99

3.6

73.59

80.55

ng/l

0.77

127

884

Other disorders of male genital organs

588

1.66

4.98

5.7

112.16

95.98

ng/l

0.68

532

Other secondary coxarthrosis

121

797

1.57

4.97

4.3

3.6

93.83

85.71

ng/l

0.40

106

697

Postpartum haemorrhage

444

4785

0.80

4.95

2.9

3.6

63.72

76.61

ng/l

5.22

396

4290

Disorder of carbohydrate metabolism, other/unspecified

3.78

4.95

5.4

3.9

71.20

86.77

ng/l

0.35

Corneal degeneration

345

1.91

4.94

5.0

3.2

92.77

76.43

ng/l

0.98

302

Human immunodeficiency virus [HIV] disease resulting in other conditions

271

2.00

4.94

2.0

4.4

75.23

88.80

ng/l

0.92

250

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

883

7585

1.18

4.93

3.7

4.2

87.97

94.35

ng/l

1.02

773

6581

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1064

7208

0.86

4.93

2.8

3.6

70.15

78.18

ng/l

2.79

954

6380

Motor neuron disease (with DMD)

336

1.89

4.92

4.1

3.7

63.77

91.29

ng/l

2.18

300

Triptan medication for migraine, single purchase ok

2615

16177

1.10

4.91

3.1

4.0

73.87

86.66

ng/l

13.13

2316

14170

Migraine, single triptan purchase ok & required. ICD-code if available is included

2615

16177

1.10

4.91

3.1

4.0

73.87

86.66

ng/l

13.13

2316

14170

Benign neoplasm of ovary

616

5144

1.22

4.91

3.6

3.2

90.52

82.06

ng/l

0.65

525

4323

Carcinoma in situ of other and unspecified digestive organs

564

1.69

4.90

4.6

3.7

109.59

92.60

ng/l

0.88

494

Benign neoplasm of bone and articular cartilage

230

1704

1.38

4.89

3.2

3.9

72.67

84.80

ng/l

1.84

206

1501

Vascular dementia (subcortical)

105

673

1.62

4.89

3.1

3.6

90.25

102.46

ng/l

0.88

564

Malignant neoplasm of respiratory system and intrathoracic organs

499

5596

0.81

4.88

2.9

3.9

82.16

102.52

ng/l

6.52

431

4696

Later onset COPD

1017

6933

1.17

4.88

3.9

3.8

112.97

100.48

ng/l

2.30

831

5755

Bullous pemphigoid

496

1.74

4.87

4.2

3.9

141.26

93.66

ng/l

1.95

428

Other and unspecified injuries of abdomen, lower back and pelvis

266

2.01

4.87

4.3

3.6

91.96

79.99

ng/l

0.29

239

Other surgical follow-up care

100

632

1.63

4.87

5.3

3.0

94.39

72.44

ng/l

1.75

556

Hypertrophy of breast

548

4525

1.23

4.87

2.8

3.4

70.72

78.54

ng/l

2.08

470

3924

Meralgia paraesthetica

112

730

1.59

4.82

2.6

3.7

74.13

87.45

ng/l

1.19

642

Other and unspecified paralytic syndromes

289

1.97

4.82

3.5

3.9

76.14

81.98

ng/l

0.31

257

Alzheimer’s disease (Early onset)

1111

0.57

4.82

3.1

3.3

86.32

94.98

ng/l

0.26

915

Suggestive for eosinophilic asthma

289

2222

1.33

4.80

3.5

4.0

92.33

92.58

ng/l

0.01

247

1924

Other peripheral vertigo

314

2444

1.31

4.79

2.6

3.7

75.95

90.79

ng/l

3.43

262

2078

Melanoma in situ of upper limb, including shoulder

148

2.44

4.79

2.6

3.4

84.19

81.19

ng/l

0.10

129

Pedestrian injured in transport accident

217

1601

1.39

4.78

3.9

91.69

88.02

ng/l

0.21

188

1378

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

255

1929

1.35

4.78

4.0

3.6

92.10

87.82

ng/l

0.22

216

1649

Arthropathic psoriasis

342

2688

1.29

4.77

3.7

4.0

80.85

89.47

ng/l

1.19

288

2357

Nystagmus and other irregular eye movements

290

1.97

4.77

6.6

5.0

98.07

72.35

ng/l

1.06

267

Alcohol induced polyneuropathy

173

2.28

4.77

4.1

4.2

98.25

86.49

ng/l

0.39

155

Cluster headache, wide

106

682

1.59

4.76

3.4

3.9

71.50

81.63

ng/l

0.85

617

Benign neoplasm: salivary glands, exclude unknown (D119)

286

2201

1.33

4.75

3.6

3.9

90.34

92.86

ng/l

0.18

242

1895

Muscle strain

613

1.63

4.73

4.6

4.2

92.23

86.40

ng/l

0.19

552

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

299

1.96

4.73

4.5

3.7

119.42

85.53

ng/l

1.48

259

Idiopathic thrombocytopenic purpura

103

662

1.61

4.73

4.9

4.3

94.28

85.39

ng/l

0.36

592

Septal defects

211

1520

1.39

4.73

5.5

5.8

73.60

72.48

ng/l

0.09

184

1404

Assault by sharp object

240

2.03

4.72

2.7

4.5

119.18

85.05

ng/l

0.71

226

Sequelae of infectious and parasitic diseases

231

1723

1.37

4.72

4.3

3.8

107.83

90.33

ng/l

1.03

184

1498

Vascular dementia (mixed)

298

1.94

4.72

2.7

3.9

103.66

105.74

ng/l

0.06

255

Congenital deformities of hip

348

1.86

4.71

6.1

5.6

61.51

61.53

ng/l

0.00

324

Benign neoplasm: Skin of lower limb, including hip

600

1.64

4.71

5.1

3.5

111.89

83.00

ng/l

1.75

532

Dental pulpitis 3

265

1439

1.34

4.69

5.0

5.6

77.04

60.42

ng/l

1.53

246

1342

Myeloproliferative diseases (CML excluded)

262

1998

1.34

4.68

3.3

3.7

87.68

93.89

ng/l

0.57

223

1698

Ménière disease

335

2638

1.30

4.68

2.9

3.6

76.67

90.36

ng/l

3.06

283

2249

Use of disulfiram, acamprosate or naltrexone

229

1708

1.36

4.67

2.9

4.6

84.20

94.13

ng/l

0.73

195

1546

Lethal midline granuloma

11.06

4.66

14.6

2.6

95.56

69.79

ng/l

—

Benign neoplasm: Skin, unspecified

136

931

1.51

4.65

5.6

3.7

99.69

86.79

ng/l

0.90

120

807

Sexual dysfunction

221

2.08

4.65

6.2

4.5

113.37

87.42

ng/l

0.83

204

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

866

4533

1.18

4.65

4.3

4.9

107.76

108.76

ng/l

0.09

747

3942

Sequelae of injuries of neck and trunk

578

1.65

4.63

3.4

3.9

68.10

86.81

ng/l

1.50

521

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

103

666

1.60

4.62

4.2

5.0

88.60

85.95

ng/l

0.10

594

Focal epilepsy, strict definition

616

5171

1.21

4.59

3.9

4.2

81.38

90.35

ng/l

1.85

528

4481

Hodgkin lymphoma, hilmo

556

1.66

4.59

3.7

4.1

88.41

83.12

ng/l

0.21

498

Persons encountering health services in circumstances related to reproduction

1811

11057

1.12

4.59

4.7

4.4

77.82

88.60

ng/l

5.42

1652

9803

Benign neoplasm of breast

441

3592

1.25

4.58

3.1

76.11

80.85

ng/l

0.61

377

3012

Hirsutism in women

278

1.94

4.58

4.3

3.6

87.48

70.31

ng/l

0.57

255

Other erythematous conditions

125

845

1.53

4.58

3.9

3.7

84.07

82.74

ng/l

0.06

109

743

Generalized epilepsy

128

867

1.51

4.56

3.7

4.8

83.18

77.79

ng/l

0.24

107

789

Secondary polycythaemia

442

1.74

4.56

4.2

4.1

97.25

90.47

ng/l

0.27

392

Neuroendocrine tumor and carcinoma of small intestine

303

1.93

4.56

4.5

3.7

119.42

83.42

ng/l

1.60

265

Endometriosis of ovary

536

4434

1.22

4.55

3.5

3.3

78.17

80.65

ng/l

0.33

454

3864

534

1.67

4.55

13.3

8.3

51.21

51.43

ng/l

0.02

522

Car occupant injured in noncollision transport accident

103

667

1.59

4.53

5.5

4.2

113.69

84.86

ng/l

1.29

602

Pyogenic granuloma

354

1.83

4.51

4.5

3.9

84.86

79.18

ng/l

0.20

315

Focal epilepsy, mode (most common among epilepsy diagnosis)

579

4843

1.21

4.50

3.7

4.2

80.29

90.39

ng/l

2.33

493

4193

Disorder of external ear, unspecified

104

678

1.59

4.50

4.8

3.9

110.41

84.67

ng/l

1.30

607

Other lack of coordination

370

1.82

4.49

2.9

4.3

73.41

80.86

ng/l

0.33

329

Viral encephalitis, not elsewhere classified/unspecified

422

1.76

4.48

4.6

3.9

91.33

82.40

ng/l

0.29

381

Severe visual impairment, monocular

199

2.16

4.48

8.1

2.8

123.33

70.72

ng/l

1.92

178

Toxic effect of alcohol

391

1.78

4.48

5.3

4.4

129.42

86.61

ng/l

0.91

349

LSIL lesion of the vulva

104

680

1.59

4.46

5.4

3.1

104.39

73.77

ng/l

1.56

606

Systemic sclerosis

586

1.64

4.45

3.7

3.4

79.18

79.86

ng/l

0.03

512

Campylobacter enteritis

561

1.64

4.45

6.7

4.0

120.85

81.51

ng/l

1.88

501

Protein-energy malnutrition of moderate and mild degree

200

2.17

4.45

3.4

5.7

75.06

75.58

ng/l

0.01

180

Atrophic disorders of skin

479

3947

1.23

4.43

3.6

3.2

83.21

80.32

ng/l

0.34

422

3316

Macular cyst

101

660

1.60

4.42

6.1

3.5

118.59

88.22

ng/l

1.65

571

Traumatic ischaemia of muscle

233

2.03

4.42

5.3

3.9

119.72

78.48

ng/l

1.07

212

Congenital malformations of eye, ear, face and neck

182

1322

1.40

4.42

5.5

4.8

88.14

76.65

ng/l

0.89

163

1204

Viral infections of the central nervous system

217

1622

1.36

4.42

3.8

3.9

84.87

83.41

ng/l

0.09

185

1420

Benign neoplasm: Parotid gland

257

1972

1.33

4.40

3.5

3.9

88.90

92.25

ng/l

0.25

216

1704

Unspecified jaundice

153

1081

1.45

4.40

4.8

3.7

94.39

90.99

ng/l

0.17

135

927

Panniculitis, unspecified

235

2.04

4.39

3.1

3.0

82.46

79.69

ng/l

0.07

208

Hereditary erythropoietic porphyria

10.50

4.38

7.7

2.1

77.00

74.70

ng/l

—

Any dementia, excluding more controls

1272

7830

1.14

4.38

2.9

3.7

92.52

98.79

ng/l

1.57

978

6547

Dronedarone medication

101

660

1.59

4.37

2.9

3.1

98.51

81.48

ng/l

1.32

562

Open wound of abdomen, lower back and pelvis

547

1.64

4.36

4.3

4.6

111.96

85.05

ng/l

0.77

498

Recurrent dislocation and subluxation of joint

172

1239

1.41

4.35

3.7

84.64

81.56

ng/l

0.15

155

1112

Other specified/unspecified hearing loss

266

2053

1.32

4.35

4.5

3.9

113.00

94.04

ng/l

1.35

238

1764

Embedded and impacted teeth

568

4031

1.21

4.34

6.7

4.1

90.58

77.57

ng/l

2.27

524

3654

Benign neoplasm: Anus and anal canal

104

686

1.57

4.32

3.8

89.92

88.11

ng/l

0.07

593

269

1.91

4.32

4.6

3.3

118.76

68.24

ng/l

1.35

248

Haemangioma, any site

249

1906

1.33

4.31

3.8

4.0

83.10

85.65

ng/l

0.19

217

1645

Maternal care for other conditions predominantly related to pregnancy

499

4077

1.22

4.27

3.4

76.33

74.45

ng/l

0.20

455

3671

Congenital absence, atresia and stenosis of small intestine

4.89

4.26

16.9

3.6

47.00

44.73

ng/l

0.09

Disorders of synovium and tendon in diseases classified elsewhere

436

1.72

4.25

6.7

4.0

109.57

86.34

ng/l

1.00

386

Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)

3.13

4.24

6.0

4.6

68.28

92.77

ng/l

1.18

Long labour

445

4723

0.82

4.22

2.7

3.5

65.17

76.55

ng/l

4.29

390

4221

Benign neoplasm of middle ear and respiratory system

235

1791

1.34

4.21

4.0

3.9

94.63

93.93

ng/l

0.04

209

1528

Pediculosis, acariasis and other infestations

153

1089

1.43

4.21

4.9

4.3

99.45

85.06

ng/l

0.87

138

979

Benign neoplasm: Long bones of lower limb

600

1.59

4.20

3.4

4.0

70.45

83.83

ng/l

0.88

542

Drug-induced obesity

169

2.20

4.20

3.8

4.5

87.29

80.00

ng/l

0.15

154

Striae atrophicae

203

2.08

4.19

3.8

3.9

81.97

71.18

ng/l

0.45

181

572

1.62

4.18

3.6

4.1

93.84

94.92

ng/l

0.04

494

Benign lipomatous neoplasm of other sites/unspecified

285

2233

1.30

4.17

3.6

87.95

91.78

ng/l

0.32

237

1875

Fracture of neck

180

1322

1.39

4.17

5.0

4.0

115.80

97.74

ng/l

0.76

154

1137

Chronic suppurative otitis media

213

1604

1.35

4.16

4.2

4.1

102.03

87.30

ng/l

0.62

187

1393

Oral lichen ruber planus, hypothyreosis or thyroxin

419

1.74

4.14

3.2

3.0

86.76

76.59

ng/l

0.29

369

Other noninflammatory disorders of vagina

254

1962

1.32

4.14

4.1

3.2

93.43

80.63

ng/l

1.12

214

1688

Seropositive rheumatoid arthritis, strict definition

509

4250

1.21

4.13

2.9

3.6

75.21

87.50

ng/l

3.48

446

3624

UC patients in KELA-register (code 208), prior to 1994

145

1029

1.45

4.13

4.4

4.0

91.36

88.49

ng/l

0.14

136

912

Other abnormal findings of blood chemistry

139

980

1.46

4.11

3.8

4.0

106.39

89.10

ng/l

1.15

115

862

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

608

5158

1.19

4.10

3.6

3.8

99.17

96.87

ng/l

0.24

542

4307

Benign neoplasm of other and unspecified sites

106

710

1.54

4.09

2.7

3.7

84.63

87.89

ng/l

0.13

621

Disturbances of smell and taste

137

965

1.46

4.08

2.8

3.5

75.35

82.63

ng/l

0.69

118

845

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

717

6169

1.18

4.06

3.0

3.9

100.04

95.48

ng/l

0.46

625

5246

Hypertensive encephalopathy

2.90

4.04

10.6

2.4

114.83

77.86

ng/l

0.98

Other and unspecified mononeuropathies of lower limb

648

1.57

4.04

3.1

3.4

71.05

85.53

ng/l

1.97

561

Etanercept

180

1329

1.38

4.01

3.6

4.1

92.58

79.72

ng/l

0.29

164

1185

Congenital malformations of trachea and bronchus

222

2.03

4.01

6.0

4.3

70.83

70.53

ng/l

0.01

197

Other inflammation of vagina/vulva

101

671

1.54

4.00

3.2

3.4

73.02

73.44

ng/l

0.02

598

Alopecia areata

537

1.62

3.99

3.3

4.0

78.49

72.85

ng/l

0.36

479

Disorders of eyelid in diseases classified elsewhere

112

763

1.51

3.99

4.8

3.5

92.62

82.45

ng/l

0.52

663

Other specified/unspecified spondylopathies

578

1.60

3.98

4.4

3.8

115.92

92.93

ng/l

1.06

495

Labour and delivery complicated by fetal stress [distress]

365

3010

0.80

3.98

3.0

3.6

63.73

74.34

ng/l

3.42

330

2742

Vertical strabismus

109

739

1.52

3.97

4.0

3.8

73.22

81.71

ng/l

0.56

663

Spirochaetal infections, other/unspecified

268

2101

1.30

3.95

3.4

4.0

68.92

90.60

ng/l

6.81

243

1817

Tongue abnormality

213

1623

1.35

3.92

4.0

3.6

88.42

87.89

ng/l

0.03

186

1381

Carcinoma in situ of other and unspecified digestive organs

598

1.59

3.91

4.6

3.7

109.59

90.60

ng/l

0.97

515

Congenital malformations of great arteries

540

1.61

3.90

7.5

7.6

66.10

58.18

ng/l

0.65

518

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

658

3638

1.18

3.90

3.2

3.4

74.96

69.96

ng/l

0.37

596

3325

Ulcerative ileocolitis

114

781

1.49

3.90

4.6

4.0

110.26

83.85

ng/l

1.16

106

706

Benign neoplasm: Pancreas

615

1.57

3.88

5.9

3.5

83.92

88.02

ng/l

0.19

530

Dementia

1541

9615

1.12

3.86

2.9

3.7

89.25

99.38

ng/l

4.45

1194

8031

Unspecified human immunodeficiency virus [HIV] disease

154

2.18

3.86

2.1

5.4

74.63

95.65

ng/l

1.02

148

Mixed disorders of conduct and emotions, excluding more controls

250

1.88

3.85

7.1

4.8

94.92

60.40

ng/l

0.88

235

Calcific tendinitis of shoulder

177

1313

1.38

3.85

2.9

3.8

76.51

86.49

ng/l

0.89

159

1150

Eosinophilia

334

1.79

3.85

6.2

4.4

115.90

81.64

ng/l

1.82

303

Other obstetric conditions, not elsewhere classified

679

3772

1.18

3.84

3.1

3.4

74.93

70.94

ng/l

0.29

616

3444

Biomechanical lesions, not elsewhere classified

157

1146

1.41

3.83

3.7

84.42

90.28

ng/l

0.45

141

993

Epiphora

553

1.60

3.83

2.9

3.6

100.59

83.48

ng/l

0.87

483

Chronic thyroiditis

2.85

3.82

2.0

2.3

59.77

69.97

ng/l

0.48

Dependent personality disorder

458

1.66

3.80

4.1

3.4

112.90

77.63

ng/l

1.65

408

Inguinal or femoral hernia, bilateral

304

2428

1.27

3.80

5.0

4.6

94.55

104.91

ng/l

0.98

273

2119

Injuries involving multiple body regions

109

745

1.50

3.80

4.5

4.0

113.16

85.02

ng/l

0.99

661

Autoimmune hepatitis

136

2.27

3.77

2.1

2.9

79.29

69.28

ng/l

0.24

122

Orthopaedic devices associated with adverse incidents

438

1.68

3.76

4.1

3.5

66.02

84.61

ng/l

1.94

381

Pollen allergy

467

3856

1.21

3.75

3.7

4.5

68.16

75.15

ng/l

1.40

416

3504

Other conjunctival vascular disorders and cysts

547

1.60

3.75

3.8

3.5

89.78

81.65

ng/l

0.30

482

Rheumatic fever incl heart disease

109

748

1.50

3.75

5.6

3.6

135.43

91.47

ng/l

1.72

642

Allergic colitis

442

1.65

3.75

8.0

7.0

59.15

57.06

ng/l

0.13

424

6-mercaptopurine

465

1.63

3.75

3.3

4.7

65.50

80.45

ng/l

1.77

427

Myotonic disorders

143

2.22

3.74

3.9

65.92

83.25

ng/l

1.11

130

L01XE Protein kinase inhibitors

193

1462

1.35

3.73

3.6

3.9

103.92

91.86

ng/l

0.88

171

1267

Other facial nerve disorders

627

1.55

3.73

3.0

3.5

81.04

81.17

ng/l

0.01

546

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

422

1.68

3.72

4.6

4.3

114.70

84.05

ng/l

0.94

372

Pregnancy with abortive outcome

2471

11926

1.09

3.71

3.2

3.3

78.26

80.31

ng/l

0.58

2125

10183

Right hemicolectomy

201

1532

1.34

3.71

5.0

3.7

112.51

97.35

ng/l

1.09

174

1304

Keratoconus

444

1.65

3.71

4.8

4.2

103.28

81.66

ng/l

1.07

401

Conduct disorder

306

1.78

3.69

4.4

5.8

103.34

72.39

ng/l

0.83

295

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

130

923

1.44

3.69

2.8

3.9

70.14

83.78

ng/l

2.02

120

817

Chalazion

333

2697

1.25

3.69

3.4

4.1

82.23

89.85

ng/l

0.70

289

2331

Alzheimer’s disease (Late onset), excluding more controls

494

2761

1.21

3.68

2.7

3.5

85.63

96.05

ng/l

1.96

393

2269

Antenatal screening

430

2923

0.82

3.67

3.0

3.7

68.63

77.82

ng/l

1.92

396

2639

Mental and behavioural disorders due to use of other stimulants, including caffeine

359

1.71

3.67

3.5

5.1

84.94

83.17

ng/l

0.05

334

Systemic sclerosis, icd10

607

1.56

3.66

3.7

3.5

79.43

79.99

ng/l

0.03

536

Malignant neoplasm of bladder

219

1690

1.32

3.65

3.8

3.9

102.90

103.61

ng/l

0.03

184

1438

Benign neoplasm: Other/unspecified site

332

1.76

3.65

3.1

3.8

91.06

87.75

ng/l

0.08

297

Other primary thrombocytopenia

2.78

3.64

3.5

4.1

144.16

68.13

ng/l

0.54

Toxic effect of ethanol

102

693

1.50

3.64

4.8

4.5

101.42

85.88

ng/l

0.40

619

Neuroendocrine tumor and carcinoma of lung, excluding all cancers (controls excluding all cancers)

159

2.16

3.64

2.2

3.5

100.16

75.04

ng/l

1.48

139

Acute appendicitis

2290

19953

1.09

3.64

4.1

4.0

90.10

90.51

ng/l

0.06

2035

17470

Benign neoplasm: Pharynx, unspecified

152

2.17

3.63

4.4

3.2

81.97

78.48

ng/l

0.12

137

Asthma mixed form (mode), excluding more controls

147

1068

1.40

3.63

3.8

3.2

92.45

78.27

ng/l

0.94

123

927

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

836

7051

1.15

3.62

3.0

3.1

82.85

81.85

ng/l

0.13

707

5879

Benign neoplasm: Connective and other soft tissue of head, face and neck

332

1.75

3.62

4.5

3.7

78.35

81.04

ng/l

0.15

299

Benign neoplasm: Skin of scalp and neck

527

1.59

3.62

4.8

4.1

92.67

86.04

ng/l

0.24

467

Triptan medication for migraine, min. 3 purchases

1658

11907

1.10

3.61

3.0

3.8

71.52

82.54

ng/l

7.20

1487

10543

Hypertension, portal

2.99

3.61

6.8

5.0

147.94

81.73

ng/l

0.89

Effects of foreign body entering through natural orifice

677

5854

1.17

3.60

3.9

4.6

85.01

94.90

ng/l

1.99

598

5170

Superficial injuries involving multiple body regions

495

1.60

3.60

4.5

3.7

92.89

80.93

ng/l

0.44

447

Vasomotor rhinitis (mode)

230

1792

1.31

3.59

3.7

3.8

83.04

86.81

ng/l

0.28

199

1566

Benign neoplasm: Skin of ear and external auricular canal

126

897

1.44

3.59

4.7

3.6

111.92

91.34

ng/l

0.99

108

774

Impetigo

119

837

1.45

3.57

5.7

5.0

72.41

73.73

ng/l

0.07

104

766

Periodontal disease, other/unspecified

2.75

3.57

9.3

4.2

104.11

74.79

ng/l

0.65

Benign neoplasm of brain and other parts of central nervous system

192

1461

1.34

3.56

4.1

3.9

85.26

86.98

ng/l

0.10

170

1257

Rare circulating lymphoid malignancy

103

709

1.50

3.53

4.2

5.1

88.60

88.81

ng/l

0.01

631

Psoriatic arthropathies, ICD10

310

2506

1.26

3.53

3.7

4.0

81.85

88.13

ng/l

0.70

266

2195

Other salmonella infections

115

808

1.46

3.51

4.1

3.5

96.07

83.23

ng/l

0.41

710

Other and unspecified mononeuropathies of upper limb

611

1.53

3.50

3.7

4.2

81.61

86.90

ng/l

0.26

540

LSIL lesion of the cervix uteri, vagina or vulva

369

3037

1.23

3.50

4.0

3.3

80.93

75.33

ng/l

0.55

337

2672

Presbyopia

180

1361

1.35

3.50

3.4

3.6

79.47

81.16

ng/l

0.11

154

1208

Acute lymphadenitis

164

1222

1.37

3.49

4.2

4.3

89.14

80.64

ng/l

0.43

144

1097

Personal history of allergy to drugs, medicaments and biological substances

203

1.96

3.48

3.1

3.0

84.38

65.10

ng/l

0.93

183

Benign neoplasm: Connective and other soft tissue of head, face and neck

336

1.73

3.48

4.5

3.7

78.35

76.79

ng/l

0.08

302

Dislocation, sprain and strain of joints and ligaments of knee

1840

15672

1.10

3.47

3.5

4.0

80.82

88.38

ng/l

3.21

1631

13780

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

540

1.57

3.47

3.6

3.8

89.14

96.09

ng/l

0.38

458

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

214

1661

1.31

3.46

3.6

3.7

85.57

91.38

ng/l

0.50

188

1397

Other secondary gonarthrosis

169

1270

1.36

3.46

4.1

4.0

82.42

93.98

ng/l

1.30

148

1099

Focal brain injury

165

1231

1.36

3.46

4.7

4.0

113.81

98.15

ng/l

0.75

140

1065

Nosocomial condition (hospital)

115

2.34

3.46

2.9

3.4

76.72

82.20

ng/l

0.19

100

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

154

2.09

3.45

2.6

3.2

70.03

63.76

ng/l

0.22

144

Lung cancer and mesothelioma

574

4203

1.18

3.44

2.9

3.5

83.72

92.31

ng/l

1.71

493

3525

Disorders of optic nerve, not elsewhere classified

487

1.60

3.44

6.6

3.6

130.91

85.17

ng/l

1.50

427

Gluteal tendinitis

112

787

1.46

3.43

3.3

3.5

79.19

81.56

ng/l

0.12

681

Paranoid personality disorder

337

1.72

3.43

3.4

3.7

81.91

78.75

ng/l

0.12

306

Polycythaemia vera

117

831

1.45

3.42

3.5

3.6

89.75

93.03

ng/l

0.16

100

711

Pleural plaque

300

2428

1.26

3.41

3.8

4.0

97.78

106.18

ng/l

0.80

245

2079

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

832

4375

1.15

3.41

4.2

4.9

106.89

109.34

ng/l

0.25

716

3795

Pedal cyclist injured in transport accident

632

5463

1.17

3.41

3.8

4.1

86.05

89.16

ng/l

0.35

555

4771

Diabetes mellitus in pregnancy

745

4206

1.16

3.39

4.3

3.4

81.77

72.69

ng/l

1.86

677

3834

Bitten or struck by other mammals

291

2346

1.26

3.38

4.7

3.9

94.92

80.50

ng/l

0.56

253

2070

Benign neoplasm: Long bones of lower limb

632

1.51

3.38

3.4

4.1

70.45

81.68

ng/l

0.69

572

Other benign neoplasms of uterus

216

1690

1.31

3.37

2.8

3.0

84.45

86.62

ng/l

0.13

158

1363

Inflammatory disorders of breast

170

1281

1.35

3.37

3.6

3.1

77.52

73.43

ng/l

0.37

152

1125

Benign neoplasm: Skin of lower limb, including hip

651

1.51

3.36

5.1

3.6

111.89

80.71

ng/l

1.97

577

Inguinal hernia, bilateral

294

2377

1.25

3.35

5.0

4.6

92.65

105.07

ng/l

1.46

266

2075

Abnormal spermatozoa

207

2651

0.77

3.35

3.6

4.9

119.65

111.58

ng/l

0.30

138

2324

Obstructed labour due to malposition and malpresentation of fetus

408

4591

0.83

3.33

2.9

3.6

69.20

76.36

ng/l

1.35

373

4144

Other disorders of Eustachian tube

652

1.50

3.33

3.9

3.5

73.07

80.75

ng/l

0.71

584

Disorders of globe

571

1.54

3.32

6.6

3.4

117.65

85.94

ng/l

1.97

497

Endometriosis ASRM stages 1,2

514

4385

1.18

3.31

3.3

70.79

76.48

ng/l

1.53

451

3818

Benign neoplasm: Pharynx, unspecified

158

2.09

3.30

4.4

3.1

81.97

73.17

ng/l

0.36

138

Problems related to social environment

562

1.53

3.30

3.5

76.93

80.18

ng/l

0.14

494

Vertigo of central origin

366

1.69

3.30

3.0

3.7

68.75

86.86

ng/l

1.19

319

Helminthiases

381

1.66

3.28

5.4

3.9

98.09

75.90

ng/l

0.89

346

Diseases of appendix

2483

21054

1.08

3.27

4.1

4.0

90.40

90.52

ng/l

0.02

2209

18390

Fistulae involving female genital tract

375

1.67

3.24

4.4

3.1

80.11

72.60

ng/l

0.25

328

Sequelae of other and unspecified infectious and parasitic diseases

146

1083

1.37

3.23

4.8

4.0

110.18

82.56

ng/l

1.23

119

974

Pedal cyclist injured in other and unspecified transport accidents

315

2577

1.24

3.23

4.1

4.2

84.51

88.23

ng/l

0.28

266

2259

Dementia in Alzheimer disease

449

4526

0.84

3.22

2.6

3.5

88.54

102.81

ng/l

2.37

286

3729

Lesion of plantar nerve

213

1671

1.30

3.22

2.6

3.4

77.56

86.26

ng/l

1.00

188

1409

Malignant neoplasm of bone and articular cartilage of limbs

2.59

3.22

3.8

4.1

87.75

76.72

ng/l

0.19

Acute otitis externa, noninfective

360

1.68

3.22

5.1

3.5

131.39

74.88

ng/l

1.46

327

Benign neoplasm: Other/unspecified site

345

1.69

3.20

3.1

3.5

91.06

82.34

ng/l

0.25

313

Deep bite

309

2205

1.24

3.20

6.8

4.6

71.17

73.78

ng/l

0.33

274

2003

Scar conditions and fibrosis of skin

121

874

1.42

3.19

4.7

3.7

85.94

80.53

ng/l

0.25

111

774

Lupus erythematosus

595

1.51

3.15

4.9

3.3

86.26

78.53

ng/l

0.43

514

Alzheimer’s disease, wide definition, excluding more controls

511

2965

1.18

3.14

2.8

3.5

86.95

95.75

ng/l

1.41

405

2452

Crushed, pushed or stepped on by crowd or human stampede

175

1338

1.33

3.14

4.0

4.9

80.00

78.94

ng/l

0.06

156

1215

Other injuries of spine and trunk, level unspecified

161

2.03

3.13

4.2

3.9

116.99

82.88

ng/l

0.67

147

Behavioural disorders

322

1.69

3.13

4.5

5.7

103.73

71.45

ng/l

0.88

307

Neuroendocrine tumor and carcinoma of lung

169

2.02

3.12

2.2

3.6

100.16

75.96

ng/l

1.40

151

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

378

1.64

3.11

3.0

4.0

68.44

100.44

ng/l

2.27

322

Brain meningioma, excluding all cancers (controls excluding all cancers)

173

1328

1.33

3.11

3.6

3.4

93.22

86.92

ng/l

0.43

144

1125

Burn and corrosion of trunk

595

1.50

3.11

3.0

4.5

74.90

82.75

ng/l

0.44

535

Appendicitis, broad definition

2451

20890

1.08

3.10

4.1

4.0

90.67

90.44

ng/l

0.03

2181

18262

Fourth [trochlear] nerve palsy

499

1.56

3.10

4.1

3.8

87.78

84.98

ng/l

0.09

445

Benign neoplasm: Skin of upper limb, including shoulder

435

1.60

3.09

5.1

3.7

150.72

86.17

ng/l

1.50

389

Other conditions related to polyarteritis nodosa

3.15

3.07

3.5

2.9

72.92

66.38

ng/l

0.12

Dislocation, sprain and strain of joints and ligaments of thorax

646

1.48

3.06

4.6

4.1

86.02

86.69

ng/l

0.03

585

Autism

324

1.67

3.05

3.4

5.8

54.00

69.50

ng/l

1.99

306

Other contact dermatitis

237

1893

1.27

3.05

4.2

3.5

92.64

85.83

ng/l

0.43

204

1642

Benign mammary dysplasia

528

4556

1.17

3.05

3.2

3.1

74.28

81.76

ng/l

2.19

452

3791

Other psoriatic arthropathies

298

2442

1.24

3.04

3.7

3.9

82.17

88.09

ng/l

0.61

255

2142

Toxic effect of other and unspecified substances

205

1.87

3.04

1.6

3.9

85.70

73.40

ng/l

0.24

190

Impacted maxillary molar

103

727

1.44

3.04

7.2

4.3

89.77

69.23

ng/l

1.38

657

Burn and corrosion of ankle and foot

250

1.79

3.04

6.3

4.2

86.55

80.79

ng/l

0.19

225

Other intracranial haemorrhages

100

707

1.45

3.03

3.5

3.9

109.44

99.78

ng/l

0.46

610

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

255

2059

1.26

3.02

4.0

3.8

92.10

86.58

ng/l

0.30

216

1770

Abscess of tendon sheath

115

2.22

3.02

6.3

2.9

150.74

75.14

ng/l

1.69

104

Other maltreatment syndromes

524

1.52

3.02

3.4

4.4

75.05

84.06

ng/l

0.45

479

Scabies

110

789

1.42

3.01

4.3

4.4

92.81

80.63

ng/l

0.58

101

714

Open wound of shoulder and upper arm

334

1.67

3.01

4.1

4.4

106.28

85.41

ng/l

0.59

297

Acute nasopharyngitis (common cold)

288

2336

1.24

3.01

5.7

4.7

108.20

93.16

ng/l

1.34

259

2103

Inguinal of femoral hernia, unilateral

642

1.48

3.01

4.0

3.7

101.09

89.28

ng/l

0.40

567

Femoral hernia, unilateral

642

1.48

3.01

4.0

3.7

101.09

89.28

ng/l

0.40

567

Inguinal hernia, unilateral

642

1.48

3.01

4.0

3.7

101.09

89.28

ng/l

0.40

567

Other and unspecified injuries of shoulder and upper arm

616

1.48

3.00

4.3

4.1

78.45

86.94

ng/l

0.45

540

Benign neoplasm: Pancreas

652

1.48

3.00

5.9

3.8

83.92

92.16

ng/l

0.44

565

Peptic ulcer

207

1.88

3.00

4.8

3.7

82.93

83.30

ng/l

0.01

177

Benign neoplasm of middle ear and respiratory system

235

1883

1.27

2.97

4.0

3.9

94.63

93.73

ng/l

0.05

209

1645

Primary angle-closure glaucoma

158

1207

1.34

2.97

4.7

3.6

96.23

97.18

ng/l

0.05

127

1004

Other and unspecified injuries of forearm

136

2.09

2.97

3.9

4.0

75.42

76.10

ng/l

0.01

125

Impacted teeth

363

2819

1.21

2.97

6.8

4.3

92.43

76.19

ng/l

1.88

326

2573

Intentional self-harm by sharp object

358

1.63

2.96

3.5

4.3

86.47

74.21

ng/l

0.19

330

Erythema nodosum

101

720

1.44

2.94

4.5

3.4

83.66

80.45

ng/l

0.15

623

Contact with heat and hot substances

144

1085

1.35

2.92

4.9

4.7

98.21

82.75

ng/l

0.98

125

975

Hereditary corneal dystrophies

112

816

1.41

2.90

3.6

3.4

91.06

84.78

ng/l

0.28

702

Other specified/unspecified deforming dorsopathies

370

1.62

2.88

3.0

3.3

76.92

76.06

ng/l

0.04

322

Diffuse brain injury

603

1.47

2.88

2.5

3.9

71.44

90.02

ng/l

1.60

537

Cytomegaloviral hepatitis

2.78

2.87

13.6

2.8

107.27

66.45

ng/l

0.82

Residual foreign body in soft tissue

128

950

1.37

2.87

4.1

4.5

98.70

88.52

ng/l

0.49

110

845

Open wound of hip and thigh

580

1.48

2.86

5.0

4.5

168.79

84.53

ng/l

1.08

527

Other and unspecified erythematous conditions

105

758

1.42

2.86

3.8

83.53

81.42

ng/l

0.09

667

Erectile dysfunction

224

1795

1.27

2.85

5.2

4.8

121.72

110.98

ng/l

0.64

189

1566

Benign neoplasm: Skin of upper limb, including shoulder

444

1.56

2.85

5.1

3.5

150.72

80.76

ng/l

1.70

399

Toxic effect of carbon monoxide

348

1.64

2.85

3.2

3.5

73.93

83.34

ng/l

0.57

311

Benign neoplasm of bone and articular cartilage

230

1848

1.26

2.84

3.2

3.9

72.67

82.88

ng/l

1.42

206

1632

Assault by unspecified means

308

1.67

2.84

3.9

4.5

111.16

80.35

ng/l

0.99

290

Lichen planus

426

3637

1.19

2.83

3.5

3.6

91.31

90.32

ng/l

0.07

362

3083

Poisoning by narcotics and psychodysleptics [hallucinogens]

232

1.77

2.83

2.6

3.8

59.28

79.83

ng/l

1.90

213

Respiratory distress of newborn

406

1.58

2.82

10.0

9.2

44.89

48.75

ng/l

0.64

401

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

1332

0.71

2.82

3.0

3.4

77.62

78.86

ng/l

0.06

1155

Non-Hodgkin lymphoma, all

121

895

1.38

2.82

3.1

3.9

81.39

100.83

ng/l

0.95

101

764

Benign neoplasm: Skin of lip

295

1.70

2.81

3.7

3.5

96.68

81.87

ng/l

0.33

260

Other, unspecified and serous retinal detachments

684

1.44

2.81

6.4

3.7

109.05

87.86

ng/l

1.12

588

Viral conjunctivitis

396

1.59

2.81

5.9

3.7

101.47

76.30

ng/l

1.20

360

Unspecified parasitic disease

168

1.94

2.80

6.4

4.1

134.65

82.11

ng/l

1.25

151

Abnormal findings on diagnostic imaging of central nervous system

127

947

1.37

2.79

3.7

3.9

78.03

81.95

ng/l

0.16

113

836

Atrial septal defect

124

916

1.38

2.79

5.5

5.4

77.83

68.00

ng/l

1.30

109

846

Granuloma annulare

311

1.67

2.79

3.9

3.8

84.76

76.73

ng/l

0.29

276

Chronic suppurative otitis media, including avohilmo

241

1953

1.25

2.78

4.3

4.4

103.36

86.32

ng/l

0.84

213

1706

Contusion of toe(s) without damage to nail

429

1.55

2.78

5.6

4.3

109.63

73.93

ng/l

1.04

398

Asthma mixed form (mode)

147

1119

1.33

2.78

3.8

3.3

92.45

83.00

ng/l

0.53

123

966

Benign neoplasm: Skin of scalp and neck

561

1.49

2.77

4.8

4.0

92.67

81.87

ng/l

0.45

499

Vascular dementia (undefined)

115

837

1.39

2.77

3.1

3.4

115.92

104.98

ng/l

0.49

693

Burns classified according to extent of body surface involved

183

1.89

2.76

6.2

4.5

115.29

78.42

ng/l

0.76

165

Primary open-angle glaucoma

1158

10272

1.11

2.76

3.5

3.6

97.80

95.34

ng/l

0.32

928

8558

Other acute skin changes due to ultraviolet radiation

110

805

1.40

2.75

3.6

3.5

94.92

86.48

ng/l

0.42

699

Pneumothorax

196

1553

1.28

2.75

4.6

4.0

93.88

96.71

ng/l

0.16

172

1356

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

127

951

1.37

2.74

3.5

4.0

95.92

91.07

ng/l

0.29

107

822

Chronic Coagulation defects

529

1.50

2.74

4.0

89.40

74.66

ng/l

0.54

479

Acute appendicitis, no complications

1702

15702

1.09

2.74

4.0

4.1

87.85

90.24

ng/l

0.34

1520

13823

Vitamin A deficiency

2.31

2.74

1.9

3.1

60.75

76.83

ng/l

0.75

Primary open-angle glaucoma, strict

941

8467

1.12

2.74

3.5

97.32

94.75

ng/l

0.31

748

7057

Tonsillectomy and adenotomy

1582

10143

1.09

2.74

4.0

4.4

73.18

84.99

ng/l

5.94

1452

9112

Palindromic rheumatism

206

1.82

2.73

2.4

4.0

79.15

85.37

ng/l

0.18

181

Uterine polyps

308

2565

1.22

2.72

3.5

3.3

83.76

82.70

ng/l

0.07

267

2224

Haemangioma and lymphangioma, any site

273

2248

1.23

2.72

3.9

4.1

86.12

84.76

ng/l

0.09

239

1953

Separation of retinal layers (serosa)

113

832

1.39

2.71

7.0

4.0

136.93

86.00

ng/l

2.41

104

743

Tuberculosis of other organs

532

1.50

2.70

4.9

3.4

108.15

87.80

ng/l

0.89

453

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

175

1372

1.30

2.69

3.8

3.6

92.52

97.75

ng/l

0.35

157

1150

Benign neoplasm of other and unspecified sites

106

775

1.40

2.69

2.7

3.6

84.63

84.79

ng/l

0.01

679

Enteropathogenic Escherichia coli infection

2.66

2.68

7.6

5.5

122.43

80.71

ng/l

0.45

Other and unspecified parapsoriasis

2.29

2.68

4.0

4.2

90.82

88.13

ng/l

0.06

Dislocation, sprain and strain of joints and ligaments of head

108

790

1.39

2.68

4.3

4.5

77.29

78.11

ng/l

0.03

718

Benign neoplasm: Skin of ear and external auricular canal

126

948

1.36

2.66

4.7

3.8

111.92

94.67

ng/l

0.75

108

825

Malignant neoplasm of peripheral nerves and autonomic nervous system, excluding all cancers (controls excluding all cancers)

2.47

2.65

5.6

4.9

63.36

90.77

ng/l

1.41

Hypothermia

371

1.59

2.64

4.3

3.8

108.34

84.16

ng/l

0.87

328

Essential (haemorrhagic) thrombocythaemia

119

889

1.37

2.64

3.2

3.5

92.77

87.42

ng/l

0.26

104

764

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

403

1.56

2.64

3.9

4.0

107.96

93.64

ng/l

0.37

358

Pedestrian injured in collision with pedal cycle

692

1.42

2.64

2.6

4.0

71.12

84.96

ng/l

1.89

615

Monoplegia

324

1.63

2.63

3.7

3.3

81.50

74.98

ng/l

0.21

289

Other and unspecified injuries of thorax

339

1.61

2.63

3.8

4.0

96.60

83.79

ng/l

0.53

305

Dislocation of lens

332

1.63

2.63

5.4

3.5

148.37

88.57

ng/l

1.96

284

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

535

1.48

2.62

3.6

3.7

108.00

85.32

ng/l

0.47

472

Pseudomembranous colitis

172

1.89

2.61

6.5

3.5

108.88

79.04

ng/l

0.87

151

Other disorders affecting eyelid function

180

1.87

2.60

3.9

3.6

81.41

78.74

ng/l

0.05

156

Other and unspecified trigeminal disorders

334

1.61

2.57

3.3

3.1

71.90

74.15

ng/l

0.10

298

Acute epiglottitis

255

1.70

2.57

3.7

4.3

95.03

81.92

ng/l

0.35

235

Peritonsillar abscess

528

4611

1.15

2.56

4.0

4.3

85.55

94.02

ng/l

1.09

455

4100

Melanoma in situ of other and unspecified parts of face

281

1.69

2.55

4.9

3.6

98.10

86.06

ng/l

0.46

243

Maltreatment syndromes

115

856

1.36

2.55

2.9

4.3

89.52

78.96

ng/l

0.41

777

Psoriasis (vulgaris), strict definition

604

1.44

2.54

3.6

4.0

77.52

84.49

ng/l

0.29

544

Propionic acid derivatives

1103

5031

1.11

2.53

3.4

5.9

84.57

110.94

ng/l

12.64

969

4429

Malignant neoplasm of pancreas

120

1580

0.75

2.53

4.0

3.7

83.13

95.55

ng/l

0.86

1327

Other articular cartilage disorders

505

1.48

2.53

3.7

3.8

115.40

91.98

ng/l

0.43

436

Benign leiomyoma with endometriosis

581

5125

1.15

2.52

3.2

3.1

81.86

81.65

ng/l

0.02

480

4308

Carcinoma in situ of colon

297

1.65

2.52

4.0

3.8

105.44

83.10

ng/l

0.74

259

Other and unspecified acute skin changes due to ultraviolet radiation

598

1.44

2.51

4.0

3.5

103.12

89.69

ng/l

0.57

512

Dermatographic urticaria

182

1447

1.28

2.51

3.6

84.14

78.49

ng/l

0.24

163

1272

Rheumatic valve diseases

531

1.47

2.51

5.6

3.6

142.04

92.80

ng/l

1.37

454

Lichen ruber planus, wide definition including periferal and oral lichen planus

684

6092

1.13

2.51

3.1

3.6

85.64

89.36

ng/l

0.51

576

5189

Meningitis

143

1104

1.32

2.50

4.1

3.9

78.90

83.45

ng/l

0.35

125

975

Wide developmental disorders

538

1.46

2.50

4.4

7.0

50.66

62.32

ng/l

2.07

516

Precocious puberty

2.29

2.50

10.9

6.8

62.83

48.83

ng/l

0.77

Other and unspecified papulosquamous disorders

132

2.01

2.48

2.3

3.3

106.60

70.45

ng/l

1.01

122

Malignant neoplasm of renal pelvis

118

2.08

2.48

4.7

3.9

90.76

96.71

ng/l

0.14

103

Persistent delusional disorders

230

1881

1.24

2.48

3.9

3.7

94.31

88.27

ng/l

0.41

195

1619

Moderate mental retardation

132

2.00

2.47

6.2

5.5

64.44

65.84

ng/l

0.04

125

Lichen planus, including avohilmo

592

5236

1.14

2.45

3.2

3.6

86.74

89.47

ng/l

0.32

501

4447

Burns and corrosions confined to eye and internal organs

483

1.48

2.45

3.1

4.2

78.13

85.48

ng/l

0.29

432

Female infertility, associated with anovulation

140

1078

1.31

2.44

2.6

3.6

87.35

72.82

ng/l

0.25

122

999

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

397

3415

1.18

2.44

3.5

3.8

81.96

90.41

ng/l

1.40

338

2961

Benign neoplasm: other/unspecified salivary gland

627

1.42

2.44

4.7

3.5

98.49

89.69

ng/l

0.38

539

Foreign body in respiratory tract

150

1171

1.30

2.43

3.7

4.4

74.66

83.11

ng/l

0.60

127

1039

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

115

866

1.36

2.43

4.4

3.8

93.27

91.26

ng/l

0.08

102

757

Carcinoma in situ of colon

300

1.63

2.43

4.0

3.8

105.45

87.07

ng/l

0.57

260

Non-small cell lung cancer, squamous, helper endpoint

1101

0.71

2.42

2.8

4.0

68.62

103.50

ng/l

4.24

927

Non-small cell lung cancer, squamous

1101

0.71

2.42

2.8

4.0

68.62

103.50

ng/l

4.24

927

Acute appendicitis, with complications

588

5199

1.14

2.42

4.4

4.0

96.75

92.92

ng/l

0.36

515

4522

Nasal polyp

552

4862

1.14

2.41

3.6

4.3

89.72

97.58

ng/l

1.33

481

4233

Postpartum hemorraghe, all women as controls

444

5089

0.86

2.41

2.9

3.5

63.72

75.10

ng/l

4.30

396

4597

Melanoma in situ of other and unspecified parts of face

286

1.66

2.40

4.9

3.4

98.10

84.46

ng/l

0.53

248

Ulcerative rectosigmoiditis

212

1725

1.24

2.39

3.9

4.1

92.04

88.57

ng/l

0.16

189

1538

HSIL lesion of the vagina

317

1.61

2.39

4.7

2.9

124.70

75.39

ng/l

1.82

284

Family history of certain disabilities and chronic diseases leading to disablement

729

1.38

2.38

4.4

2.7

86.74

64.90

ng/l

1.85

654

Hordeolum and other deep inflammation of eyelid

151

1183

1.30

2.38

4.3

4.1

94.60

84.00

ng/l

0.58

131

1044

Viral agents as the cause of diseases classified to other chapters

446

1.50

2.38

7.4

4.5

95.41

76.81

ng/l

0.98

407

Ankylosing hyperostosis [Forestier]

262

1.66

2.36

4.3

4.0

108.24

87.39

ng/l

0.73

224

Ill-defined and unknown causes of mortality

131

1687

0.76

2.36

4.7

3.8

139.91

100.15

ng/l

2.12

100

1419

Benign neoplasm: Skin of lip

310

1.61

2.35

3.7

3.4

96.68

83.09

ng/l

0.30

277

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

326

1.58

2.33

3.1

4.2

103.64

92.77

ng/l

0.24

285

Haemorrhagic disorder due to circulating anticoagulants

256

1.67

2.32

3.6

3.7

126.03

89.89

ng/l

1.41

225

Unspecified abortion

143

1117

1.30

2.32

3.7

3.4

81.50

75.28

ng/l

0.49

121

993

Classical phenylketonuria

5.32

2.31

4.7

3.6

69.92

58.19

ng/l

—

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

352

1.56

2.30

5.2

3.7

94.33

83.33

ng/l

0.39

309

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

386

1.54

2.30

3.2

2.9

96.77

79.97

ng/l

0.64

331

Benign neoplasm: Vulva

551

1.44

2.29

3.1

3.2

109.07

79.59

ng/l

1.25

477

Other benign neoplasms of uterus

216

1778

1.24

2.29

2.8

3.0

84.45

84.30

ng/l

0.01

158

1451

Other hyperalimentation

2.43

2.29

3.9

3.7

65.60

78.89

ng/l

—

Use of cabergoline

225

1.70

2.29

7.1

3.9

102.98

81.18

ng/l

0.34

205

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

178

1431

1.26

2.28

4.4

3.9

86.51

91.53

ng/l

0.38

150

1238

Left ventricular outflow tract obstruction, narrow definition

133

1032

1.31

2.28

6.0

5.5

85.01

79.14

ng/l

0.37

125

953

Pedal cyclist injured in noncollision transport accidents

297

2510

1.20

2.28

3.9

4.2

84.84

87.51

ng/l

0.20

275

2224

Endovascular or surgical operations to intracerebral aneurysms

193

1567

1.25

2.27

5.5

3.6

94.98

88.84

ng/l

0.37

180

1364

Other benign neoplasm of uterus: Other parts/unspecified

171

1375

1.28

2.27

2.3

2.9

81.45

87.38

ng/l

0.48

120

1096

218

1.71

2.27

4.3

4.2

128.58

87.16

ng/l

0.46

198

Myeloid leukaemia

551

1.43

2.27

4.1

4.0

83.74

90.76

ng/l

0.40

483

Nonpyogenic thrombosis of intracranial venous system

173

1.81

2.26

5.0

4.6

68.38

71.49

ng/l

0.10

157

Injury of nerves at wrist and hand level

712

1.37

2.25

3.9

4.0

103.13

88.07

ng/l

0.53

637

Contact with other hot metals

289

1.61

2.25

3.4

4.7

75.58

77.85

ng/l

0.06

262

Contracture of joint

242

1.67

2.24

4.8

3.5

114.83

82.41

ng/l

0.55

215

Foreign body in alimentary tract

152

1203

1.28

2.24

3.0

4.3

77.94

89.54

ng/l

1.08

132

1062

Other diseases of gallbladder

144

1134

1.29

2.23

3.8

3.6

95.49

90.39

ng/l

0.25

128

968

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

152

1.87

2.22

3.3

3.6

81.27

80.32

ng/l

0.02

137

Aortic arch syndrome [Takayasu]

2.85

2.22

4.5

4.1

80.27

69.66

ng/l

0.16

All dysplastic lesions of the vagina

596

1.41

2.22

4.9

3.2

117.81

75.44

ng/l

2.06

529

FESS (DNB20)

338

2895

1.18

2.22

2.8

4.0

68.28

89.66

ng/l

8.32

289

2545

Ankylosis of teeth

4.69

2.22

16.2

6.9

194.33

86.36

ng/l

—

Ethmoidectomy

352

3025

1.17

2.21

2.9

4.0

71.91

90.00

ng/l

3.64

303

2661

Von Willebrand disease

267

1.63

2.20

3.3

3.5

80.70

69.82

ng/l

0.37

241

Nontraumatic intracranial haemmorrhage

640

5726

1.13

2.20

4.7

3.6

109.08

93.63

ng/l

2.98

541

4804

Abscess of external ear

251

1.64

2.20

6.3

3.9

116.67

79.95

ng/l

1.24

228

Erythema multiforme

504

1.45

2.20

4.7

4.0

88.69

81.82

ng/l

0.34

455

Disorders of brain, other and unspecified

190

1.75

2.19

8.6

3.8

101.27

84.48

ng/l

0.40

165

Tuberculosis of other organs, strict

615

1.40

2.19

5.3

3.5

110.41

91.06

ng/l

0.86

521

Laparoscopic right hemicolectomy

182

1479

1.26

2.18

3.4

3.7

104.23

94.37

ng/l

0.70

161

1256

Malignant neoplasm of head and neck

237

1974

1.22

2.17

3.0

4.0

76.49

100.46

ng/l

5.24

200

1709

Ulcer of vagina/vulva

548

1.42

2.16

2.5

3.4

81.96

77.37

ng/l

0.18

474

Postpartum hemorraghe, parous women as controls

444

4438

0.87

2.16

2.9

3.2

63.72

73.37

ng/l

3.18

396

4003

Cluster headache, strict, including avohilmo

118

908

1.32

2.16

3.3

3.8

69.66

79.27

ng/l

0.91

106

821

Burn and corrosion confined to eye and adnexa

397

1.49

2.15

3.4

4.3

76.38

85.38

ng/l

0.41

361

Dental pulpitis 3, only avohilmo

222

1334

1.22

2.15

3.9

5.7

75.82

60.13

ng/l

1.12

204

1242

Small cell lung cancer

508

0.60

2.15

3.3

3.9

115.48

99.81

ng/l

0.24

435

Small cell lung cancer, helper endpoint

508

0.60

2.15

3.3

3.9

115.48

99.81

ng/l

0.24

435

Other vitreous opacities

118

911

1.32

2.14

4.0

3.6

92.87

90.03

ng/l

0.11

786

Haemangioma, any site

249

2087

1.21

2.14

3.8

4.0

83.10

84.26

ng/l

0.08

217

1828

Other specified and unspecified disorders of lens

255

1.65

2.14

2.4

3.1

134.10

82.98

ng/l

0.66

216

Postpartum haemorrhage due to retained placenta

176

2169

0.81

2.14

2.3

3.1

57.76

73.34

ng/l

5.19

159

1974

Glaucoma secondary to drugs

2.50

2.14

3.4

4.2

72.31

75.23

ng/l

0.04

Injury of muscle and tendon at wrist and hand level

360

3109

1.17

2.13

4.3

93.00

94.85

ng/l

0.13

321

2750

Exposure to other and unspecified animate mechanical forces

549

1.41

2.12

4.8

4.6

95.19

76.36

ng/l

0.78

498

Exposure to smoke, fire and flames

457

1.45

2.11

2.6

4.2

80.85

87.95

ng/l

0.31

412

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

177

1437

1.25

2.11

3.4

3.7

83.46

97.36

ng/l

1.97

163

1200

Malignant neoplasm of thymus

2.40

2.11

6.4

4.5

74.00

84.36

ng/l

0.34

Mental and behavioural disorders associated with the puerperium

184

1.74

2.11

2.6

3.5

70.03

70.28

ng/l

0.01

168

Congenital malformations of ovaries, fallopian tubes and broad ligaments

140

1105

1.28

2.11

3.4

3.2

82.23

72.46

ng/l

0.45

128

985

Impaction of intestines

125

1.93

2.11

4.3

4.5

104.54

92.51

ng/l

0.22

109

Peroneal tendinitis

302

1.57

2.10

4.9

3.5

90.85

76.65

ng/l

0.40

275

All dysplastic lesions of the cervix uteri, vagina or vulva

735

6598

1.11

2.10

3.9

3.3

84.24

75.72

ng/l

1.49

664

5831

Varus deformity, not elsewhere classified

255

1.63

2.10

3.6

4.2

61.99

81.56

ng/l

1.13

223

Tuberculosis, IBD comorbidity

231

1927

1.21

2.10

4.1

3.5

95.58

95.22

ng/l

0.02

200

1619

Respiratory conditions due to other external agents

476

1.45

2.10

4.0

3.4

89.59

83.82

ng/l

0.25

409

Dysplasia of cervi uteri

643

4454

1.12

2.10

3.8

3.3

80.51

78.67

ng/l

0.19

584

3913

Drug-induced neutropenia

216

1792

1.22

2.10

4.0

3.8

97.09

85.97

ng/l

0.74

193

1541

Assault by other specified means

132

1.88

2.09

5.2

4.2

93.67

78.33

ng/l

0.29

122

Polycystic ovarian syndrome, broad definition

206

1696

1.22

2.09

2.9

3.2

85.01

72.01

ng/l

0.34

180

1542

Autism spe

334

1.52

2.08

3.4

6.0

53.32

68.93

ng/l

2.03

315

Benign neoplasm of male genital organs

343

1.52

2.08

4.9

4.6

109.88

110.17

ng/l

0.01

303

Alzheimer’s disease, wide definition

681

6313

0.90

2.08

2.8

3.4

87.91

100.69

ng/l

3.27

529

5146

Dislocation, sprain and strain of joints and ligaments of elbow

162

1305

1.26

2.06

4.1

4.2

79.89

77.14

ng/l

0.20

142

1174

Other and unspecified intracranial injuries

612

1.38

2.06

3.0

4.2

78.57

91.20

ng/l

0.88

541

Congenital malformations of spine and bony thorax

119

1.94

2.06

7.3

5.6

47.91

61.17

ng/l

0.88

111

Carcinoma in situ of breast, intraductal

274

2328

1.19

2.06

2.9

3.2

77.39

81.11

ng/l

0.40

230

1962

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

313

1.56

2.06

5.6

3.4

115.08

87.64

ng/l

1.22

270

Other operation for atrial fibrillation

105

2.02

2.05

4.1

4.7

191.43

95.65

ng/l

1.20

Phlebitis and thrombophlebitis of femoral vein, drug-induced

5.47

2.05

1.6

5.4

174.20

96.27

ng/l

—

Stenosis and insufficiency of lacrimal passages

299

2558

1.18

2.05

3.8

3.7

91.39

88.57

ng/l

0.19

258

2152

Otitis media in diseases classified elsewhere

4.41

2.05

6.2

4.3

101.17

91.00

ng/l

—

Localized skin eruption due to drugs and medicaments

233

1.65

2.05

3.1

3.6

72.03

71.42

ng/l

0.02

209

Conductive hearing loss, unspecified

241

2024

1.21

2.04

4.2

4.1

83.15

87.94

ng/l

0.34

213

1767

Benign neoplasm of brain and other parts of central nervous system

192

1579

1.23

2.04

4.1

3.9

85.26

87.92

ng/l

0.16

170

1371

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

623

1.38

2.03

3.0

3.6

79.00

93.80

ng/l

1.50

534

Chronic lymphocytic leukaemia, helper endpoint

623

1.38

2.03

3.0

3.6

79.00

93.80

ng/l

1.50

534

Bursitis of shoulder

546

1.41

2.03

2.8

3.6

75.90

84.45

ng/l

0.50

483

Malignant neoplasm of larynx

305

1.55

2.03

3.1

4.4

70.33

99.94

ng/l

1.41

265

Autonomic disorders

479

1.44

2.02

4.5

3.6

74.24

81.51

ng/l

0.29

419

Sixth [abducent] nerve palsy

101

771

1.34

2.02

4.0

3.8

101.52

89.75

ng/l

0.42

664

L01XX Other antineoplastic agents

177

1448

1.24

2.01

3.0

3.7

85.96

93.19

ng/l

0.65

158

1233

Neuroendocrine tumor and carcinoma of stomach

2.04

2.00

2.8

3.2

89.84

76.45

ng/l

0.48

Benign lipomatous neoplasm of other sites/unspecified

285

2435

1.19

2.00

3.6

3.7

87.95

92.08

ng/l

0.34

237

2063

Postinfectious hypothyroidism

106

1.98

1.99

8.7

3.0

149.71

78.28

ng/l

0.84

ILD medications: acetylcysteine

157

1.78

1.99

3.3

4.1

96.65

92.71

ng/l

0.06

136

Benign neoplasm: Vulva

567

1.40

1.98

3.1

3.2

109.07

78.87

ng/l

1.30

492

Benign neoplasm of ovary

616

5544

1.12

1.98

3.6

3.2

90.52

81.28

ng/l

0.74

525

4672

Colorectal cancer, excluding all cancers (controls excluding all cancers)

852

7528

1.10

1.98

3.5

3.8

98.26

96.59

ng/l

0.20

745

6284

Other and unspecified medical devices associated with adverse incidents

114

1.96

1.98

10.2

3.8

137.62

81.52

ng/l

1.04

101

HSIL lesion of the vulva

415

1.47

1.98

5.5

3.1

102.75

77.97

ng/l

1.20

368

Aphakia

282

1.56

1.97

6.9

3.8

128.50

86.07

ng/l

0.96

248

Intracerebral haemorrhage

383

3347

1.16

1.97

4.8

3.6

117.52

95.57

ng/l

3.00

313

2801

Anti-inflammatory and antirheumatic products, non-steroids

1089

5034

1.09

1.96

3.9

5.9

88.04

110.90

ng/l

8.92

955

4432

Other congenital malformations of circulatory system

550

1.40

1.96

3.0

4.0

80.08

82.30

ng/l

0.07

492

Tibial collateral bursitis [Pellegrini-Stieda]

228

1.64

1.95

3.1

3.0

97.25

75.74

ng/l

0.85

203

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

100

2.02

1.95

2.8

4.1

89.84

82.41

ng/l

0.23

Benign neoplasm: Brain, unspecified

114

1.93

1.95

3.7

3.4

79.00

74.91

ng/l

0.15

104

Malignant neoplasm of ovary

107

1370

0.77

1.94

2.4

3.2

72.30

82.06

ng/l

0.94

1144

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

159

1.78

1.94

3.3

3.6

81.27

79.98

ng/l

0.03

144

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

127

1004

1.29

1.94

2.8

3.7

69.31

93.65

ng/l

4.58

110

859

Embolic stroke

140

1120

1.27

1.92

4.6

3.6

118.37

97.81

ng/l

1.61

124

941

Superficial injury of ankle and foot, unspecified

2.08

1.92

2.3

3.9

86.29

71.89

ng/l

0.18

Injury of muscle and tendon at shoulder and upper arm level

1094

10121

1.09

1.92

3.7

4.2

87.86

97.05

ng/l

2.79

962

8759

Cutis laxa senilis

183

1.72

1.92

1.9

2.6

70.08

75.66

ng/l

0.24

158

Galactorrhea

182

1.70

1.92

2.7

3.7

60.32

77.56

ng/l

1.29

164

Normotensive glaucoma

290

2494

1.18

1.91

3.8

3.5

101.31

92.91

ng/l

0.60

239

2074

Other ill-defined and unspecified causes of mortality

115

1460

0.78

1.91

4.8

3.8

144.25

101.30

ng/l

2.13

1225

Other degenerative diseases of the basal ganglia

360

1.50

1.91

2.0

4.1

74.30

91.74

ng/l

0.80

313

Motor neuron disease

309

1.52

1.91

2.7

3.4

75.86

95.22

ng/l

0.91

273

Melanoma in situ of trunk

286

1.56

1.91

3.6

4.2

113.60

92.60

ng/l

0.60

251

Achalasia of cardia

384

1.47

1.90

3.0

3.7

76.01

89.53

ng/l

1.01

324

Benign neoplasm: Brain, unspecified

115

1.91

1.90

3.7

3.6

79.00

81.05

ng/l

0.07

100

Mental and behavioural disorders of puerperium, not classified elsewhere

190

1.68

1.90

2.6

3.4

70.03

74.69

ng/l

0.15

174

Drug-induced polyneuropathy

215

1.66

1.90

4.8

5.2

108.59

72.31

ng/l

0.74

190

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

3.13

1.90

10.3

1.6

114.65

67.28

ng/l

—

Apocrine sweat disorders, other sweat gland disorders

2.04

1.90

3.0

2.9

91.66

73.09

ng/l

0.34

Foreign body in ear

352

1.48

1.87

4.7

4.8

94.10

72.39

ng/l

0.87

324

Melanoma in situ of trunk

288

1.55

1.86

3.6

4.0

113.60

87.77

ng/l

0.79

254

Vascular dementia (other)

139

1.82

1.85

2.5

3.8

70.22

92.27

ng/l

1.01

125

Secondary uncertain malignant neoplasm

382

3356

1.15

1.85

3.3

3.8

83.73

94.92

ng/l

1.60

325

2832

Sequelae of poliomyelitis

177

1.71

1.85

4.2

3.2

119.06

81.22

ng/l

0.84

155

Cluster headache, wide,, including avohilmo

125

992

1.28

1.85

3.2

3.7

68.60

79.11

ng/l

1.11

112

892

Other congenital malformations of skin

113

887

1.30

1.84

3.6

4.4

80.15

75.68

ng/l

0.25

101

798

Histrionic personality disorder

117

1.90

1.84

1.9

3.2

56.06

70.61

ng/l

0.86

102

Hand

117

1.89

1.83

6.1

3.0

72.07

74.04

ng/l

0.04

107

CR(E)ST syndrome

380

1.47

1.83

4.0

3.0

79.06

73.90

ng/l

0.21

340

Blood alcohol or alcohol intoxication level

403

1.44

1.83

4.8

4.7

81.11

85.51

ng/l

0.15

362

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

548

1.38

1.82

5.4

3.3

93.88

74.65

ng/l

0.63

487

Other specified disorders of external ear

101

784

1.31

1.81

3.8

4.4

88.08

101.17

ng/l

0.92

698

L02BA Anti-estrogens

556

5005

1.12

1.81

2.6

3.2

77.91

81.60

ng/l

0.61

480

4236

Oral leukoplakia

423

1.44

1.80

4.1

3.5

74.19

81.22

ng/l

0.49

379

Foreign body entering into or through eye or natural orifice

203

1702

1.21

1.79

3.9

4.6

88.43

92.24

ng/l

0.23

180

1522

Dermatitis herpetiformis

407

1.44

1.77

3.8

3.9

121.37

84.08

ng/l

0.88

363

Benign neoplasm: other/unspecified salivary gland

665

1.34

1.77

4.7

3.7

98.49

87.94

ng/l

0.48

581

Dyshidrosis [pompholyx]

307

1.50

1.77

3.6

3.8

68.03

74.70

ng/l

0.26

271

Carcinoma in situ of skin, other sites/unspecified

284

1.54

1.76

7.5

3.5

160.74

87.55

ng/l

1.01

240

Allergic contact dermatitis due to drugs in contact with skin

527

1.38

1.76

4.1

3.5

131.74

77.76

ng/l

1.16

475

Status post-ami

158

1576

0.81

1.75

3.8

3.4

120.04

95.07

ng/l

2.87

137

1277

Sequelae of injuries of head

132

1063

1.26

1.74

3.8

4.3

90.76

92.29

ng/l

0.07

108

959

L02BX Other hormone antagonists and related agents

140

1137

1.25

1.74

2.3

4.7

119.52

111.65

ng/l

0.24

120

990

Benign neoplasm of other and unspecified female genital organs

142

1156

1.25

1.74

3.2

3.4

95.64

81.86

ng/l

0.78

118

981

Other and unspecified injuries of wrist and hand

753

1.31

1.73

4.6

4.3

97.23

79.69

ng/l

1.01

683

Alzheimer’s disease (Early onset), excluding more controls

819

0.73

1.73

3.1

3.4

86.32

97.66

ng/l

0.36

671

Glaucoma-related operations

188

1575

1.21

1.73

3.5

3.6

94.80

94.34

ng/l

0.02

162

1320

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

581

1.36

1.72

3.6

3.7

108.00

82.54

ng/l

0.54

515

Other bullous disorders

642

1.34

1.71

5.2

4.0

129.55

83.38

ng/l

1.51

568

Vitiligo

204

1.62

1.71

7.0

3.1

118.35

71.78

ng/l

1.39

184

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

651

1.33

1.71

3.0

3.5

89.37

92.36

ng/l

0.16

558

Maternal care for known or suspected abnormality of pelvic organs

498

3833

0.89

1.70

2.8

3.6

69.96

78.14

ng/l

1.20

443

3435

Exposure to excessive natural cold

173

1.67

1.69

5.3

4.0

106.91

84.82

ng/l

0.49

154

Carcinoma in situ of other and unspecified sites

713

1.31

1.69

4.7

3.9

107.49

98.34

ng/l

0.36

613

Herpesviral keratitis and keratoconjunctivitis

126

1017

1.26

1.66

4.6

3.7

100.31

88.59

ng/l

0.68

110

886

LSIL lesion of the cervix uteri

258

2222

1.17

1.66

3.5

3.2

72.37

73.43

ng/l

0.08

238

1974

Narcolepsy and cataplexy

113

1.83

1.65

4.5

3.4

83.14

71.17

ng/l

0.29

102

Myeloid leukaemia

585

1.35

1.65

4.1

83.74

90.21

ng/l

0.36

514

Brain meningioma

166

1382

1.22

1.65

3.3

3.4

85.99

85.07

ng/l

0.06

138

1175

Bacterial meningitis

760

1.30

1.64

3.7

3.9

76.57

84.93

ng/l

0.63

672

Benign neoplasm: Conjunctiva

708

1.31

1.63

4.0

3.7

84.44

86.84

ng/l

0.11

618

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

122

983

1.26

1.63

4.0

3.7

95.29

86.93

ng/l

0.42

109

862

Other benign neoplasm of uterus: Other parts/unspecified

171

1432

1.22

1.63

2.3

2.8

81.45

84.94

ng/l

0.25

120

1156

Use of levodopa decarboxylase inhibitor

418

3730

1.13

1.63

2.8

3.7

81.68

98.78

ng/l

3.59

336

3124

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

322

1.47

1.62

3.9

3.8

84.44

82.14

ng/l

0.07

293

Struck by thrown, projected or falling objec

112

894

1.27

1.62

3.8

4.7

71.54

85.60

ng/l

1.39

100

799

Nonspecific lymphadenitis

159

1318

1.22

1.62

3.7

3.6

83.52

80.10

ng/l

0.25

132

1163

Labyrinthitis

2.16

1.61

5.8

2.5

91.42

72.04

ng/l

0.36

Parapsoriasis

364

1.43

1.60

3.8

82.01

78.21

ng/l

0.14

331

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

249

1.54

1.60

4.4

4.0

99.59

89.67

ng/l

0.18

216

Spermatocele

176

1474

1.21

1.60

4.6

4.8

100.91

107.99

ng/l

0.47

157

1279

Serous carcinoma of ovary

1020

0.76

1.60

2.7

3.2

74.94

80.05

ng/l

0.34

862

Viral meningitis

701

1.30

1.59

2.9

3.8

70.07

80.56

ng/l

0.70

640

conjunctival degenerations and deposits

520

1.36

1.58

4.3

3.5

107.25

82.49

ng/l

0.53

459

Other abortion

169

1.65

1.58

2.9

3.5

75.05

70.64

ng/l

0.17

149

Personal history of certain other diseases

240

1.53

1.58

3.7

2.8

105.87

61.18

ng/l

2.31

218

Female infertility, tubal origin

119

960

1.25

1.57

3.4

74.14

76.47

ng/l

0.19

108

883

Normal-pressure hydrocephalus

110

1363

0.79

1.57

2.5

3.6

76.19

99.56

ng/l

3.11

1139

Malignant melanoma of skin

337

2977

1.14

1.56

4.4

3.8

107.63

95.58

ng/l

0.97

296

2526

Contraceptive management

1141

7489

1.07

1.55

4.0

4.1

78.47

87.63

ng/l

2.91

1028

6676

Tuberculosis, wide

236

2035

1.17

1.55

4.3

3.6

97.20

96.09

ng/l

0.06

205

1712

Injury of muscle and tendon at hip and thigh level

246

2127

1.17

1.54

4.4

4.1

90.23

91.03

ng/l

0.05

228

1881

Other bursal cyst

351

1.43

1.54

4.7

3.7

90.39

84.47

ng/l

0.21

318

Syndrome of inappropriate secretion of antidiuretic hormone

1.89

1.53

3.0

3.4

69.30

82.74

ng/l

—

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

219

1.56

1.53

1.8

3.9

50.82

85.03

ng/l

4.40

195

Benign neoplasm: Other and unspecified parts of mouth

760

1.29

1.52

4.3

3.7

99.04

85.75

ng/l

0.99

662

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

263

2289

1.16

1.52

5.6

3.0

102.58

74.49

ng/l

4.50

241

1959

Burn and corrosion of shoulder and upper limb, except wrist and hand

402

1.40

1.52

4.3

4.5

105.80

79.99

ng/l

0.75

360

Benign neoplasm: Nasopharynx

179

1.62

1.52

2.4

3.8

74.22

84.36

ng/l

0.46

158

Atypical virus infections of central nervous system

195

1.59

1.52

3.8

3.3

94.43

73.61

ng/l

0.47

172

Perioral dermatitis

428

1.38

1.51

5.3

3.5

87.05

73.90

ng/l

0.51

384

Eustachian salpingitis and obstruction

169

1418

1.20

1.51

5.0

4.2

106.22

83.79

ng/l

1.06

153

1294

Benign neoplasm: Larynx

610

1.32

1.51

2.9

3.8

82.38

92.03

ng/l

0.53

534

Other corneal oedema

188

1.61

1.51

3.2

3.7

112.09

82.32

ng/l

0.74

168

Malignant neoplasm of vulva

262

1.51

1.50

3.0

2.5

93.24

73.80

ng/l

0.87

222

Ankylosing spondylitis, strict definition

102

814

1.27

1.50

2.9

4.2

69.15

82.59

ng/l

0.92

732

Other papulosquamous disorders

228

1.54

1.50

3.0

3.4

142.19

74.08

ng/l

0.96

209

Other noninflammatory disorders of cervix uteri

160

1342

1.21

1.49

3.1

3.2

79.91

81.16

ng/l

0.07

130

1143

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

212

1.55

1.49

5.1

4.0

126.59

103.77

ng/l

0.56

183

Benign neoplasm: Brain, supratentorial

294

1.46

1.48

4.9

3.8

89.72

77.46

ng/l

0.32

263

Golimumab

603

1.31

1.48

2.5

3.8

70.70

77.89

ng/l

0.30

546

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

461

0.66

1.47

3.3

3.6

115.48

93.03

ng/l

0.38

385

False labour

600

4131

0.91

1.47

2.7

3.7

62.41

76.92

ng/l

9.19

540

3754

Carcinoma in situ of other and unspecified genital organs

423

1.38

1.47

4.1

3.1

92.46

78.07

ng/l

0.74

374

Other meningitis

312

1.44

1.45

5.5

3.6

87.33

75.22

ng/l

0.53

279

Benign neoplasm: Tongue

615

1.31

1.45

4.1

3.7

89.68

86.05

ng/l

0.07

542

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

115

936

1.25

1.45

4.4

3.8

93.27

89.90

ng/l

0.14

102

824

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

213

1.54

1.45

2.3

4.3

79.58

78.75

ng/l

0.02

194

Drug-induced myopathy

2.20

1.44

3.4

2.8

195.45

70.99

ng/l

1.04

Pregnancy, childbirth and the puerperium

1040

5827

0.93

1.44

2.9

3.3

80.44

84.66

ng/l

0.86

870

4846

Female infertility

826

4719

1.08

1.44

2.9

3.4

73.97

77.71

ng/l

0.36

735

4155

Adult-onset Still disease

2.03

1.43

2.9

3.5

62.66

74.23

ng/l

0.28

Mixed disorders of conduct and emotions

329

1.42

1.43

7.1

6.2

94.92

62.14

ng/l

0.82

305

Haemorrhage in early pregnancy

768

6932

1.09

1.43

3.1

3.3

75.04

76.45

ng/l

0.17

687

6074

Whooping cough

104

1.79

1.41

12.6

3.7

187.44

68.23

ng/l

1.26

Generalized epilepsy, mode (most common among epilepsy diagnosis)

643

1.29

1.41

3.5

4.6

96.07

77.32

ng/l

0.70

585

Occlusion and stenosis of arteries, not leading to stroke

289

1.45

1.41

4.8

3.8

121.11

96.74

ng/l

0.53

255

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

290

1.45

1.40

4.0

4.2

97.06

93.81

ng/l

0.06

255

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

368

1.40

1.39

7.5

9.9

52.51

48.08

ng/l

0.48

362

Benign neoplasm: Respiratory system, unspecified

2.29

1.39

4.8

4.1

113.00

74.92

ng/l

—

Frostbite

191

1.56

1.39

4.6

3.9

128.25

83.94

ng/l

1.12

176

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

470

1.34

1.38

2.8

4.1

99.41

95.24

ng/l

0.10

421

Burn and corrosion of wrist and hand

707

1.28

1.38

3.6

4.8

90.71

80.28

ng/l

0.52

644

Gastrointestinal stromal tumor and sarcoma

258

1.48

1.38

4.4

3.8

99.59

82.59

ng/l

0.34

224

Preterm labour and delivery

749

6935

1.09

1.38

3.6

3.5

83.01

79.29

ng/l

0.51

650

6065

Schizotypal disorder

409

1.37

1.38

2.7

4.0

71.97

80.17

ng/l

0.35

369

Foreign body or object entering through skin

150

1260

1.20

1.37

3.6

4.5

83.39

86.79

ng/l

0.18

129

1134

Carcinoma in situ of skin, other sites/unspecified

301

1.44

1.36

7.5

3.7

160.74

91.07

ng/l

0.94

258

Malignant neoplasm of other connective and soft tissue

534

1.32

1.35

3.6

3.5

95.03

84.95

ng/l

0.47

459

Vestibular neuronitis

254

2229

1.15

1.35

4.0

93.38

92.20

ng/l

0.07

208

1932

Chronic lymphocytic leukaemia

667

1.28

1.35

3.0

4.0

79.00

98.21

ng/l

1.87

579

Kaposi sarcoma, excluding all cancers (controls excluding all cancers)

2.66

1.34

3.2

5.8

71.50

99.21

ng/l

—

Benign neoplasm: Floor of mouth

2.03

1.32

4.0

4.7

128.33

87.99

ng/l

0.49

Female infertility, cervigal, vaginal, other or unspecified origin

743

4605

1.08

1.31

2.8

3.4

73.79

77.80

ng/l

0.35

664

4059

Degenerative myopia

146

1.64

1.31

4.7

3.5

80.00

81.61

ng/l

0.05

129

Other specific arthropathies, wide

448

1.34

1.31

2.4

3.8

81.11

86.67

ng/l

0.23

393

Early lumbar disc prolapse, operated

180

1541

1.17

1.31

4.0

4.5

84.93

89.03

ng/l

0.18

170

1430

Infections of genitourinary tract in pregnancy

253

2224

1.15

1.30

3.3

88.63

75.53

ng/l

1.27

217

1924

Procedures for purposes other than remedying health state

554

1.30

3.8

2.6

80.82

69.60

ng/l

0.59

496

Multiple gestation

151

1782

0.84

1.30

3.0

3.7

63.20

79.19

ng/l

3.32

140

1611

Circumscribed brain atrophy

476

1.33

1.30

3.1

3.9

77.63

90.32

ng/l

0.68

416

Dementia in other diseases classified elsewhere

129

1077

1.21

1.30

3.4

4.1

92.42

99.06

ng/l

0.22

937

Benign lipomatous neoplasm of of intra-abdominal organs

2.02

1.28

6.1

4.3

86.75

83.74

ng/l

0.05

Femoral hernia

134

1124

1.21

1.28

4.3

3.6

96.24

93.06

ng/l

0.12

111

961

Assault by blunt object

236

1.47

1.28

4.0

4.8

91.59

86.00

ng/l

0.13

219

Personality and behavioural disorders due to brain disease, damage and dysfunction

312

1.41

1.28

2.7

4.1

76.20

83.91

ng/l

0.56

286

Malignant neoplasm of breast, HER-negative

733

6807

1.08

1.28

3.0

3.2

82.91

83.87

ng/l

0.12

616

5695

Kaposi sarcoma

2.55

1.27

3.2

4.4

71.50

94.56

ng/l

—

malignant neoplasm of male genital organs

1164

6963

1.07

1.26

4.0

4.7

108.28

109.61

ng/l

0.14

976

6066

Benign neoplasm: Tonsil

246

1.46

1.26

2.9

3.2

75.30

75.56

ng/l

0.01

219

Bilateral sagittal split ramus osteotomy operation

595

0.73

1.25

2.2

3.8

72.58

78.07

ng/l

0.30

540

Injury of muscle and tendon at lower leg level

381

3441

1.11

1.25

4.6

4.3

98.63

97.23

ng/l

0.09

342

3027

Postpartum care and examination

234

1705

0.87

1.25

3.8

3.5

79.15

73.65

ng/l

0.28

206

1538

Carcinoma in situ, bladder

657

1.27

1.23

4.7

4.0

112.11

99.90

ng/l

0.46

565

Transitory endocrine and metabolic disorders specific to fetus and newborn

376

1.36

1.23

7.5

9.8

52.51

48.33

ng/l

0.44

370

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

981

0.79

1.22

2.7

3.2

74.94

83.27

ng/l

0.63

824

Other specified and unspecified disorders of eyelid

316

1.40

1.22

3.2

3.4

83.25

82.16

ng/l

0.02

281

Mandibular retrognathia AND surgery (BSSRO)

476

0.70

1.21

2.3

3.8

68.10

76.90

ng/l

0.50

436

Benign lipomatous neoplasm of intrathoracic organs

0.00

1.21

0.0

3.6

—

78.05

—

Demyelinating diseases of the central nervous system

205

1788

1.16

1.21

3.4

3.7

73.24

79.27

ng/l

0.51

177

1599

Disorders of optic chiasm

2.80

1.20

2.8

3.7

92.20

87.65

ng/l

—

Other sexually transmitted chlamydial diseases

105

865

1.22

1.19

4.4

4.1

71.39

74.56

ng/l

0.15

793

Fall on and from ladder

197

1718

1.16

1.18

3.9

4.4

90.62

100.78

ng/l

0.82

178

1524

Parkinson's disease, including avohilmo

485

4451

1.10

1.18

2.8

3.8

86.12

98.56

ng/l

1.33

391

3749

Loose body in joint

456

1.31

1.18

3.0

4.0

78.56

90.25

ng/l

0.93

398

Idiopathic pulmonary fibrosis

223

1963

1.15

1.18

3.8

3.7

92.04

99.15

ng/l

0.64

198

1652

Acute alcohol intoxication ICD-9

715

1.25

1.17

3.6

4.6

90.48

100.96

ng/l

0.45

634

Inflammatory disease of cervix uteri

209

1833

1.15

1.17

3.2

81.84

81.03

ng/l

0.06

173

1539

Benign neoplasm: Tonsil

250

1.44

1.17

2.9

3.1

75.30

74.92

ng/l

0.02

220

Other and unspecified disease of Bartholin gland

771

1.24

1.17

3.1

3.3

86.73

79.76

ng/l

0.43

660

Pneumoconiosis due to asbestos and other mineral fibres

457

1.31

1.17

3.9

4.6

101.06

116.72

ng/l

0.64

390

MS-disease / Multiple Sclerosis

172

1487

1.17

1.15

2.7

3.7

65.01

79.54

ng/l

2.78

147

1334

Localized scleroderma [morphea]

337

1.37

1.14

5.5

2.8

101.96

73.36

ng/l

1.25

298

Benign neoplasm: Peripheral nerves and autonomic nervous system

337

1.37

1.14

2.0

3.9

71.19

82.35

ng/l

0.64

299

Certain zoonotic bacterial diseases

389

1.34

1.14

3.7

83.64

79.87

ng/l

0.12

344

Gonococcal infection

737

1.24

1.13

3.4

3.2

83.77

76.37

ng/l

0.41

656

Hypertrophy of tongue papillae

261

1.41

1.12

6.2

3.4

98.87

76.65

ng/l

0.54

230

Benign neoplasm: Nasopharynx

194

1.49

1.11

2.4

3.2

74.22

79.14

ng/l

0.19

172

Any dementia

1326

8884

1.06

1.11

2.9

3.6

93.63

99.60

ng/l

1.41

1016

7368

Benign neoplasm of male genital organs

391

1.33

1.10

4.9

5.2

109.88

113.71

ng/l

0.07

345

Peripheral retinal degeneration

722

1.24

1.10

3.7

3.5

85.56

81.82

ng/l

0.24

633

Arthropathy in Crohn disease

186

1.49

1.09

2.2

3.4

83.28

76.75

ng/l

0.11

171

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

970

0.81

1.09

2.8

3.6

68.62

97.88

ng/l

3.40

811

Other and unspecified bullous disorders

203

1.47

1.09

8.3

3.7

168.39

75.15

ng/l

1.34

180

Congenital malformations of uterus and cervix

339

1.35

1.09

4.0

3.5

66.34

71.91

ng/l

0.29

309

Twin gestation

148

1718

0.86

1.09

3.0

3.8

63.64

78.53

ng/l

2.98

138

1556

Benign neoplasm: Floor of mouth

1.87

1.09

4.0

5.0

128.33

86.02

ng/l

0.52

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

178

1554

1.16

1.08

4.4

4.0

86.51

93.11

ng/l

0.52

150

1366

Frontotemporal dementia

122

1.62

1.07

3.2

3.4

85.15

84.46

ng/l

0.02

109

Malignant neoplasm of rectum

220

2478

0.88

1.07

3.2

3.9

96.36

99.47

ng/l

0.17

179

2102

Injury of blood vessels at wrist and hand level

130

1.59

1.06

7.0

3.5

152.65

80.92

ng/l

0.96

122

Operations for atrial fibrillation

333

1.35

1.06

4.0

139.68

92.75

ng/l

1.48

290

Injury of muscle and tendon at ankle and foot level

455

1.29

1.06

3.0

3.9

70.55

80.75

ng/l

0.72

407

Other diseases of spinal cord

653

1.24

1.05

3.2

3.8

81.61

85.00

ng/l

0.13

573

Benign lipomatous neoplasm of of intra-abdominal organs

1.86

1.05

6.1

4.3

86.75

85.99

ng/l

0.01

Malignant neoplasm of oropharynx

316

1.36

1.05

2.8

3.8

84.89

84.05

ng/l

0.02

276

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

228

2559

0.88

1.05

3.0

4.0

93.08

99.67

ng/l

0.44

189

2175

Adenocarcinoma and papilloma adenocarcinoma of rectum

219

2463

0.88

1.04

3.0

4.0

94.23

99.60

ng/l

0.32

181

2097

Oral leukoplakia, including avohilmo

637

1.24

1.04

4.1

3.7

74.38

85.24

ng/l

0.95

563

Other deformities of toe(s)

101

846

1.21

1.03

3.5

94.29

88.89

ng/l

0.25

716

Benign neoplasm: Conjunctiva

755

1.22

1.03

4.0

3.8

84.44

83.49

ng/l

0.04

665

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

273

1.37

1.03

7.1

4.4

125.73

95.64

ng/l

1.01

244

Left hemicolectomy

575

1.26

1.02

4.5

3.8

106.86

91.81

ng/l

0.44

505

Dysplastic lesion of the vagina of unknown severity

0.00

1.02

0.0

4.0

—

87.86

—

Benign neoplasm of other and unspecified female genital organs

142

1227

1.17

1.02

3.2

95.64

78.17

ng/l

1.11

118

1033

Polyhydramnios

800

1.21

1.02

4.5

3.7

80.21

75.59

ng/l

0.18

722

Benign neoplasm: Peripheral nerves and autonomic nervous system

344

1.34

1.02

2.0

3.4

71.19

77.77

ng/l

0.32

304

Gestational [pregnancy-induced] hypertension

627

5839

1.08

1.01

3.9

3.2

81.20

75.38

ng/l

0.93

569

5149

Other disorders of peripheral nervous system

124

1.58

1.01

2.3

3.9

73.83

80.50

ng/l

0.19

108

Abnormal reflex

1.69

1.00

4.3

3.7

119.80

78.01

ng/l

—

LSIL lesion of the vagina

328

1.34

0.99

4.9

3.0

97.88

72.30

ng/l

0.68

295

Alzheimer’s disease (Atypical or mixed)

271

2438

1.12

0.99

2.4

3.2

99.09

100.94

ng/l

0.10

186

1971

Follicular lymphoma

118

1008

1.19

0.98

3.1

3.7

74.40

89.33

ng/l

1.07

871

Carcinoma in situ of breast, intraductal

274

2476

1.12

0.98

2.9

3.2

77.39

80.02

ng/l

0.26

230

2084

Simple and mucopurulent chronic bronchitis

118

1007

1.18

0.98

4.3

4.0

91.58

90.25

ng/l

0.05

863

LeFortI or BSSRO operation

715

0.79

0.98

2.7

3.9

70.72

79.00

ng/l

0.59

648

Myasthenia gravis

382

1.31

0.97

4.0

4.1

98.52

83.79

ng/l

0.34

341

Other congenital malformations of face and neck

533

1.25

0.97

3.7

4.4

82.71

79.63

ng/l

0.09

483

Other acquired deformities of musculoskeletal system and connective tissue

122

1046

1.18

0.97

3.4

3.9

89.13

86.90

ng/l

0.09

103

917

Sequelae of tuberculosis

445

1.28

0.96

3.0

3.7

94.44

96.31

ng/l

0.06

374

Complications following abortion and ectopic and molar pregnancy

112

956

1.19

0.96

2.5

3.2

88.24

77.05

ng/l

0.37

814

Malignant neoplasm of heart, mediastinum and pleura

256

0.65

0.95

2.8

4.2

94.91

91.99

ng/l

0.02

222

Malignant neoplasm of eye, brain and central nervous system

930

0.82

0.95

3.2

4.3

89.69

90.32

ng/l

0.02

823

Alzheimer’s disease (Late onset)

641

5856

0.93

0.94

2.7

3.4

86.38

101.06

ng/l

4.19

497

4764

Divergent concomitant strabismus

194

1722

1.13

0.94

3.8

88.96

80.85

ng/l

0.54

174

1513

Carcinoma in situ of other and unspecified genital organs

456

1.28

0.94

4.1

3.0

92.46

76.77

ng/l

0.84

396

Subarachnoid haemorrhage

303

2758

1.11

0.94

4.6

3.6

99.66

91.02

ng/l

0.81

268

2334

Benign neoplasm: Other and unspecified parts of mouth

811

1.20

0.92

4.3

3.7

99.04

85.64

ng/l

0.99

714

Injury of blood vessels of thorax

1.76

0.92

1.8

3.1

85.76

70.12

ng/l

0.34

Benign neoplasm: Tongue

656

1.22

0.92

4.1

3.7

89.68

85.14

ng/l

0.09

580

Benign neoplasm: Vagina

333

1.32

0.92

3.7

3.1

76.92

78.09

ng/l

0.04

295

Diseases caused by chlamydiae

211

1.40

0.91

4.1

3.5

84.83

72.03

ng/l

0.20

191

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

612

5641

1.07

0.91

3.4

3.1

87.22

83.26

ng/l

0.58

505

4661

Benign neoplasm: Brain, supratentorial

324

1.32

0.91

4.9

3.9

89.72

77.01

ng/l

0.34

289

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

739

1.21

0.91

3.0

3.7

86.76

94.88

ng/l

0.59

630

Mental and behavioural disorders due to cannabinoids

367

1.29

0.91

1.7

5.0

65.95

86.33

ng/l

1.09

343

Other disorders of breast and lactation associated with childbirth

245

1.36

0.91

3.3

3.7

58.68

69.89

ng/l

1.10

221

Endometroid carcinoma of ovary

252

0.66

0.90

3.1

2.7

85.29

74.61

ng/l

0.37

222

Crushing injury of head

2.13

0.90

1.2

3.7

80.50

71.86

ng/l

—

Bus occupant injured in other and unspecified transport accidents

136

1.51

0.90

5.9

2.9

153.50

72.60

ng/l

1.03

120

Other demyelinating diseases of the central nervous system

675

1.21

0.90

4.1

3.8

84.10

79.19

ng/l

0.17

607

Pedestrian injured in collision with car, pick-up truck or van

540

1.24

0.89

5.0

3.9

118.65

83.72

ng/l

0.98

480

Other puerperal infections

139

1213

1.15

0.88

2.5

3.3

62.85

69.54

ng/l

0.84

129

1096

Contact with other hot fluids

586

1.23

0.88

4.3

4.9

74.91

77.07

ng/l

0.11

530

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

250

0.66

0.87

3.1

3.2

85.29

77.83

ng/l

0.24

217

Myocardial infarction, unclassifiable

709

5964

1.06

0.87

5.5

3.7

133.84

101.01

ng/l

9.23

604

4936

Benign neoplasm: Other parts of oropharynx

179

1.43

0.87

3.9

3.8

67.20

82.88

ng/l

0.87

156

Spinal enthesopathy

686

1.20

0.86

4.0

3.3

118.71

99.03

ng/l

0.44

539

Injury of nerves and spinal cord at neck level

461

1.25

0.86

3.3

4.0

67.89

87.51

ng/l

1.30

406

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

122

1059

1.16

0.86

4.0

3.7

95.29

83.30

ng/l

0.69

109

923

Toxic effect of contact with venomous animals

103

884

1.18

0.84

3.5

4.0

75.78

83.16

ng/l

0.59

785

Transient synovitis

155

1.45

0.83

4.9

5.1

64.84

71.18

ng/l

0.24

145

Use of rasagiline

619

1.21

0.83

2.2

3.9

72.89

92.49

ng/l

1.94

536

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

191

1711

1.12

0.82

3.4

3.0

72.99

72.03

ng/l

0.06

170

1521

Parkinson's disease

459

4284

1.08

0.82

2.9

3.8

87.49

98.37

ng/l

1.00

367

3613

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

166

1861

0.88

0.81

3.2

79.67

82.51

ng/l

0.17

144

1549

Generalized epilepsy, strict definition

446

1.25

0.81

3.1

4.8

85.07

72.53

ng/l

0.35

409

Distal bite

771

1.18

0.80

10.2

5.6

64.93

62.33

ng/l

0.20

730

Malignant neoplasm of prostate

1132

6835

1.05

0.80

3.9

4.7

107.24

110.07

ng/l

0.35

948

5947

Cyst of Bartholin Gland

851

1.17

0.80

3.2

3.3

81.08

74.52

ng/l

0.28

744

Complications predominantly related to the puerperium

670

6331

1.06

0.80

2.7

3.4

72.25

76.44

ng/l

0.74

585

5585

All dysplastic lesions of the cervix uteri

582

5465

1.07

0.80

3.7

3.4

77.94

75.85

ng/l

0.21

533

4855

Dissocial personality disorder

234

1.34

0.79

2.9

4.8

75.25

92.56

ng/l

0.53

217

Retained placenta and membranes, without haemorrhage

292

3177

0.91

0.79

2.9

3.3

80.76

77.21

ng/l

0.34

250

2763

Adhesive middle ear disease

305

1.30

0.78

3.6

3.9

109.81

75.64

ng/l

0.65

276

Benign neoplasm: Thymus

1.75

0.78

8.9

4.7

64.00

98.33

ng/l

—

Other congenital malformations of digestive system

1.74

0.77

5.0

4.2

69.11

70.86

ng/l

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

1.70

0.77

2.4

3.8

89.15

68.26

ng/l

0.32

Benign neoplasm: Thymus

1.72

0.77

8.9

3.5

64.00

88.72

ng/l

—

Habit and impulse disorders

244

1.33

0.77

1.8

4.8

79.20

79.36

ng/l

0.00

229

Macular hole

174

1562

1.13

0.77

4.2

3.6

90.08

90.28

ng/l

0.01

143

1319

Chondromalacia

624

1.20

0.76

3.3

4.1

61.42

85.10

ng/l

3.25

567

Benign neoplasm: Lip

469

1.23

0.76

3.3

3.6

76.91

88.12

ng/l

0.76

411

Retinoschisis and retinal cysts

570

1.21

0.76

4.2

3.7

98.46

87.18

ng/l

0.50

503

Conditions involving the integument and temperature regulation of fetus and newborn

2.13

0.75

9.4

8.1

63.60

44.48

ng/l

—

Chronic myeloproliferative disease

317

1.29

0.75

2.1

3.8

80.57

82.13

ng/l

0.04

278

Prophylactic surgery

125

1.47

0.75

3.3

2.9

52.30

66.91

ng/l

1.29

118

Carcinoma in situ of other and unspecified sites

793

1.17

0.74

4.7

4.2

107.49

102.65

ng/l

0.16

685

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

2.08

0.74

2.0

1.7

29.40

65.55

ng/l

—

Intussusception

490

1.22

0.73

3.9

3.8

72.28

79.00

ng/l

0.34

425

Morphin

332

0.74

0.72

3.2

3.5

102.87

89.87

ng/l

0.13

288

Folliculitis decalvans

1.78

0.72

4.6

3.5

81.43

76.76

ng/l

—

Benign neoplasm: Vagina

346

1.27

0.72

3.7

2.9

76.92

75.26

ng/l

0.05

303

HSIL lesion of the cervix uteri, vagina or vulva

449

4209

1.07

0.72

3.9

3.3

85.33

75.78

ng/l

1.25

409

3718

Symptoms and signs involving appearance and behaviour

143

1.43

0.72

3.6

100.83

75.73

ng/l

0.45

128

Antepartum haemorrhage, not elsewhere classified

172

1547

1.12

0.72

2.8

3.8

65.56

78.13

ng/l

1.53

160

1408

Degeneration of the brain due to alcohol

436

1.23

0.72

2.8

4.3

116.22

102.65

ng/l

0.25

391

Other obstetric trauma

923

0.85

0.71

2.9

3.4

73.52

72.42

ng/l

0.04

837

Other diseases caused by chlamydiae

239

1.32

0.71

3.9

3.5

82.92

69.95

ng/l

0.22

214

Non-allergic asthma

251

2305

1.09

0.70

4.4

4.3

95.62

87.71

ng/l

0.65

220

2009

Lichen sclerosus et atrophicus

305

2826

1.09

0.70

3.1

3.2

81.48

81.61

ng/l

0.01

267

2349

Outcome of delivery

318

2128

0.92

0.70

2.7

3.6

58.87

76.13

ng/l

7.02

298

1919

Alcohol abuse counselling and surveillance

262

0.72

0.70

4.0

4.8

112.86

89.37

ng/l

0.25

238

Tuberculosis

186

1686

1.11

0.69

3.5

3.6

90.56

97.74

ng/l

0.62

154

1400

Degeneration of nervous system due to alcohol

438

1.23

0.69

2.8

4.2

116.22

100.43

ng/l

0.30

389

Inflammation of lacrimal passages (acute and unspecified)

402

1.24

0.69

4.8

3.4

108.28

78.69

ng/l

1.32

356

Maxillary prognathism

1.53

0.69

5.2

6.6

70.50

68.55

ng/l

0.05

Endometriosis ASRM stages 3,4

701

6673

1.05

0.68

3.4

3.2

77.95

79.69

ng/l

0.24

585

5695

malignant neoplasm of female genital organs

468

4966

0.94

0.68

3.3

3.0

86.75

82.72

ng/l

0.50

384

4102

Varicose veins of other sites

162

1460

1.12

0.67

3.0

4.2

72.19

91.91

ng/l

2.97

138

1278

Unspecific neurodegenerative disorder

1409

9384

1.04

0.67

2.7

3.6

87.01

100.01

ng/l

6.76

1086

7770

Respiratory tuberculosis, confirmed

395

1.23

0.66

4.6

4.0

95.10

90.98

ng/l

0.11

347

Benign neoplasm: Larynx

681

1.17

0.66

2.9

3.9

82.38

93.84

ng/l

0.65

599

Malignant neoplasm of liver and intrahepatic bile ducts

691

1.17

0.65

3.5

4.2

91.16

103.50

ng/l

0.76

595

Other spirochaetal diseases

764

7302

1.05

0.65

3.0

3.9

72.56

90.03

ng/l

10.95

647

6278

Other and unspecified hydrocephalus

433

1.22

0.65

3.3

3.9

90.98

82.59

ng/l

0.26

387

Malignant neoplasm of vagina

1.69

0.64

7.3

3.4

139.06

75.52

ng/l

—

Sequelae of transport accidents

1.56

0.64

3.6

3.0

84.56

72.06

ng/l

0.57

Frontotemporal dementia, wide, incl. Pick's disease

147

1.40

0.64

3.1

3.6

85.15

86.87

ng/l

0.04

129

Intentional self-harm by hanging, strangulation and suffocation

101

0.58

0.63

2.2

4.8

64.00

95.63

ng/l

—

Contact with and exposure to communicable diseases

708

6728

1.05

0.63

4.1

4.3

75.63

79.90

ng/l

0.65

596

6100

Malignant neoplasm of gum

105

1.48

0.63

1.6

3.6

43.40

80.82

ng/l

—

Occupant of railway train or railway vehicle injured in transport accident

0.00

0.63

0.0

3.2

—

58.09

—

Malignant neoplasm of mesothelium and soft tissue

119

1060

1.13

0.63

3.5

3.8

84.91

96.06

ng/l

0.76

100

909

Oral lichen ruber planus

629

1.18

0.63

3.6

3.3

102.68

79.62

ng/l

0.59

551

Suppurative otitis media, unspecified

498

1.20

0.63

5.8

3.7

95.51

76.98

ng/l

0.46

446

Carcinoma in situ of uteri, other/unspecified

141

0.62

2.3

3.1

48.78

71.95

ng/l

—

125

Other osteochondropathies

162

1469

1.11

0.62

4.1

4.2

93.83

85.83

ng/l

0.65

142

1321

Congenital malformations of eyelid, lacrimal apparatus and orbit

174

1.35

0.61

6.1

7.5

74.28

62.45

ng/l

0.26

163

Other acute disseminated demyelination

174

1.34

0.61

6.7

3.3

89.24

71.04

ng/l

0.37

160

Respiratory tuberculosis, bacteriologically and histologically confirmed

408

1.21

0.61

4.6

3.9

95.10

91.16

ng/l

0.11

357

Glaucoma, exfoliation

360

3378

1.07

0.61

3.1

3.3

93.39

95.50

ng/l

0.13

297

2762

Maternal care for known or suspected malpresentation of fetus

317

2533

0.93

0.61

2.9

3.7

67.13

77.24

ng/l

1.29

289

2312

Abscess of Bartholin gland

528

1.19

0.61

4.1

3.3

73.35

75.01

ng/l

0.07

470

Malignant neoplasm of tonsil

291

1.26

0.60

2.8

3.8

93.45

84.08

ng/l

0.28

254

Bullous keratopathy

202

1.32

0.60

2.9

3.6

71.68

83.25

ng/l

0.53

177

Infectious mononucleosis

148

1338

1.11

0.59

4.0

4.2

68.76

71.56

ng/l

0.24

137

1227

Superficial injury of neck

327

1.24

0.59

3.6

4.7

80.15

78.91

ng/l

0.03

305

Benign neoplasm: Other parts of oropharynx

193

1.32

0.59

3.9

67.20

83.08

ng/l

0.89

175

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

127

1139

1.12

0.59

2.7

3.0

72.66

71.35

ng/l

0.07

118

1025

Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)

115

1.43

0.59

4.6

2.7

138.50

86.99

ng/l

—

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

327

3063

1.07

0.59

3.6

104.82

97.61

ng/l

0.66

288

2529

Noise effects on inner ear

773

1.15

0.58

4.1

5.1

101.09

104.81

ng/l

0.10

689

Contact with blunt object, undetermined intent

115

1.42

0.58

5.5

4.1

76.75

77.90

ng/l

0.02

105

Transient global amnesia

281

2621

1.08

0.58

3.1

3.7

85.78

93.60

ng/l

0.68

236

2209

Drowning and submersion while in natural water

0.55

0.58

2.2

4.0

45.60

90.68

ng/l

—

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

159

1.35

0.57

3.3

4.0

94.33

84.50

ng/l

0.31

138

Unspecified chronic bronchitis

813

1.14

0.56

5.2

3.6

105.20

93.49

ng/l

0.61

696

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

189

2054

0.92

0.56

3.9

3.6

83.99

96.88

ng/l

1.37

159

1713

Hypertrophy of bone

1.54

0.56

2.4

4.4

58.78

82.65

ng/l

—

Dementia due to Parkinson's disease

557

0.83

0.56

2.4

4.0

69.62

101.13

ng/l

2.13

469

Occupant of pick-up truck or van injured in other and unspecified transport accidents

0.59

0.53

5.2

4.5

83.37

79.42

ng/l

—

Carcinoma in situ of cervix uteri, exocervix

135

0.65

0.53

2.9

3.4

61.00

74.46

ng/l

—

130

Poor fetal growth

215

1993

1.08

0.52

4.7

3.3

79.28

74.30

ng/l

0.34

195

1800

Benign neoplasm: Lip

491

1.17

0.52

3.3

4.0

76.91

86.71

ng/l

0.62

438

Cerebral atherosclerosis

251

1.25

0.51

4.9

3.6

95.42

91.05

ng/l

0.10

216

Surgical ablation of atrial fibrillation

108

0.63

0.50

3.9

4.2

122.86

85.12

ng/l

—

Injury of heart

1.58

0.50

3.3

3.9

117.71

83.03

ng/l

—

Respiratory tuberculosis

151

1385

1.10

0.49

3.7

3.6

89.91

96.50

ng/l

0.48

129

1167

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

728

1.14

0.49

4.3

4.5

80.03

79.83

ng/l

0.01

659

Respiratory tuberculosis, confirmed and not-confirmed

151

1386

1.10

0.49

3.7

3.6

89.91

96.58

ng/l

0.49

129

1168

Marfan's syndrome

102

1.40

0.49

3.9

4.2

106.29

84.10

ng/l

0.59

Colorectal adenocarcinoma

543

5671

0.95

0.49

3.4

3.8

100.45

97.36

ng/l

0.30

468

4743

Burn and corrosion of hip and lower limb, except ankle and foot

438

1.17

0.48

2.9

4.0

78.27

80.06

ng/l

0.04

391

Other appendicitis

210

1955

1.08

0.48

5.3

3.9

101.07

87.96

ng/l

0.89

189

1724

Dermatitis due to ingested food

702

1.13

0.48

7.0

7.1

58.11

56.22

ng/l

0.11

670

Congenital malformations of breast

263

1.23

0.48

2.3

3.6

67.33

69.45

ng/l

0.09

240

Malignant neoplasm of oral cavity

778

1.13

0.47

2.5

3.8

66.97

89.76

ng/l

2.94

677

Other/unspecified mastoiditis and related conditions

1.41

0.47

4.4

3.6

111.29

79.39

ng/l

—

Parkinson's disease, strict definition

415

3954

1.05

0.46

2.8

3.8

83.05

98.94

ng/l

3.18

332

3332

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

174

1.28

0.46

2.6

3.5

75.07

79.64

ng/l

0.14

160

Burn and corrosion of head and neck

375

1.18

0.46

2.5

4.5

70.99

82.78

ng/l

0.56

340

Chronic mastoiditis

619

1.14

0.46

3.3

3.8

88.61

89.02

ng/l

0.02

540

Non-small cell lung cancer

410

4303

0.95

0.46

2.8

3.9

80.41

100.72

ng/l

6.90

363

3628

Malignant neoplasm of testis

247

1.23

0.45

7.5

5.0

135.16

95.69

ng/l

1.25

225

Dental caries 2 and operation codes, only avohilmo

2338

14801

0.98

0.45

4.1

4.4

83.44

91.65

ng/l

4.37

2044

12952

Traumatic amputation of hip and thigh

1.68

0.44

30.2

2.7

150.40

70.38

ng/l

—

Carcinoma in situ of cervix uteri, exocervix

126

0.70

0.44

2.9

3.6

61.00

73.83

ng/l

—

117

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

563

4886

0.96

0.44

2.9

3.9

83.04

98.91

ng/l

5.03

485

4089

Malignant neoplasm of other and unspecified male genital organs, excluding all cancers (controls excluding all cancers)

1.62

0.43

6.8

5.1

87.58

109.31

ng/l

—

Guttate psoriasis

267

1.21

0.43

5.2

3.6

131.92

76.08

ng/l

1.13

242

Follicular lymphoma, hilmo

118

1081

1.10

0.43

3.1

3.8

74.40

89.48

ng/l

1.07

932

Oral lichen ruber planus, including avohilmo

166

1543

1.08

0.43

3.0

3.6

89.96

83.59

ng/l

0.27

138

1323

Leprosy [Hansen's disease]

0.00

0.42

0.0

2.2

—

57.34

—

Deep endometriosis

245

2597

0.94

0.41

2.8

3.2

76.07

79.25

ng/l

0.24

189

2180

Perforation of oesophagus

1.39

0.41

3.1

3.6

102.50

82.08

ng/l

0.32

Ectopic pregnancy

467

4480

1.05

0.41

3.0

3.4

73.82

78.29

ng/l

0.82

408

3927

Carcinoma in situ, bladder

740

1.12

0.40

4.7

4.1

112.11

101.82

ng/l

0.36

641

Use of ropinirole

893

1.11

0.40

2.4

3.9

89.68

93.19

ng/l

0.13

778

Alzheimer disease, including avohilmo

1175

8264

1.03

0.40

2.7

3.5

89.10

100.12

ng/l

4.25

932

6793

Other specified/unspecified disorders of tympanic membrane

1.41

0.40

10.7

4.2

111.18

82.62

ng/l

0.23

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

172

1606

1.08

0.39

3.9

4.0

110.09

89.99

ng/l

1.25

149

1375

Other fibroblastic disorders

1.42

0.38

6.3

2.6

109.90

71.13

ng/l

—

Cholesteatoma of middle ear

141

1311

1.08

0.37

3.9

3.8

95.51

92.24

ng/l

0.17

118

1126

Use of donepezil

586

5832

0.96

0.37

2.7

3.4

88.55

98.28

ng/l

2.44

435

4756

Dementia due to Parkinsons disease, excluding more controls

412

1.15

0.37

2.4

3.4

69.62

97.42

ng/l

1.69

349

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

543

5239

1.04

0.37

3.4

3.8

100.45

98.24

ng/l

0.20

468

4383

Contact with machinery

241

2283

1.06

0.36

4.6

4.7

99.08

104.37

ng/l

0.35

213

2035

Pedal cyclist injured in collision with motor vehicle

618

0.88

0.36

1.8

4.0

86.01

82.44

ng/l

0.11

552

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

451

1.14

0.36

3.2

3.5

63.88

85.04

ng/l

1.66

400

Carcinoma in situ of uteri, other/unspecified

125

0.71

0.36

2.3

3.4

48.78

76.22

ng/l

—

108

Anisometropia and aniseikonia

708

1.11

0.36

4.9

4.0

107.30

78.50

ng/l

0.57

628

Malignant neoplasm of stomach

130

1208

1.08

0.36

4.1

3.8

95.40

97.06

ng/l

0.07

114

1019

Fibrosarcoma

167

0.77

0.35

4.2

3.6

100.83

83.63

ng/l

0.38

152

Cyst of spleen

1.40

0.35

7.7

4.2

62.17

76.72

ng/l

—

Lyme disease

744

7227

1.03

0.35

2.9

3.9

71.88

90.19

ng/l

11.76

630

6212

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

576

1.12

0.35

6.0

3.1

108.11

79.11

ng/l

1.18

508

Foreign body on external eye

316

3020

1.05

0.35

4.2

4.8

92.56

99.89

ng/l

0.63

284

2723

Evidence of alcohol involvement determined by level of intoxication

163

1.24

0.34

6.6

4.2

83.92

78.38

ng/l

0.10

150

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

191

1.22

0.34

2.7

4.1

69.39

86.61

ng/l

0.82

168

L02BB Anti-androgens

217

2055

1.06

0.34

3.2

4.5

108.17

111.03

ng/l

0.15

191

1762

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

293

1.17

0.34

4.4

3.7

103.39

77.67

ng/l

0.68

261

Congenital musculoskeletal deformities of head, face, spine and chest

228

1.20

0.34

8.6

5.5

68.11

67.48

ng/l

0.02

218

Other/unspecified postprocedural disorders of ear and mastoid process

1.39

0.34

3.0

3.4

75.70

85.60

ng/l

—

Contact with other sharp object(s)

128

1193

1.08

0.33

4.6

78.36

84.07

ng/l

0.40

111

1079

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

191

1805

1.06

0.33

3.4

3.3

72.99

74.10

ng/l

0.08

170

1596

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

550

1.12

0.33

2.9

3.6

65.53

88.26

ng/l

2.12

485

Endometriosis of rectovaginal septum and vagina

220

2089

1.06

0.32

2.9

3.1

77.78

81.89

ng/l

0.30

168

1786

Horner syndrome

258

1.17

0.32

5.4

3.6

72.09

79.80

ng/l

0.23

230

Pregnancy examination and test

329

1968

1.05

0.31

2.8

3.6

67.21

74.77

ng/l

1.10

298

1769

Unspecified maternal hypertension

186

0.80

0.31

2.5

3.3

67.65

65.03

ng/l

0.10

174

Malignant neoplasm, without specification of site

694

0.90

0.31

3.1

3.7

81.96

99.36

ng/l

0.92

590

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

1016

0.92

0.31

2.9

4.2

87.68

90.21

ng/l

0.08

896

HSIL lesion of the cervix uteri

377

3633

1.04

0.30

3.8

3.3

80.41

75.04

ng/l

0.49

347

3250

Maternal care for other known or suspected fetal problems

444

2948

0.96

0.30

3.3

3.7

71.37

75.69

ng/l

0.44

400

2690

Endometriosis diagnosis and infertility diagnosis occurring together

210

2206

0.95

0.29

2.5

3.3

65.11

74.15

ng/l

1.58

191

1962

Other disorders of amniotic fluid and membranes

235

2439

0.95

0.29

2.9

3.7

66.68

78.47

ng/l

1.92

198

2213

Puerperal sepsis

374

3608

1.04

0.29

2.6

3.3

77.55

78.09

ng/l

0.04

312

3145

Malignant neoplasm of colon

434

4199

1.04

0.29

3.7

102.16

95.88

ng/l

0.65

381

3518

Unspecified multiple injuries

1.29

0.28

3.6

4.6

82.88

87.47

ng/l

—

Congenital hydrocephalus

1.29

0.28

3.9

29.88

66.02

ng/l

—

Acute myringitis

131

1.24

0.28

9.4

4.2

92.44

72.60

ng/l

0.62

120

Optic neuritis

837

1.08

0.27

3.9

3.7

81.03

78.97

ng/l

0.09

749

Malignant neoplasm of digestive organs

1172

11749

0.98

0.26

3.6

3.8

95.43

97.27

ng/l

0.28

1015

9887

Abnormal findings on antenatal screening of mother

122

1148

1.06

0.26

2.5

3.4

67.61

71.47

ng/l

0.23

110

1051

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

301

3121

0.96

0.26

3.3

3.8

91.86

97.28

ng/l

0.46

254

2619

Complications of the puerperium, not elsewhere classified

696

0.92

0.26

3.4

3.3

72.01

71.01

ng/l

0.05

633

Mandibular retrognathia

139

1312

1.06

0.25

5.8

4.7

71.20

74.21

ng/l

0.21

122

1203

Use of rivastigmine

407

4185

0.97

0.25

2.5

3.3

79.68

97.78

ng/l

4.93

330

3392

Other and unspecified degenerative diseases of nervous system

522

1.10

0.25

3.4

3.7

103.12

93.28

ng/l

0.31

453

Contact with nonpowered hand tool

813

1.07

0.24

5.0

4.5

84.77

91.42

ng/l

0.30

734

Perichondritis of external ear

418

1.11

0.24

3.8

3.7

98.60

85.85

ng/l

0.39

369

Otosclerosis

214

2054

1.05

0.24

3.8

3.9

94.48

90.93

ng/l

0.18

180

1762

Alzheimer disease

958

7356

0.98

0.23

2.7

3.4

90.90

99.51

ng/l

2.09

735

6027

Carcinoma in situ of other/unspecified female genital organs

0.00

0.22

0.0

1.5

—

66.20

—

Carcinoma in situ of cervix uteri

167

1597

1.05

0.22

3.3

81.96

77.19

ng/l

0.25

151

1394

Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)

135

1.20

0.22

3.6

3.5

65.19

80.03

ng/l

0.72

119

Crushing injury of thorax and traumatic amputation of part of thorax

0.00

0.22

0.0

7.9

—

94.45

—

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

158

1510

1.05

0.22

2.6

3.6

83.61

95.03

ng/l

1.23

144

1256

Fibrosarcoma, excluding all cancers (controls excluding all cancers)

188

0.84

0.22

3.9

4.0

89.42

81.00

ng/l

0.19

170

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

1.20

0.22

2.0

6.3

65.20

89.55

ng/l

—

Unspecified dementia

313

2735

1.03

0.21

3.0

3.4

96.85

104.00

ng/l

0.59

236

2260

Labour and delivery complicated by umbilical cord complications

108

1022

1.06

0.21

2.4

3.3

67.34

73.54

ng/l

0.44

912

Myiasis

0.00

0.21

0.0

2.8

—

70.62

—

Family history of mental and behavioural disorders

1.30

0.21

9.5

3.0

80.33

60.63

ng/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

239

2474

0.96

0.21

3.1

3.8

93.04

97.28

ng/l

0.27

200

2074

Migraine without aura, drug-induced

219

0.86

0.21

5.0

3.4

131.78

73.40

ng/l

0.85

194

Labyrinthine dysfunction

0.00

0.20

0.0

4.0

—

87.41

—

Inhalation of gastric contents

1.24

0.20

4.8

5.3

74.00

101.47

ng/l

—

Mechanical strabismus

1.22

0.20

1.3

3.0

35.33

70.80

ng/l

—

Occupational exposure to risk-factors

684

1.07

0.20

3.7

4.4

81.52

94.99

ng/l

0.84

612

Systemic atrophies primarily affecting the central nervous system

102

967

1.06

0.20

4.5

4.1

96.98

93.09

ng/l

0.15

838

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

409

1.10

0.19

11.9

9.7

59.89

50.13

ng/l

0.54

404

Dental caries 1 and operation codes, only avohilmo

1013

5174

0.98

0.19

3.9

5.4

85.53

99.71

ng/l

4.64

883

4560

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

110

1046

1.06

0.19

3.2

3.8

86.35

99.84

ng/l

1.25

100

888

Degenerative diseases of the nervous system

1107

8210

1.02

0.19

2.8

3.6

91.83

100.54

ng/l

2.30

859

6770

Malignant neoplasm of corpus uteri

256

2640

0.97

0.19

3.1

3.0

89.55

84.60

ng/l

0.44

203

2155

Respiratory tuberculosis, not confirmed

109

1037

1.05

0.19

3.2

3.6

85.46

98.10

ng/l

1.14

874

Benign neoplasm: Rectum/anal canal icd-9

213

1.14

0.19

5.2

3.4

138.41

88.34

ng/l

1.02

178

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

310

3017

1.03

0.18

3.4

3.1

92.63

84.56

ng/l

0.95

247

2483

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

476

4659

1.02

0.18

3.1

3.8

90.40

94.35

ng/l

0.36

407

3924

Mumps

542

1.07

0.18

3.4

4.0

79.17

81.49

ng/l

0.08

488

Other acantholytic disorders

1.14

0.18

1.7

4.5

92.86

90.94

ng/l

—

Carcinoma in situ of breast, other/unspecified

378

1.09

0.17

2.2

3.1

63.76

79.57

ng/l

0.98

329

Maxillary hypoplasia

0.75

0.17

1.2

4.9

65.40

61.66

ng/l

—

Exposure to ignition of highly flammable material

0.73

0.17

2.0

4.0

129.00

75.90

ng/l

—

Mucinous and mucinous cystic tumor

101

1.20

0.17

1.8

2.4

66.83

69.88

ng/l

0.10

Hydrocephalus

200

2065

0.97

0.17

3.2

3.6

76.34

91.59

ng/l

2.50

171

1725

Oher contracture of tendon (sheath)

1.15

0.16

6.4

4.4

95.50

88.25

ng/l

—

Beningn neoplasm: Meninges, unspecified

389

1.09

0.16

3.4

3.5

79.70

82.05

ng/l

0.06

341

Polypectomy (DHB20)

145

1505

0.96

0.16

4.3

4.4

98.58

97.57

ng/l

0.05

134

1334

N06DA Anticholinesterases

1069

8541

1.01

0.16

2.7

3.5

85.03

100.52

ng/l

7.80

821

7034

Use of anticholinesterases

1069

8541

1.01

0.16

2.7

3.5

85.03

100.52

ng/l

7.80

821

7034

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

1.15

0.15

8.1

4.6

128.18

88.24

ng/l

—

Universal erythroderma, KELA reimbursement

274

1.10

0.15

4.6

3.9

79.26

84.09

ng/l

0.16

243

Foreign body in genitourinary tract

178

1.13

0.15

2.9

4.0

61.60

80.52

ng/l

1.09

165

Colorectal neuroendocrine tumor and carcinoma

313

1.09

0.15

4.4

3.5

103.39

79.24

ng/l

0.62

279

Other maternal disorders predominantly related to pregnancy

1717

10688

1.01

0.15

3.5

3.3

80.31

76.85

ng/l

0.88

1512

9310

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

410

3787

1.02

0.15

2.8

3.8

80.41

99.68

ng/l

6.29

363

3159

Benign neoplasm: Rectum/anal canal icd-9

217

1.11

0.15

5.2

3.5

138.41

87.65

ng/l

1.05

190

Prolapse and hernia of ovary and fallopian tube

130

1241

1.04

0.14

3.1

2.7

82.83

87.07

ng/l

0.28

104

973

Other disorders following mastoidectomy

103

1.18

0.14

3.5

3.6

85.83

91.43

ng/l

0.12

Pedal cyclist injured in collision with pedestrian or animal

122

1.16

0.14

5.7

3.4

113.31

69.83

ng/l

0.96

114

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

735

0.95

0.13

3.8

4.0

104.21

97.82

ng/l

0.20

645

Major anomalies of jaw size

551

0.94

0.13

2.9

4.5

75.09

76.42

ng/l

0.04

503

Gestational diabetes (for exclusion)

752

5392

0.99

0.13

3.5

73.77

73.58

ng/l

0.02

680

4897

Abnormalities of forces of labour

230

2244

1.03

0.13

3.3

3.5

71.70

77.94

ng/l

0.85

207

2024

Use of selegiline

112

1161

0.96

0.13

2.5

3.8

70.17

96.33

ng/l

4.66

992

Arthropod-borne viral fevers and viral haemorrhagic fevers

229

2235

1.03

0.13

3.8

4.1

93.94

92.69

ng/l

0.05

204

1968

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1389

10811

1.01

0.13

3.5

3.3

77.79

77.95

ng/l

0.02

1266

9397

Maternal care for known or suspected disproportion

816

1.04

0.12

2.8

3.5

75.59

75.48

ng/l

0.00

740

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

561

1.05

0.12

4.3

3.4

109.45

92.28

ng/l

0.52

475

Undefined dementia

315

2952

0.98

0.12

3.1

3.2

97.69

99.49

ng/l

0.11

236

2391

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

677

5607

1.01

0.11

3.1

4.0

83.16

98.61

ng/l

4.76

584

4705

Use of levodopa decarbox-comt-inhibitor

771

0.96

0.11

2.6

3.9

84.12

95.64

ng/l

0.89

662

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

233

2379

0.98

0.11

3.2

3.8

93.65

97.05

ng/l

0.20

195

1994

Viral haemorrhagic fevers, not elsewhere classified/unspecified

175

1794

0.97

0.11

3.7

4.1

91.57

91.96

ng/l

0.01

153

1583

Lesion of sciatic nerve

123

1194

1.03

0.11

3.4

3.5

100.69

97.50

ng/l

0.09

109

993

Carcinoma in situ of cervix uteri

167

1712

0.97

0.10

3.3

3.2

81.96

74.41

ng/l

0.45

151

1510

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

433

0.94

0.10

2.4

3.6

58.76

89.30

ng/l

4.65

373

Exposure to excessive natural heat

1.17

0.10

8.4

4.6

136.00

82.17

ng/l

—

Other congenital malformations of ear

183

1.10

0.10

4.5

6.0

59.80

63.75

ng/l

0.16

168

Obstructed labour due to maternal pelvic abnormality

434

4400

0.99

0.10

3.4

74.41

79.47

ng/l

0.92

390

3817

Malignant neoplasm of tongue

428

1.06

0.09

2.8

3.9

69.23

87.64

ng/l

1.08

378

Intrahepatic Cholestasis of Pregnancy (ICP)

127

1237

1.03

0.09

2.7

3.2

72.66

71.55

ng/l

0.06

118

1114

Benign neoplasm: Cranial nerves

675

1.04

0.09

4.2

3.6

91.11

87.09

ng/l

0.12

587

Colon adenocarcinoma

327

3318

0.98

0.09

3.6

104.82

96.57

ng/l

0.79

288

2784

Unattended death

165

0.90

0.09

1.9

4.2

63.13

91.58

ng/l

—

148

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

165

1.10

0.09

3.6

4.2

57.37

77.42

ng/l

1.00

145

Use of memantine

801

6909

1.01

0.09

2.2

3.5

85.23

101.22

ng/l

6.22

603

5647

Use of other anti-dementia drugs

801

6909

1.01

0.09

2.2

3.5

85.23

101.22

ng/l

6.22

603

5647

Benign neoplasm: Lymph nodes

1.08

0.09

3.5

2.5

124.83

76.16

ng/l

—

Motorcycle rider injured in other and unspecified transport accidents

928

0.97

0.09

4.5

5.2

85.44

84.95

ng/l

0.02

845

Other abnormal products of conception

711

4691

1.01

0.08

3.3

3.6

71.51

75.42

ng/l

0.69

647

4239

Other obstructed labour

181

1777

1.02

0.08

2.9

3.4

78.47

75.83

ng/l

0.15

158

1562

Benign neoplasm: Testis

0.84

0.08

7.5

4.8

62.48

89.21

ng/l

—

Erosion and ectropion of cervix uteri

757

1.03

0.07

3.4

3.3

79.12

82.34

ng/l

0.15

643

Dental caries 3 and operation codes, only avohilmo

1167

5900

0.99

0.07

3.9

5.3

84.64

97.35

ng/l

4.50

1017

5210

Idiopathic peripheral autonomic neuropathy

0.86

0.07

1.9

4.4

63.29

87.15

ng/l

—

Benign neoplasm: Lower jaw bone

0.86

0.07

4.4

109.57

77.14

ng/l

—

Benign neoplasm: Lower jaw bone

0.83

0.07

4.4

4.0

109.57

73.74

ng/l

—

Vascular dementia (sudden onset)

0.85

0.07

3.0

3.2

81.57

94.10

ng/l

—

Hypertrophy of (infrapatellar) fat pad

196

1.08

0.07

2.8

4.3

78.37

79.62

ng/l

0.03

182

Mandibular prognathia AND surgery (LeFortI or BSSRO)

1.09

0.07

2.2

3.7

68.11

69.24

ng/l

—

Rubella [German measles]

531

1.04

0.07

5.5

4.6

112.88

95.29

ng/l

0.58

496

Postpartum haemorrhage due to anatomy

140

1427

0.98

0.06

3.1

3.0

60.66

70.69

ng/l

1.42

130

1308

Communicating hydrocephalus

522

1.04

0.06

4.1

3.8

85.31

83.50

ng/l

0.06

456

Acquired stenosis of external ear canal

187

1.07

0.06

5.1

4.1

132.38

85.34

ng/l

0.69

173

Desensitization to allergens

912

0.97

0.06

2.9

4.7

62.54

73.16

ng/l

1.24

834

Maternal care for known or suspected fetal abnormality and damage

278

2502

0.99

0.06

2.7

3.7

64.01

78.63

ng/l

4.67

261

2282

Beningn neoplasm: Meninges, unspecified

405

1.04

0.05

3.4

3.2

79.70

78.34

ng/l

0.03

359

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

334

0.96

0.05

2.3

3.9

80.06

97.98

ng/l

0.47

292

Malaria

100

1.11

0.05

3.5

4.1

100.36

81.71

ng/l

0.17

128

1297

0.98

0.05

4.2

3.2

94.17

94.37

ng/l

0.01

108

1049

Use of interferon beta-1a

416

1.04

0.05

4.1

3.8

77.39

78.28

ng/l

0.02

387

Adenocarcinoma and papillary adenocarcinoma of stomach

605

0.97

0.04

4.3

4.0

109.45

98.23

ng/l

0.30

529

Vascular dementia (multiple infarctions)

251

0.95

0.04

2.3

3.8

113.19

103.96

ng/l

0.14

218

Spontaneous abortion

1357

9196

1.00

0.04

3.4

3.3

76.49

78.39

ng/l

0.34

1190

7978

Left side

111

1.09

0.04

3.1

3.9

99.00

82.21

ng/l

—

Squamous cell neoplasms and carcinoma of cervix

129

0.93

0.03

10.2

2.9

107.33

75.91

ng/l

0.42

116

Use of amantadine

359

1.03

0.03

3.8

3.1

66.36

75.00

ng/l

0.78

314

Leukaemia of unspecified cell type

179

0.95

0.03

2.8

4.2

93.31

82.23

ng/l

0.38

157

Supervision of high-risk pregnancy

455

2765

0.99

0.03

3.1

3.6

68.23

76.99

ng/l

1.55

425

2496

Traumatic amputation of wrist and hand

872

0.99

0.02

3.4

4.9

88.30

101.41

ng/l

0.46

779

Other bursitis of knee

269

0.96

0.02

3.3

4.3

72.31

89.10

ng/l

0.90

244

Malignant neoplasm of other and unspecified parts of biliary tract

279

0.97

0.02

2.3

3.9

66.15

85.71

ng/l

1.45

248

Early lumbar disc prolapse operation

184

1826

1.01

0.02

4.0

4.1

84.68

83.58

ng/l

0.04

173

1661

Failed induction of labour

859

1.01

0.02

3.0

3.5

62.96

75.77

ng/l

1.05

777

Non-small cell lung cancer, adenocarcinoma, helper endpoint

158

1592

0.99

0.02

2.6

3.9

83.61

96.58

ng/l

1.43

144

1357

Non-small cell lung cancer, adenocarcinoma

158

1592

0.99

0.02

2.6

3.9

83.61

96.58

ng/l

1.43

144

1357

Benign neoplasm: Connective and other soft tissue, unspecified

258

0.97

0.02

3.3

3.6

87.96

77.63

ng/l

0.35

230

Vaginal lichen planus

107

0.93

0.02

4.6

2.5

106.00

69.54

ng/l

—

Medical treatment for female infertility

384

3845

1.00

0.02

3.0

3.4

75.36

73.13

ng/l

0.09

351

3507

Other menopausal disorders

870

5003

1.00

0.02

2.7

3.3

72.24

81.19

ng/l

3.33

751

4349

Pterygium

679

0.99

0.01

2.6

3.9

97.10

96.84

ng/l

0.01

594

Colorectal cancer

683

6845

1.00

0.01

3.5

3.8

98.61

96.80

ng/l

0.18

588

5736

Maternal care for cervical incompetence

959

0.99

0.01

2.7

3.3

87.41

78.23

ng/l

0.29

831

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

109

1080

1.01

0.01

3.8

3.4

83.37

93.07

ng/l

0.60

903

Benign neoplasm: Connective and other soft tissue, unspecified

243

1.03

0.01

3.3

3.5

87.96

78.79

ng/l

0.31

214

Use of dimethyl fumarate

126

0.95

0.00

3.4

3.6

72.00

74.24

ng/l

0.05

118

Use of galantamine

194

1945

1.00

0.00

2.7

3.3

85.32

99.26

ng/l

1.17

153

1574

Leukaemia of unspecified cell type

172

0.99

0.00

2.8

4.1

93.31

77.39

ng/l

0.65

150

Carcinoma in situ of breast, other/unspecified

407

1.01

0.00

2.2

2.9

63.76

76.36

ng/l

0.72

357

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1701

13873

1.00

0.00

3.6

82.96

84.78

ng/l

0.33

1502

12067

Benign neoplasm: Cranial nerves

697

1.00

0.00

4.2

3.5

91.11

84.55

ng/l

0.20

612

Postprocedural disorders of ear and mastoid process, not elsewhere classified

207

1.02

0.00

3.1

3.5

96.33

85.71

ng/l

0.27

183

Squamous cell neoplasms and carcinoma of cervix, excluding all cancers (controls excluding all cancers)

116

1.04

0.00

10.2

3.0

107.33

76.69

ng/l

0.41

101

Congenital malformations of oesophagus

102

0.98

0.00

4.8

4.7

65.20

66.20

ng/l

—

Carcinoma in situ of other/unspecified female genital organs

0.00

0.0

1.0

—

52.83

—

Carcinoma in situ of other/unspecified digestive organs

0.00

0.0

2.5

—

39.67

—

Disorders of plasma-protein metabolism, not elsewhere classified, drug-induced

0.00

0.0

1.4

—

46.74

—

Anthrax

0.00

0.0

4.6

—

117.40

—

Total (external) ophthalmoplegia

0.00

0.0

1.6

—

47.50

—

Carcinoma in situ of other and unspecified parts of intestine

0.00

0.0

3.0

—

60.94

—

Deficiency of vitamin E

0.00

0.0

3.4

—

69.71

—

Carcinoma in situ of other/unspecified digestive organs

0.00

0.0

2.8

—

55.88

—

Hip and thigh

0.87

0.00

8.8

4.4

82.20

79.95

ng/l

—

Other congenital infectious and parasitic diseases

0.00

0.0

14.0

—

40.60

—

Other transitory neonatal endocrine disorders

0.00

0.0

8.7

—

36.71

—

Alcohol-induced pseudo-Cushing syndrome

0.00

0.0

4.6

—

93.80

—

Carcinoma in situ of other/unspecified male genital organs

0.00

0.0

8.9

—

123.71

—

Infantile papular acrodermatitis [Gianotti-Crosti]

0.00

0.0

4.6

—

36.00

—

Carcinoma in situ of other/unspecified male genital organs

0.00

0.0

10.0

—

111.25

—

Malignant neoplasm of penis

0.97

0.00

8.7

5.6

166.00

102.59

ng/l

—

Congenital malformation of vitreous humour

0.00

0.0

3.5

—

63.33

—

Benign neoplasm: Lymph nodes

1.02

0.00

3.5

2.8

124.83

76.84

ng/l

—

Carcoma in situ of toher and unspecified parts of intestine

0.00

0.0

3.4

—

72.20

—

Contact urticaria

0.95

0.00

2.5

2.4

61.33

65.52

ng/l

—

Toxic effect of soaps and detergents

0.00

0.0

5.6

—

41.00

—

Hereditary angioödema type 2

0.00

0.0

1.1

—

105.53

—

Unspecified effects of radiation

0.00

0.0

1.8

—

58.40

—

Rheumatic fever without mention of heart involvement

0.98

0.00

2.7

5.0

98.08

79.60

ng/l

—

Hereditary factor XI deficiency

0.00

0.0

3.7

—

82.83

—

Crushing injury of shoulder and upper arm

0.00

0.0

5.6

—

72.29

—

Diving or jumping into water causing injury other than drowning or submersion

0.96

0.00

2.4

5.1

71.50

79.94

ng/l

—

Benign neoplasm: Testis

0.88

0.00

7.5

4.1

62.48

85.89

ng/l

—

Recurrent cholesteatoma of postmastoidectomy cavity

1.02

0.00

5.7

4.0

135.00

86.33

ng/l

—

Acquired epidermolysis bullosa

0.00

0.0

4.4

—

60.43

—

Gangrene and necrosis of lung

0.00

0.0

7.8

—

106.33

—

Malignant neoplasm of placenta

0.00

0.0

1.6

—

120.71

—

Sequelae of complication of pregnancy, childbirth and the puerperium

0.00

0.0

3.2

—

56.00

—

Fetus and newborn affected by maternal use of alcohol

0.00

0.0

7.4

—

32.41

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Parathyrin.intact [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS